Efficient synthetic receptors for endotoxin detection using molecular imprinting by Huckle, Danielle Louise
 
 
Efficient Synthetic Receptors 
for Endotoxin Detection 
using Molecular Imprinting 
 
 
Thesis presented for the degree of 
Doctor of Philosophy 
 
 
March 2019 
 
 
Danielle Louise Huckle 
 
Institute of Infection and Immunity 
Cardiff University 
 
 i 
 
Declaration 
This work has not been submitted in substance for any other degree or 
award at this or any other university or place of learning, nor is being 
submitted concurrently in candidature for any degree or other award. 
 
Signed                                                      (candidate)       Date ………………………… 
 
STATEMENT 1 
This thesis is being submitted in partial fulfillment of the requirements for 
the degree of …PhD… 
 
 
Signed                                                   (candidate)       Date ………………………… 
 
STATEMENT 2 
This thesis is the result of my own independent work/investigation, except 
where otherwise stated. 
Other sources are acknowledged by explicit references.  The views 
expressed are my own. 
 
 
Signed                                                    (candidate)       Date ………………………… 
 ii 
 
STATEMENT 3 
I hereby give consent for my thesis, if accepted, to be available for 
photocopying and for inter-library loan, and for the title and summary to 
be made available to outside organisations. 
 
 
Signed                                              (candidate)       Date ………………………… 
 
STATEMENT 4: PREVIOUSLY APPROVED BAR ON ACCESS 
I hereby give consent for my thesis, if accepted, to be available for 
photocopying and for inter-library loans after expiry of a bar on access 
previously approved by the Academic Standards & Quality Committee.  
 
 
Signed                                             (candidate)       Date ………………………… 
 
 
Final word count: 35,382 (59,082 including prelim pages, refs, captions, 
contents)  
 iii 
 
Dedication 
This thesis is dedicated to my husband Ed. 
Nothing I have done during the course of this work would have been 
possible without you. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
 
Acknowledgements 
Interminable thanks to my initial supervisor team Professor Judith Hall, Dr. 
Chris Allender and Dr. Jenna Bowen. Vast gratitude is also extended for the 
invaluable help provided by Professor Adrian Porch who kindly came on 
board at a later stage. 
Many thanks to fellow MRRU lab members Dr. Nick Williams and Dr. Vibha 
Tamboli; I’m confident we will all remain in touch and enjoy good meals 
over the coming years. Thanks to Dr. Erica Loizidou with organic chemistry 
help for work in chapter three. 
Members of the Centre for High Frequency Engineering, Cardiff School of 
Engineering were incredibly patient, knowledgeable and helpful. Thanks 
are extended to Dr. Nick Clark, Dr. Jerome Cuena, Nick Inoue, Professor 
David Barrow and Professor Adrian Porch. Thanks also to Professor Philip 
Davies from Cardiff University School of Chemistry for use of equipment 
during the course of this work. 
Thanks are also extended to the Welsh Deanery and the Royal College of 
Anaesthetists. It is the flexibility you granted me in my anaesthesia training 
programme that ultimately afforded me the opportunity to undertake a 
PhD. As an NHS consultant, I would also like to extend thanks to my 
anaesthesia department and especially Dr. Anthony Turley, Dr. Abraham 
Theron and Dr. Caryl Taylor for understanding the challenges associated 
with completion of this work. 
Finally thanks to my family for support and encouragement over the years 
(especially my cousin Duncan for invaluable help with chapter four). Ed- 
the dedication is enough; you were more than vital to proceedings. 
 
 v 
 
Presentations and publications 
Work from this thesis has been presented at the following national 
conferences: 
Jan 2019: Association of Anaesthetists of Great Britain and Ireland, Winter 
Scientific Meeting, London UK 
April 2017:  Anaesthetic Research Society, Spring Scientific Meeting, 
London UK 
Jan 2017: Association of Anaesthetists of Great Britain and Ireland, Winter 
Scientific Meeting, London UK 
March 2014: Society of Anaesthetists in Wales, Spring Scientific Meeting, 
Brecon, Wales UK 
August 2013: Graduate Student Symposium on Molecularly Imprinted 
Polymers, Belfast, Ireland  
Oct 2013: Anaesthetic Research Society, Winter Scientific Meeting, London 
UK 
Work from this thesis has been presented at the following international 
conferences: 
June 2017: Euroanaesthesia, Geneva, Switzerland 
May 2015:  4th International Conference on Bio-sensing Technology, Lisbon, 
Portugal 
Conference abstract publications: 
Huckle D, Bowen J, Allender C, Hall J. Novel approaches to biosensor 
development for endotoxin detection: e-Supplement of the European 
Journal of Anaesthesiology, Volume 34, Supplement 55, June 2017 
Huckle D, Loizidou E, et al. Structure manipulation of polymyxin B and 
subsequent integration into polymer capable of endotoxin detection and 
sequestration. Anaesthesia. 2015; 70 (Supp S4).  
Huckle D, Hall J, Bowen J, Allender C, Cuenca J, Porch A. Towards an 
efficient biosensor for the detection of lipopolysaccharide in sepsis using 
molecularly imprinted polymers. BJA. 2014 Jan; 112 (1): 199.  
  
 vi 
 
Summary 
Sepsis remains a poorly understood and potentially devastating medical 
syndrome. Unlike other medical emergencies there is no definitive, 
measureable biomarker. Lipopolysaccharide (LPS) is widely implicated in 
the pathogenesis of sepsis. It is not routinely measured owing to a lack of 
reliable diagnostic assay.  
Molecular imprinting is a novel approach to LPS detection. It describes the 
generation of synthetic, polymeric receptors through the polymerisation of 
monomers around a template molecule. The resultant polymers possess 
recognition properties akin to an antibody with the ability to recognise the 
original target molecule. LPS is not a suitable template for conventional 
molecular imprinting techniques, therefore, techniques that circumvent 
problems associated with the imprinting of biological macromolecules are 
needed. Modified approaches that localise the template at a surface via 
chemical immobilisation at a solid-solvent interface (surface imprinting on 
a solid support) or via self-assembly at a solvent-solvent interface 
(microfluidic techniques plus microwave-assisted polymerisation) have 
been investigated. Polymyxin B (PMB), a peptide antibiotic, has high 
affinity for LPS and was utilised in this study to help localise LPS at an 
interface under a variety of experimental conditions; including the 
synthesis of a polymerisable PMB (p-PMB). 
A synthesised p-PMB polymer was subsequently found able to bind LPS 
from solution with an apparent Kd of 0.327 µM. Furthermore, using a 
bespoke microfluidic/microwave hybrid system, with benzethonium 
chloride (BC) used as a LPS surrogate, BC imprinted polymer beads were 
produced. Subsequent binding experiments demonstrated ability of the 
imprinted bead to bind to the original template with a Bmax of 0.014 
nmol/mg and an apparent Kd of 0.536 µM. 
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1.1 General overview 
1.1.1 Background 
Sepsis, the overwhelming result of severe infection, is a leading cause of 
mortality globally (1,2). It remains a poorly understood and potentially 
devastating medical syndrome and, unlike other medical emergencies, 
there is no definitive collection of diagnostic parameters, including 
measureable biomarker. Lipopolysaccharide (LPS) is widely implicated in 
the pathogenesis of significant physiological disturbance in sepsis (3–6). It 
is not currently routinely measured owing to a lack of reliable diagnostic 
assay. The overarching aim of this work therefore was the synthesis of an 
efficient biosensor for the detection of LPS. Each experimental chapter 
describes a distinct investigative pathway, utilising a variety of techniques; 
all contributing to this aim.  
1.1.2 General overview of thesis 
The thesis will demonstrate a stepwise approach towards the molecular 
imprinting of a complex biomacromolecule. It will show novel use of the 
antibiotic polymyxin B (PMB; chapters two and three) and will also describe 
the integration of two technologies (microfluidics and microwave-initiated 
polymerisation; chapters four and five) in a specifically designed system for 
the manufacture of polymer beads. A schematic overview is shown in 
figure 1.1. 
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Figure 1.1: Overview of thesis. Also indicated are the key 
novel findings of this work.  
Molecular imprinting is a novel approach to LPS detection, it describes the 
generation of synthetic, polymeric receptors through the polymerisation of 
monomers around a template molecule. The resultant polymers possess 
recognition properties akin to an antibody with the ability to recognise the 
original target molecule. Molecular imprinting is reviewed in this chapter 
(section 1.4). Chapter two describes development of surface modification 
strategies on chloromethyl polystyrene resin (Merrifield resin) to facilitate 
the attachment of PMB and subsequent imprinting of LPS.  
Chapter three explores PMB further with experiments that negate the 
need for a solid, Merrifield resin support. This chapter describes methods 
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of PMB structure manipulation to render it polymerisable (p-PMB) with 
subsequent synthesis of a polymyxin B polymer.  
Thereafter, chapter four describes the initial stages of a microfluidic system 
development for the production of polymer beads. The system was also 
designed to incorporate in-situ bead polymerisation and this chapter 
describes iterations of a microfluidic system tested prior to eventual use of 
microwave-initiated polymerisation. 
Chapter five describes the integration of microwave delivery into an 
established microfluidic system in order to polymerise molecularly 
imprinted polymer beads. In addition, microwave technology is used to 
characterise individual reactants to guide experimental design and to 
provide insight into the polymerisation process. Chapter five therefore 
describes proof-of-concept work on a small scale indicating the potential of 
microfluidic and microwave technology integration in molecular imprinting 
strategies. Moreover, this application of microwave technology has not 
been described previously and offers a novel method of monitoring 
polymerisation. 
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1.2 Sepsis and critical illness 
1.2.1 Introduction  
Sepsis is a common cause for admission to critical care units in the UK (7) 
and carries a significant economic cost worldwide (8). There is also a 
growing wealth of evidence indicating the detrimental effects on ongoing 
health for sepsis survivors, both physical and psychological (9–11). 
Furthermore, secondary infection and development of sepsis subsequent 
to admission to critical care is also a major cause of morbidity and 
mortality. Conditions such as ventilator associated pneumonia (12), fungal 
infection (13), severe gastrointestinal infection (14) and infection 
associated with indwelling medical devices (15,16) can detrimentally affect 
critical care patients.  
The definition of sepsis has recently been revised and has been generally 
well received (17). The revision was necessary to clarify the descriptive 
difficulty surrounding this syndrome and improve understanding of its 
prevalence and virulence (18). Therefore, in February 2016, a consensus 
definition of sepsis and septic shock was published in JAMA, superseding 
the standing definition from 2001 (19). In this paper, sepsis is succinctly 
defined as ‘a life threatening organ dysfunction caused by a dysregulated 
host response to infection’ (20). Septic shock is also given a clear set of 
diagnostic criteria: a vasopressor requirement to maintain mean arterial 
blood pressure of 65 mmHg (or greater) and a serum lactate level of 
greater than 2 mmolL-1 (in a normovolaemic patient) (20). 
The early recognition and correct initial diagnosis of sepsis are key 
concepts that govern the effective treatment of the syndrome. Both may 
seem eminently achievable, however, they are not always straightforward.  
Sepsis is a time critical medical condition with outcome for patients 
improving when diagnosis and institution of treatment is achieved quickly 
(21–24). Furthermore, emphasis on timely recognition and delivery of 
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therapy is an overarching theme of sepsis treatment guidelines such as 
those from the Surviving Sepsis Campaign (SSC) (25) and the National 
Institute of Clinical Excellence (NICE) (26). Care ‘bundles’, a compendium of 
guidelines from evidence based practice, are used by many institutions for 
the treatment of sepsis and compliance with these guidelines has 
repeatedly been shown to improve patient outcome (27,28). In 2010 Levy 
et al. investigated the impact of SSC guidelines and included data from over 
15,000 patients from 162 hospitals. The authors demonstrated 
improvement in the compliance of several time critical interventions, 
including early intervention administration of antibiotics (OR- 0.70 (p < 
0.001)). Moreover, a sustained improvement in patient outcome was 
highlighted along with improved guideline compliance (30.8% mortality to 
27 % (p < 0.01)) (21).  
Early recognition of sepsis can be difficult as patients will often present late 
to community physicians and even later to tertiary centres. Symptoms are 
brushed off and coped with, preventing the necessary medical 
intervention.  When a patient does present to medical services, correct 
diagnosis of infective conditions may still be troublesome. Adjuvant 
diagnostic tools within community pharmacies or primary care would be 
highly beneficial to supplement clinical acumen. Furthermore, standard 
diagnostic tests, blood cultures for example, may not be reliable (29). In 
the 2009 EPIC II study, investigators looking at infection prevalence data 
from 14,414 patients from 1265 worldwide intensive care units found 30% 
of patients with suspected sepsis had negative blood culture results (30). 
Moreover, blood culture techniques also have practical limitations. Results 
can often take days, possibly causing initial diagnostic delay and could 
prevent stewardship of broad spectrum antibiotics (31). Furthermore, 
using larger volumes of sampled blood improves accuracy of blood culture 
results and this can be practically difficult in certain patients (32). Needless 
culturing of blood is also a problem and recent guidance designed to help 
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streamline the ordering of blood cultures have been published, in a bid to 
prevent the culture of blood samples from very low risk patients (33). 
1.2.2 Biomarkers of sepsis 
Considering sepsis is a ‘deregulated host response to infection’ (20) focus 
on circulating biomarkers (indicative of this host response) could hold the 
key to an earlier, accurate diagnosis of sepsis. Subsequently, many 
biomarkers have gained research focus and have also been the subject of 
many comprehensive reviews (34–39). Pierrakos and Vincent in their 2010 
review classify circulating biomarkers of sepsis into the following 
categories: cytocine/chemokines, cell markers, receptors, biomarkers 
related to vascular endothelial damage, biomarkers related to 
vasodilatation, acute phase proteins and ‘other’ (over 50 potential 
biomarkers are in this category (36)). Figure 1.2 shows a variety of 
biomarkers that could be clinically significant in patients with suspected 
sepsis. 
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Figure 1.2: Schematic representation of selected key 
circulating biomarkers involved in the pathophysiology of 
sepsis. NFҡB: Nuclear Factor kappa B; TREM: Triggering 
Receptor Expressed on Myeloid cells; sTREM: soluble 
Triggering Receptor found on Myeloid cells; LPS: 
Lipopolysaccharide; CD-14: Cluster Differentiation-14; TLR-4: 
Toll-like Receptor type 4; IL-1: Interleukin-1; IL-6: 
Interleukin- 6; TNF: Tumour Necrosis Factor; CRP: C Reactive 
Protein; PCT: Procalcitonin; PTX3: P entraxin-related protein; 
PAMPs: Pathogen Associated Molecular Patterns; PAI -1:  
Plasminogen Activator Inhibitor-1. Adapted from (38).  
Blood serum levels of C-reactive protein (CRP) and white cell count (WCC) 
are routinely checked in the clinical setting in patients with suspected 
sepsis, but the true potential of lesser-known biological markers remains 
elusive (40). The latest Surviving Sepsis Campaign guidelines (2016) 
recommend measurement of serum procalcitonin (PCT) in patients with 
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suspected sepsis in the context of antibiotic stewardship. However, this is 
classed as a ‘weak recommendation’ with ‘low quality evidence’ (25).  PCT, 
a hormone used for the regulation of serum calcium, has received much 
attention in recent years and many studies have shown promise, including 
large randomised controlled trials (41). Studies continue to emerge that 
support the use of routine PCT measurement and conclude PCT should be 
used to guide diagnosis and treatment of sepsis (41,42). However, other 
authors have highlighted the problem of the non-specific nature of serum 
PCT fluctuations (38), highlighting that elevated PCT is also seen following 
trauma (43), severe burns (44) and certain neoplasms (45). Other 
potentially useful circulating biomarkers include the Soluble Triggering 
Receptor Expressed on Myeloid cells (s-TREM), a member of the 
immunoglobulin family (46). The non-soluble receptor TREM was identified 
by Bouchon and colleagues in 2000, who demonstrated significant 
upregulation of TREM in the presence of the pathogens Pseudomonas 
aeruginosa and Staphylococcus aureus. Increased expression was also seen 
in the presence of both LPS and Gram-positive derived lipoteichoic acid 
(LTA) (46,47). A recent prospective study found significantly higher levels of 
s-TREM in patients with sepsis who had a poorer outcome. However, the 
study included 63 patients, only 24 of which had documented blood borne 
infection (48). Soluble urokinase Plasminogen Activator Receptor (suPAR) is 
another circulating biomarker that has been the subject of review (49,50). 
This circulating protein is released from the membrane bound urokinase 
plasminogen activator receptor upon immune system activation (50). In 
agreement with other papers on the subject, a 2012 review by Backes et al.  
concluded that suPAR detection may be useful in the prognosis of patients 
with sepsis, however, it is of limited use in the initial diagnosis of sepsis 
(49). In recent work from Cirstea et al. in Canada, the detection of high-
density lipoprotein cholesterol (HDL-C) levels as a prognosticator in sepsis 
was investigated. Results from Cristea et a. showed that low HDL-C levels 
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were independently associated with the development of multi organ 
failure in patients with sepsis and had a high predictive value for poor 
outcome compared to other measured markers such as lactate and WCC 
(51).  
In more recent years, sepsis biomarker researchers have increasing interest 
in genomics (52), pharmacogenomics (53), lipidomics (54,55) and 
metabolomics (56,57). These less ‘conventional’ marker subsets refer to 
the study of the genome; known cellular drug pathways for biomarker 
discovery; cellular lipids; and cell metabolites, respectively. Taking 
metabolomics as an example, several promising studies have highlighted 
the potential clinical value of obtaining a metabolomic profile for patients 
with sepsis. Seymour and colleagues, publishing results from the GenIMS 
study cohort (Genetic and Inflammatory Markers of Sepsis), investigated 
differences in the plasma metabolomic profile of surviving and non-
surviving patients with community acquired pneumonia who developed 
sepsis. Albeit a small sample size (15 in each group), the difference in 
metabolomic profile between 90 day survivors and non-survivors was 
clearly evident and furthermore, metabolomes identified within the profile 
belonged to molecular patterns of known importance in sepsis (56). 
Similarly, Langley et al. investigated the metabolomic profile of 1,152 
patients with sepsis and demonstrated a markedly different metabolomic 
profile between survivors and non-survivors. However, they were not able 
to delineate survivors dependent on the severity of sepsis or causative 
pathogen (57). Using a metabolomic profile to reliably prognosticate and 
stratify patients with sepsis remains an elusive technique (58). 
The answer may be in monitoring a combination of different circulating 
biomarkers, combining conventional and non-conventional marker 
detection in a bid to diagnose and prognosticate in sepsis. This approach is 
also the subject of many recent reviews, with numerous combinations of 
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biomarkers investigated (59–63). The focus of investigative work described 
in this thesis was lipopolysaccharide (LPS; also known as endotoxin) and its 
potential as a sepsis marker. 
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1.3 Lipopolysaccharide 
1.3.1 Structure of LPS 
Gram-negative bacteria cells, unlike eukaryotic cells, have dual level 
protection from the surrounding environment with two cell membranes 
(64). A phospholipid bilayer constitutes the inner membrane, whereas the 
outer membrane has two distinct bilayers (64). The inner leaflet is also a 
layer of zwitterionic phospholipids similar to the layers of the inner 
membrane. However, in contrast to the neighbouring layers, the outer 
leaflet of the outer membrane is littered with lipopolysaccharide (LPS) (65) 
(figure 1.3). 
 
 
Figure 1.3: Schematic of the Gram-negative cell  membrane 
structure demonstrating the placement of LPS on its outer 
membrane of the outer cell  wall .  Adapted from (66).  
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Figure 1.4 shows the general architecture of LPS, demonstrating three 
distinct regions: Lipid A region, a core oligosaccharide region and the O-
specific antigen chain (polysaccharide region).   
 
Figure 1.4: The architecture of Escherichia coli  LPS. Hep: L-
glycerol-D-manno-heptose; P: Phosphate residue; Kdo: 2 -
keto-3-deoxyoctamate; GlcN: 1,4 - bisphosphorylated β1,6 - 
linked D-glucosamine. The number at the end of the carbon 
chains indicates number of carbons. Adapted from (66),  
copyright (2003).   
1.3.1.1  Lipid A 
Lipid A is a glycophospolipid containing fatty acids with chains of 10 to 20 
carbons (67) and attaches the long polysaccharide chain to the outer leaflet 
of the outer cell wall. The inherent toxicity of LPS is thanks to this 
hydrophobic portion (68,69) and even in picomolar amounts the 
administration of lipid A can trigger release of pro-inflammatory cytokines 
(70). The structure of lipid A plays an important role in the outer cell wall 
barrier functions of Gram-negative bacteria. For example, the 
physicochemical attribute of outer cell membrane viscosity is due to the 
close proximity of Lipid A fatty acid arrangement, therefore aiding the 
impermeable nature of the membrane (71). Moreover, lipid A serves to 
maintain the overall shape of the bacterium and also further maintains 
membrane integrity through close approximation to membrane proteins 
(71,72). Less structural variability between bacterial species is seen in the 
lipid A portion compared to both the core region and the O-specific antigen 
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chain. For example, fatty acid chain length varies between Escherichia coli 
and Pseudomonas aeruginosa, the latter displaying shorter chain lengths 
down to 10 carbons compared to the 14 length chains found in Escherichia 
coli (66,73,74).  
1.3.1.2 Core region 
As demonstrated in figure 1.4, the inner portion of the short core region is 
composed of repeating 2-keto-3-deoxyoctamate (KDO) and L-glycerol-D-
manno-heptoses (heptose) residues (66). The outermost portion of the 
core region demonstrates interspecies variability; using varied 
combinations of sugars, phosphates and amino acids (75). Some LPS 
structures end at this core region and do not have an O-specific antigen 
chain; these are described as ‘rough’. In this case antigenic properties are 
derived from their core region (LPS is described as ‘smooth’ if it has an O-
specific antigen chain) (74,76).  
1.3.1.3  O- Specific chain 
The O-specific antigen chain, composed of repeating polysaccharide 
subunits, is capable of great complexity. It therefore demonstrates 
significant diversity and varies between Gram-negative species (75,77). The 
architecture determines the bacterial serotype and is described as 
providing the bacterial ‘fingerprint’ by Caroff & Karibian in their extensive 
2003 review (76). The O-specific antigen chain has been found responsible 
for a diverse range of immunogenic roles (75,78–80). For example, 
bacterial adhesion to mucosal cells and subsequent virulence is facilitated 
by the O-specific chains of Actinobacillus pleuropneumoniae (76,79). 
Furthermore, this portion of LPS structure can shield bacteria from host 
defences including complement induced lysis (78) and phagocytosis (80).  
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1.3.2 Function of LPS 
1.3.2.1  Pro- inflammatory 
LPS is a potent pro-inflammatory molecule capable of activating the innate 
immune system at concentrations below 1nM (81). Shown in figure 1.5 is 
the inflammatory cascade triggered by LPS. The figure is a simplified 
representation of several highly complex amplification pathways involved 
in this process. LPS is initially bound to a soluble lipopolysaccharide binding 
protein (LBP), a 60 kDa glycoprotein (82,83). This LPS/LBP complex is then 
recognised by the membrane bound Toll-like receptor 4 (TLR-4) (84). 
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Figure 1.5: Simplified schematic overview of the host 
inflammatory cascade initiated  by endotoxin pathogen 
invasion. LPS binds to l ipopolysaccharide binding protein and 
the complex recognition is facilitated by TLR4/MD -2 
transmembrane complex. The two distinct pathways (MyD88 
dependent and independent) constitute the ongoing cascade 
and represent several complex steps. The end result is the 
production of inflammatory cytokines that are responsible 
for the clinical manifestations of sepsis. CD14: cluster of 
differentiation 14; TLR4: Toll  Like Receptor 4; (TIR: 
Toll/Interleukin 1 Receptor); MD -2: lymphocyte antigen 96; 
TIRAP: TIR domain-containing Adaptor Protein; TRIF: TIR 
domain-containing Inducing Interferon β ; MyD88: Myeloid 
Differentiation gene primary product 88; LBP: 
Lipopolysaccharide Binding Protein; NF -KB: Nuclear Factor-
Kappa B. Adapted from (85) with permission.   
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In 1998, the search for the receptor responsible for initial detection of LPS 
led Poltorak et al. via genomic mapping, to identify an intact gene in the 
region of the Lps d locus (84). This Lps d locus was previously found to be 
responsible for an induced endotoxin-unresponsive state in mice (86), 
mapping of which revealed the gene encoding TLR-4 which is now widely 
recognised as the LPS recognition receptor. TLR-4 is found primarily on 
macrophages, activation of which allows LPS to exert its pro-inflammatory 
action with subsequent generation of several inflammatory mediators such 
as IL-1β, IL-6, IL-8 and TNFα (87). This sequence of events instigated by LPS 
is efficient and essential in host clearance of minor, local infection. 
However, overproduction of these inflammatory mediators can prove 
detrimental and leads to the clinical manifestations of sepsis (88). In effect, 
the very systems in place to protect us become our downfall in severe 
sepsis. However, humans still need to retain the ability to recognise and 
respond to LPS. Subsequent to identification of the TLR-4 encoding gene, 
Poltorak et al. provided evidence that mice with a deleterious mutation in 
this TLR-4 gene were unable to respond to LPS and therefore unable to 
mount an important initial immunogenic response (89).  
1.3.2.2 Pro-pathogenic 
LPS also has a key role in the promotion of bacterial virulence. Many 
pathogens (Neisseria meningitides, Neisseria gonorrhoeae, Haemophilus 
influenzae, for example) express LPS on their outer cell membrane that 
share vital structural elements with human antigens such as lactosyl and 
platelet activating factor (PAF), effectively providing a level of camouflage 
(90). This adaptation of ‘molecular mimicry’ also allows bacteria to take 
advantage of any host receptor systems for the mimicked antigens, 
improving entry into host cells and adherence to host tissue (90,91). The 
LPS of certain pathogenic species have also adapted to allow incorporation 
of extra chemical groups, such as sialic acid, a move that often confers 
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resistance to host immune systems and to antimicrobial agents (92,93). 
Antimicrobial resistance (AMR) refers to this adaptation of pathogens that 
ultimately renders certain antimicrobials ineffective for that particular 
pathogen (94). A global action plan for tackling AMR was launched by the 
World Health Organisation in 2015 (95), furthermore, such is the perceived 
threat of AMR that a two year review was commissioned by the UK 
Department of Health and the Wellcome Trust in 2014, with the final 
report published in 2016. Incidentally, one of the key recommendations of 
this report is the promotion of new, rapid diagnostics for infection to guide 
antibiotic use (96).  
1.3.2.3 LPS in sepsis  
LPS has been widely implicated in the pathophysiology of sepsis (3–5,97). 
The reaction of both animals (3,98) and humans (99,100) to endotoxin 
administration consistently and reliably triggers the sepsis-like syndrome 
and detection of endotoxin in the blood of patients who meet the 
diagnostic criteria for sepsis has been demonstrated (6,101). However, 
wide ranges for the percentage of patients diagnosed clinically with sepsis 
who have endotoxemia are quoted in the literature (20 to 40% (102)). This 
highlights two main problems for the interpretation of studies measuring 
serum endotoxin levels. Firstly, the clinical diagnosis of sepsis by even the 
most experienced of clinicians can be difficult and if a study relies on the 
accuracy of this initial diagnosis, error is undoubtedly introduced. Secondly, 
interpretation of studies is problematic considering the problems with 
commercially available assays for endotoxin. Without a highly sensitive and 
specific detection test for endotoxin, clinical studies looking to evaluate 
levels in patients will continue to be contentious. Furthermore, the 
presence of endotoxin in blood is not unique to sepsis, and not even 
unique to pathological conditions with evidence of endotoxemia in 
triatheletes following vigorous exercise (103). Increased endotoxin levels 
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have been found in patients with liver disease (104), cardiovascular disease 
(105,106) and also following open heart surgery requiring cardiopulmonary 
bypass (107). Interestingly, authors have also suggested the usefulness of 
measuring endotoxin in patients diagnosed with sepsis following 
cardiopulmonary bypass to predict outcome (108). Furthermore, humans 
carry as much as 25 grams of endotoxin in the gastrointestinal tract 
(6,109), representing around 80% of the gut cell wall mass of Gram-
negative bacteria (110). During illness the translocation of GI tract 
endotoxin secondary to increased permeability of the gut mucosa (67,111), 
or via direct damage to the mucosa caused by trauma, ischemia or ionising 
radiation (111) can contribute to elevated blood levels. Therefore, 
interpretation of elevated endotoxin in patients with multiple causative 
possibilities is potentially complex. 
1.3.2.4 Measuring LPS 
Currently, LPS detection is not used routinely in the clinical setting; 
however, it is a vital step in pharmaceutical quality control (112). The 
ubiquitous nature and associated virulence of LPS (troublesome to patients 
at picogram levels) is a problem for the pharmaceutical industry and levels 
in parenteral preparations are tightly regulated (113). Reliable and specific 
LPS detection is paramount and commonly undertaken with the Limulus 
Amebocyte Lysate (LAL) assay, which relies on the haematological host 
clotting response of the horseshoe crab to invading endotoxin (114). 
Shown in figure 1.6 is the simplified clotting cascade of the Atlantic 
horseshoe crab when exposed to endotoxin. This amplification pathway 
forms the basis of the LAL assay which was first described by Fredrick Bang 
and Jack Levin in 1968, following their independent observations of the 
effect of endotoxin pyrogen on the blood cells of the horseshoe crab (114).  
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Figure 1.6: Diagram of the horseshoe crab coagul ation 
cascade triggered by endotoxin.  The purpose of the final step 
(coagulin gel production) is to effectively trap the invading 
Gram-negative bacteria/endotoxin source. 1 -3β-D-glucan is a  
fungal toxin and drives the conversion of Factor G to Factor 
G*; this in turn can also effect the endotoxin driven cascade. 
LICI: Limulus Intracellular Coagulation Inhibitor; pNA: p  
Nitroaniline. Diagram adapted from (102,115,116) .  
However, the LAL assay has limitations. Specificity is a problem and several 
endogenous factors can trigger the same amplification clotting cascade 
shown in figure 1.6. For example, 1-3β-D-glucan is a fungal toxin that can 
also amplify the conversion of pro-clotting enzyme to clotting enzyme and 
can therefore cause false positive results (115,117). Furthermore, false 
positives have been demonstrated with the LAL assay from a diverse range 
of substrates, including: immunglobulins (118), synthetic polyneucleotides 
(119), thrombin and thromboplastin (120) and gold nanoparticles (121). 
Moreover, harvested Gram-positive pepdidoglycans can also give false 
positive results (122). Considering the interference from a variety of 
substances when using this assay, it is unsurprising that sample 
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preparation is an important consideration and there are several strategies 
employed by pharmaceutical companies to compensate (dilution, filtration, 
dialysis or temperature control for example (123)). Furthermore, there is 
an ecological consideration secondary to widespread use of this assay. The 
overharvesting of horseshoe crab is having detrimental effects on the 
crab’s population and it was labelled an endangered species in Japan over 
40 years ago (115,124). 
Advances in genetic engineering have allowed the successful derivatisation 
of an enzymatically active recombinant Factor C (rFC), the key factor in the 
cascade shown in figure 1.6. Based on rFC, Ding and Ho (2001) described an 
endotoxin assay with impressive LPS sensitivity (125) and the PyroGene 
(Lonza Inc, USA)  detection kit became commercially available in 2004. 
However, although the ecological considerations for the horseshoe crab 
are addressed with this innovation, the reliance on the same coagulation 
cascade will undoubtedly involve the risk of false positives that plague the 
LAL assay. Using LAL-based assays with clinical samples can be problematic; 
in his 2000 paper J. Cohen highlighted four key considerations for the 
clinical use of the LAL assay: contamination (considering the assay is highly 
sensitive); specificity (results are referenced to a standard endotoxin and 
may not correlate); confounding substances in plasma; and accuracy (semi-
quantitative nature of the assay) (102). Furthermore, if a patient has 
received antibiotics this may also interfere with the LAL assay (126).  
As an alternative to the LAL assay, the Endotoxin Activity Assay (EAA; 
Spectral Medical Inc, USA) is a chemiluminescent assay reliant on the 
oxidative burst reaction of neutrophils when they are exposed to LPS-IgM 
immune complexes (127). The assay gives a semi-quantitative result, 
grouping endotoxin activity levels as low (< 0.4), intermediate (0.4 – 0.59) 
or high (>0.6). Several observational studies have commented on the 
clinical use of the EAA in patients with sepsis (108,128), but a notable 
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cohort study was the MEDIC trial, published in 2004 (6). This study looked 
at 857 patients admitted to intensive care units in the USA, Canada, 
Belgium and the UK. EAA levels were measured on day one and patients 
stratified according to EAA level (low, intermediate or high). Significant 
differences in patient outcome and organ dysfunction were found between 
these groups and high EAA levels were associated with increased mortality, 
irrespective of the causative organism. However, sensitivity and specificity 
levels for the detection of Gram-negative infection were poor: 85.3% and 
44% respectively (6). More recently, the EAA from Spectral Medic Inc is 
known more as the detection device used in large multi centre randomised 
controlled trials investigating extracorporeal LPS removal strategies in 
sepsis using polymyxin B coated cartridges (Toramyxin) (129,130). 
Detection of LPS in this project was investigated using the principles of 
molecular imprinting, a polymer chemistry discipline that has been used in 
various detection applications since the 1970s (131). 
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1.4 Molecular Imprinting 
1.4.1 General introduction 
The ability to generate synthetic recognition systems to mimic antibodies 
certainly sounds like an attractive prospect. The synthesis of molecularly 
imprinted polymers (MIPs) is an approach with the credentials to realise 
this possibility. Molecular imprinting describes the method of ‘imprinting’ a 
target molecule (template) into a polymer matrix (132). This serves to 
provide the polymer with recognition properties akin to the original target 
molecule. The individual work of two pioneering scientists, Günter Wulff 
and Klaus Mosbach, led to the first modern descriptions of molecular 
imprinting techniques in the 1970s and 1990s, respectively (133–135). A 
seminal Nature publication by Mosbach and colleagues in 1993 catapulted 
molecular imprinting into the wider scientific community and introduced 
the use of MIPs in ‘antibody mimicry’ (135). Writing in 2005, Andrew 
Mayes highlights the impact of this paper, stating: ‘The exponential growth 
in interest and activity in the field of imprinting can be traced back to the 
influence of the publication’ (136).  
1.4.2 Conventional Imprinting  
Shown in figure 1.7 is a simplified representation of the conventional bulk 
imprinting process.  This can utilise a covalent approach (covalent bonds 
between template and monomers) or a non-covalent approach to produce 
an imprinted material with high affinity for the target molecule (132).  
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Figure 1.7: Schematic 2D representation of traditional , bulk 
molecular imprinting method.  The self assembly of the 
template molecule and functiona l monomers takes place 
followed by polymerisation. The template mol ecule is then 
removed, leaving an imprint of the template molecule within 
the polymer matrix.   
As shown in figure 1.7, the template is imprinted as a whole and thereafter 
removed from the polymer matrix as a complete molecule, this figure 
therefore represents an exemplar bulk imprinting process (132). Bulk 
imprinting is effective for the imprinting of small molecules (137); however, 
less success has been demonstrated with large, cumbersome templates 
such as proteins or whole cells (138,139). Therefore, molecular imprinting 
technology (MIT) has continuously evolved to circumvent issues with the 
imprinting of macromolecular templates (131,132,139).  
1.4.3 Macromolecular imprinting 
Macromolecular imprinting is a challenging and complex branch of MIT due 
to the specific obstacles faced when working with large molecules.  In their 
extensive 2006 review, Turner et al. describe these obstacles under the 
following headings: size, complexity, conformational flexibility and 
solubility (139). Briefly, these subcategories describe the following 
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problems with macromolecular imprinting: the logistical issues of large 
molecules finding, and successfully leaving, binding sites due to their size; 
the sheer complexity of large molecules such as proteins increases the 
chances of different areas of the same molecule possessing multiple 
binding sites and exhibiting differing chemical properties;  proteins tend to 
adopt conformations secondary to any environmental changes, these 
environmental changes may be necessary for the polymerisation stage; 
and, as described by Turner ‘perhaps the greatest challenge of all is the 
limited choice of solvent’, finding the balance of protein/template stability  
and conditions suitable for the molecular imprinting processes can prove 
challenging (139).  
Advances in the field of macromolecular imprinting have developed to 
address the problems outlined above. Surface imprinting, a method used in 
this study, is one such advance that tackles problems with template size 
and manoeuvrability (140). Surface imprinting describes the formation of 
high affinity binding sites located at the surface of the polymer, with 
binding performance indicative of the ease of accessibility of these binding 
sites (141,142). An exemplar surface imprinting strategy is shown in figure 
1.8.  
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Figure 1.8: Schematic demonstrating the principles of surface 
imprinting.  1).  A polymer surface (support) is modified with 
a second, co-polymer grafted onto its surface. 2).  The 
modified polymer surface is now capable of displaying 
functional monomers chosen to interact with the desired 
template.  3).  The template is now introduced  to the system 
and following conventional imprinting methodology, the 
template and functional monomers self assemble, however,   
unlike conventional imprinting this only tak es place on the 
support surface. (Diagram adapted from educational material  
shown on PolyAn® website. All permissions granted).  
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Surface imprinting strategies fall under two broad headings: the synthesis 
of a polymer film (143–145) or template immobilisation (using resin for 
example) with subsequent polymerisation on this support surface. 
Template immobilisation was branded a ‘new approach to molecular 
imprinting’ by Mosbach in a 2000 communication paper (146) and 
developing suitable immobilisation strategies is now often a key part of the 
successful imprinting. For example, in Mosbach’s 2000 paper a 
theophylline derivative  was  immobilised on an amino derivatised silica gel 
via amide bonds and successfully imprinted (146). Further examples 
include immobilisation of cholesterol via a carbonate ester to diol-derived 
carbon chain spacer moiety interaction (147); immobilisation of amlodipine 
through hydrogen bonding with carboxyl modified silica microspheres 
(148) and covalent immobilisation of haemoglobin via imine bonds 
between the haemoglobin amino groups and aldehyde groups on an  
aminopropyl silica surface (149). 
Epitope imprinting represents a bridge between bulk and surface 
imprinting strategies and describes the imprinting of a larger protein via 
the imprinting of a representative short polypeptide chain (140,150,151). 
Rachkov et al. published seminal work on epitope imprinting in 2000. The 
group demonstrated successful recognition of the nonapeptide oxytocin 
subsequent to the imprinting of a smaller, representative tetrapeptide 
(150). Subsequently, epitope imprinting strategies have been developed to 
successfully imprint complex macromolecules such as albumin (143,152), 
immunoglobulin G (153) and lysozyme (154). Shea’s 2006 paper combines 
the technique of epitope imprinting and surface imprinting (both template 
immobilisation and polymer film synthesis) (143). Using three key 
biological proteins (cytochrome c, alcohol dehydrogenase and bovine 
serum albumin) the group demonstrated covalent epitope attachment to a 
silicon surface with subsequent MIP film synthesis via surface 
polymerisation (143).  
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In 2010, Shea and co-workers pushed MIPs into an exciting biomedical 
arena. They elegantly demonstrated this use of molecular imprinting to 
produce ‘plastic antibodies’ with the ability to neutralise a toxin in vivo; 
work that heralded a sea change in the true potential of MIT. The target 
was melittin, the active ingredient of bee venom (155,156) and Shea et al. 
demonstrated a significant increase in survival time of mice injected with a 
MIP nanoparticle following an injection of melittin compared to mice who 
received an injection of melittin alone. A common reservation concerning 
the use of synthetic nanoparticles in vivo is toxicity (157), however, in this 
study no toxicity was seen with intravenous administration of the MIP. 
Shea’s work provides an interesting background for the pursuit of 
generating a MIP with the ability to detect and sequester LPS. 
Table 1.1 outlines some of the advantages of developing recognition 
systems using molecular imprinting compared to using naturally occurring, 
endogenous recognition systems. Many of these advantages ensure 
molecular imprinting remains an important research focus in the 
development of potential ‘plastic antibodies’. 
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Table 1.1: Comparison of naturally occurring recognition 
elements with synthesised MIPs.  Adapted from (140) and 
(158).   
Property 
 
Natural recognition 
template 
MIPs 
 
Binding affinity 
 
High 
 
Variable 
 
Robustness Limited stability/poor 
performance in non-
aqueous media 
Stable under a variety of 
conditions/ can work in 
organic solvents 
 
Cost Expensive synthesis Inexpensive 
 
Storage Days at room temp Long term storage without 
any loss in performance 
 
Sensor integration Poor compatibility with 
transducer 
surfaces/micromachining 
/miniaturisation 
Polymers are fully 
compatible with 
micromachining technology 
 
1.4.4 Molecular imprinting and biosensing 
Molecular imprinting has many attributes that make it an attractive 
technology in the field of biosensing and extensive reviews have been 
written solely focussed on this application (159–163). Polymer sensors 
offer advantages such as robustness, reduced cost and increased shelf life 
when compared to traditional, antibody based sensors and biosensing 
MIPs have been developed to work with a variety of media including urine 
(164,165), cerebrospinal fluid (166) and blood (167,168). Imprinted 
polymer nanoparticles have also been shown to out-perform enzyme-
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linked immunosorbent assays for a variety of biologically relevant targets 
(137). 
The detection of drugs by MIPs was first highlighted in 1993 by Mosbach’s 
group (theophylline and diazepam detection (135)) and is now an 
established field of MIT. With implications for therapeutic drug monitoring 
and evidence based dosing regimens for antibiotics, the detection of 
ciprofloxacin (169), metronidazole (167) and tetracycline (170) have been 
demonstrated by MIPs. Furthermore, well established imprinting methods 
for a common drug template propranolol have been successfully applied to 
drug detection in human plasma and urine, utilising strategies for the 
production of aqueous compatible MIPs (165,171). The detection of beta 
blockers in urine has relevance for the sports industry, an application 
highlighted by Santos et al. in their 2015 paper describing a water 
compatible oxprenolol MIP capable of the detection of a variety of beta 
blockers in urine (165).  
Clinically relevant circulating biomarkers have also been successfully 
imprinted to provide a viable alternative to gold-standard detection 
methods. MIPs for cancer diagnostics have been successfully synthesised 
for prostate specific antigen (PSA) (172,173), ovarian cancer antigen 125 
(CA-125) (174) and nuclear matrix protein 22 (NMP-22) (175), the latter 
being a relatively newly discovered biomarker for urethral cancer screening 
in patients with microscopic haematuria (176). In their 2017 MIP cancer 
diagnostic sensors review, Selvolini and Marrazza echo sentiments from 
previous MIP biosensor papers by highlighting advantages such as stability, 
low cost and high affinity profiles. Furthermore, the authors stress the 
nanoscale potential of MIPs and hint at the use of MIP sensors in near-
patient testing devices (177).  
Despite the growing wealth of MIP research concerning biosensors, 
attention has not been paid to the development of MIPs for potential 
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biomarkers in sepsis. Considering the global burden and time sensitive 
nature of the condition, MIT application to sepsis diagnostics is a 
worthwhile pursuit. 
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2.1 Introduction 
2.1.1 Chapter outline 
This first experimental chapter outlines work with molecular imprinting 
strategies using a solid support as the first stage of working towards the 
detection of LPS. The solid support investigated was Merrifield resin and is 
introduced in section 2.1.2. Thereafter, surface imprinting and 
polymerisation approaches are explored in sections 2.1.3 and 2.1.4, 
respectively. Polymyxin B (PMB), a peptide antibiotic, is used in this 
experimental chapter to facilitate the template and monomer self 
assembly stage of a surface molecular imprinting process. Chapter three, 
however, introduces PMB in more detail with an account of PMB/LPS 
interaction (sections 3.1.2 to 3.1.5). 
2.1.2 Merrifield Resin and its modification 
Granted the Nobel Prize for chemistry in 1984, Bruce Merrifield’s 
contribution to the science of peptide synthesis is well documented. 
Commencing in 1959, Merrifield’s work on solid phase peptide synthesis 
(SPPS) provided an historic paradigm shift from the conventional solution 
phase synthesis of peptides. Bruce Merrifield’s namesake resin is a 
chloromethylated polystyrene resin (figure 2.1) and was first described by 
Merrifield in 1963 for the synthesis of a tetrapeptide (1). Along with 
peptide synthesis, Merrifield resin is now used for a variety of applications 
including oligonucleotide and oligosaccharide synthesis (2,3), biopolymer 
synthesis and molecular imprinting (4–6). 
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Figure 2.1: Structure of Merrifield resin.  Merrifield resin is a  
cross-linked polystyrene resin that is also known as 
chloromethyl resin owing to its chloromethyl functional 
groups.  
In 1976 the first description of aminomethyl polystyrene (7) marked the 
start of investigative work that would lead to the complex multi-
functionalisation of resins for organic synthesis reactions. The preparation 
of aminomethyl polystyrene has itself developed; for example, Arseniyadis 
and colleagues described the formation of amino-polystyrene from a 
Merrifield resin and trifluoromethanesulfonic acid reaction (Schmitt 
rearrangement) (8). The addition of multiple functional groups to 
Merrifield resin can allow further diversification of coupling reactions 
(9,10) and can facilitate resin use in the comprehensive testing of small 
peptide libraries to identify peptides of catalysis interest (10,11). Multi-
detachable linkers, for example, allow the preparation of different 
products during the same reaction (12) and the direct purchase of bi or tri-
functionalised resins for a variety of applications is now possible. 
Merrifield resin therefore is versatile and can allow functionalisation via 
attachment chemistries. These properties were exploited in this chapter’s 
work to facilitate surface molecular imprinting of a complex template 
(lipopolysaccharide). 
2.1.3 Surface Molecular imprinting  
Surface imprinting is a technique used to optimise molecular imprinting, 
often of complex molecular targets. It describes the avoidance of steps that 
create imprinting sites within a matrix and concentrates imprinting efforts 
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to a functionalised surface. This approach results in re-binding sites with 
increased exposure to template compared to bulk imprinting. Therefore, 
the mass transfer of template in and out of binding sites is improved 
(13,14).  
Whether it is though synthesising polymer films or attaching templates to a 
support surface, surface imprinting strategies are used regularly by many 
imprinting groups. Molecularly imprinted polymers have been produced 
for a diverse range of targets using a wide range of solid supports. For 
example, silica (15–17), quartz crystals (18), quantum dots (19), carbon 
nanotubes (20,21), and, as in this study, polystyrene resins (6) have all 
been used to successfully produce MIPs. 
Imprinted polymers produced with surface imprinting techniques have also 
been developed for biomedical application. Recently, Hussain et al. 
synthesised a MIP for platelet aggregation detection, a desirable diagnostic 
in the detection of HIT (heparin induced thrombocytopenia), a cause of 
significant bleeding dyscrasias in patients who are administered heparin 
(18). This was a small study, however, by imprinting platelets on the 
surface of quartz crystals Hussain et al. showed detection of characteristic 
platelet aggregation in patient serum samples. Additionally, Cumbo et al. 
described, in their 2013 paper, a surface imprinted MIP for virus detection. 
Named VIPs (Virus Imprinted Particles), Cumbo et al. imprinted the surface 
of silica nanoparticles and demonstrated virus detection in the picomolar 
range (15). 
2.1.4 Polymerisation methods  
The control of polymer synthesis is an integral step in any molecular 
imprinting process. Furthermore, different imprinting strategies may 
require polymers with differing properties and selection of the 
polymerisation method is therefore important (22). Typically, chain 
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polymerisation describes polymerisation of unsaturated monomers via 
free-radical reactive centres generated on selected monomers (23). It 
consists of three phases: initiation, propagation and termination and 
describes the basic strategy for polymerisation in most conventional 
imprinting methods. An azobisisobutyronitrile (AIBN) free radical initiator is 
also commonly used in molecular imprinting to initiate and propagate 
polymerisation and provides an economic and reliable route to 
polymerisation (24). Moreover, the process is tolerant of many different 
solvents, can be used for a wide variety of monomers and often only needs 
mild polymerisation conditions (heat or UV application) (25). However, the 
process is not controlled and often produces polymers with high molecular 
weights and high dispersity indices, indicating poor control over polymer 
growth and resultant polymer architecture (22,25,26).  
Reversible-deactivation Radical Polymerisation (RDRP) is a growing 
polymer chemistry field which is also regularly referred to as controlled/ 
living polymerisation (27,28). RDRP describes polymerisation un-hindered 
by a dead-ended polymer chain formation, allowing the development of 
polymers with ever increasing architectural complexity in a highly 
controlled reaction (29). The main advantage of these techniques that 
constitute RDRP for molecular imprinting is the production of a 
homogenous polymer with a greater correlation between the affinities of 
binding sites (30). A methodology for synthesis of ‘living’ polymers was first 
described by Szwarc in 1956 when he described anionic polymerisation 
with a slower propagation step allowing for greater control of polymer 
growth (31). Decades later, RDRP is an established polymerisation 
technique and describes several mechanistic routes, all of which display 
greater control over polymer growth than conventional chain 
polymerisation methods. Two examples of controlled/living polymerisation 
are Reversible Addition Fragmentation (chain) Transfer (RAFT) 
polymerisation and Atom Transfer Radical Polymerisation (ATRP) (23). Both 
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methods involve free radicals, RAFT relies on an agent that is both a chain 
transfer agent and an initiator (known as a RAFT agent) and ATRP uses a 
transition metal catalyst (copper complexes for example) (23). These 
methods, although controlled, both often require undesirable 
experimental conditions for working with both polymyxin (peptide) and 
lipopolysaccharide (template molecule). For example, commonly used 
RAFT agents (trithiocarbonates and dithioesters) require a solution 
temperature of over 90 degrees to initiate polymerisation (32). 
Furthermore, despite descriptions of RAFT polymerisation under aqueous 
conditions (33), typically, organic solvents are required for the process. 
This chapter therefore investigates an alternative RDRP approach and 
describes the synthesis and use of a hydrophilic iniferter in the 
polymerisation stage of molecular imprinting methods. The term ‘iniferter’ 
describes a species that has polymerisation initiator, transfer agent and 
terminator capability and was first described in the 1980s (34). Iniferter 
controlled polymerisation involves the insertion of monomers into the 
iniferter bond itself and produces polymer chains with iniferter fragments 
at each end, effectively end-capping the polymer chain with a free radical 
capable of further polymerisation (35). A commonly used iniferter species 
are dithiocarbamates which, under certain conditions, split into non 
reactive and reactive radicals; therefore acting as terminators and 
initiators, respectively (36). Crucially, dithiocarbamate will readily react 
with chloromethyl groups on the surface of Merrifield resin, giving a 
reactive radical on the surface. Therefore, greater control of polymer 
growth on the resin surface could be achieved using this RDRP method. An 
outline of RDRP methods is shown in figure 2.2. 
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Figure 2.2: Summary of Reversible-deactivation Radical 
Polymerisation (RDRP) methods. 
Many molecular imprinters have used iniferter agents for their RDRP 
processes (6,36–39), producing a diverse range of MIPs.  As a comparison 
to the complex nature of the template used in this study 
(lipopolysaccharide), protein MIP synthesis studies have demonstrated 
success by using iniferter living radical polymerisation. For example, in 
2009, Qin et al. described the use of iniferter living radical polymerisation 
for protein MIP synthesis using a dithiocarbamate iniferter species (40). 
Moreover, imprinters have used iniferter facilitated polymerisation to 
prepare MIP microspheres (36,41), to prepare molecularly imprinted 
membranes (37) and to produce cross-linked biomedical polymer film for 
potential biosensing application (42).  
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2.2 Chapter aims and objectives 
The main aim of this chapter was to generate a solid support capable of 
accommodating two distinct attachment chemistries to facilitate the 
molecular imprinting of LPS. 
Key objectives were as follows: 
1. Controlled modification of chloromethylated polystyrene resin with 
azide groups to generate solid supports displaying two attachment 
chemistries. 
2. Modification of polymyxin B (PMB) with an alkyne group to enable 
click chemistry. 
3. Demonstrate binding capability of PMB modified resins to LPS. 
4. Synthesis and attachment of a hydrophilic iniferter onto the surface 
of azide functionalised resin and subsequent molecular imprinting 
of LPS. 
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2.3 Materials and methods 
2.3.1 Materials 
Polymyxin B from Enzo (Exeter, UK). All chemicals (including FITC- labelled 
Escherichia coli 0111:B4 LPS) purchased from Sigma-Aldrich (Poole, UK). All 
organic solvents were of HPLC grade and were obtained from Fisher 
Scientific (Loughborough, UK).  
2.3.2 Analysis  
2.3.2.1 FTIR 
All FTIR analysis was carried out on a Varian 3100 Excalibur FTIR from 
Agilent Technologies UK Ltd (Cheshire, UK) and using the Varian 
Resolutions Pro software.  
2.3.2.2 Fluorescence  
Fluorescence analysis was undertaken using a FLUOstar OPTIMA 
platereader (BMG Labtech GmbH, Ortenburg, Germany). The fluorescence 
properties of the FITC labelled Escherichia coli 0111: B4 LPS used in all 
binding experiments was as follows: excitation wavelength of 485 nm and 
emission wavelength 520 nm (λex 485 nm/ λem 520 nm). Analysis of binding 
performance data obtained from fluorescence analysis was carried out 
with GraphPad Prism® V8 software (Bmax and apparent Kd values calculated 
from a single-site specific binding curve fitting algorithm). 
2.3.2.3 Elemental  
Elemental analysis (carbon, hydrogen, nitrogen and sulphur) was by Medac 
Ltd. (Surrey, UK). 
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2.3.3 General method overview 
Figure 2.3 summarises the overall resin modification process. Firstly, 
chloromethylated polystyrene resin was modified with azide groups in a 
controlled fashion as to allow the preservation of a pre-defined proportion 
of chloromethyl groups on the resin surface. Secondly, the coexistence of 
surface azide and chloromethyl groups allowed further modification with 
iniferter attachment.  
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Figure 2.3: Simplified diagram of general method overview.  
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2.3.4 Preparation of modified Merrifield Resin 
2.3.4.1 Azidomethyl resin 
A series of azidomethyl resins were synthesised with increasing degrees of 
chloromethyl to azidomethyl conversion via manipulation of the chloride: 
azide molar ratio. Following a method described by Arseniyadis et al. (8),  
250 mg (0.5 mmol chloride) of Merrifield resin was added to 10 ml dry 
dimethylformamide (DMF) and a pre-defined quantity of sodium azide 
(dependent on desired conversion percentage) was added. The reaction 
was gently stirred at 60°C overnight. Resins were then washed with the 
following through a nylon filter: DMF/water (50/50; 100 ml), DMF, water, 
ethanol and ether (100 ml each, two cycles). Resins were then dried 
overnight under vacuum at 40°C and thereafter all synthesised resins were 
analysed using FTIR. Table 2.1 summarises quantities for azidomethyl resin 
experiments.   
Table 2.1: Reactants for azidomethyl resin synthesis  
 
Azide molar 
equivalence 
Mol 
Predicted resultant 
% azide modification 
Merrifield resin mg 
(mmol chloride) 
Sodium azide mg 
(mmol) 
 
0 
 
0 
 
250 (0.5) 
 
0 
0.2 20 250 (0.5) 6.5 (0.1) 
0.4 40 250 (0.5) 13.0 (0.2) 
0.5 50 250 (0.5) 16.25 (0.25) 
0.6 60 250 (0.5) 19.8 (0.3) 
0.7 70 250 (0.5) 22.75 (0.35) 
0.8 80 250 (0.5) 26.0 (0.4) 
1 100 250 (0.5) 32.5 (0.5) 
 
Chapter Two: Molecular imprinting studies using a solid support 
60 
 
2.3.4.2 Preparation of alkyne PMB 
Synthesis of an alkyne PMB was necessary to facilitate the coupling of PMB 
to the surface of azidomethyl polystyrene. PMB 100 mg (72 µmol) was 
added to 7.76 µl (72 µmol) of glycidyl propargyl ether in 10 ml methanol. 
This was gently stirred overnight at 40°C. The resultant liquid was rota-
evaporated to a dry white powder and re-suspended in DI water (15ml per 
100mg). 
2.3.4.3 Attachment of alkyne PMB to azidomethyl resin 
A metal catalysed alkyne-azide ‘click’ reaction as described by Sharpless in 
1990 (43) was followed for the coupling of alkyne PMB and azidomethyl 
resin. Alkyne PMB 50 mg (36 µmol) was added to 10 mg of 1 molar 
equivalent azidomethyl resin in 15 ml DI water. Added to this were sodium 
ascorbate 88.5 mg (0.45 mmol) and copper (II) sulphate 4.78 mg (0.03 
mmol). Following 10 minutes vortex, the reaction was gently stirred 
overnight at room temperature. The resultant yellow solution was filtered 
and washed with 100 ml DI water (x3), 100 ml 50/50 DI water/methanol 
and 50 ml methanol prior to being dried under vacuum at 40°C overnight.   
2.3.5 Binding experiments with PMB modified resin 
The synthesised series of modified alkyne PMB coupled azidomethyl resins 
were tested to ascertain LPS binding ability in a binding experiment. All 
modified resins plus control resins (unmodified chloromethyl resin) were 
incubated with increasing concentrations of LPS in water for injection (WFI) 
overnight (5 mg resin per repeat), 3 repeats of each. The LPS 
concentrations were as follows: 0.1 µg ml-1, 0.5 µg ml-1, 1 µg ml-1, 5 µg ml-1 
and 10 µg ml-1. Following incubation all samples were filtered through 
Whatman 1 paper, analysis with fluorescence spectroscopy was then 
performed on the resultant filtrate.  
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2.3.6 Polymerisation Experiments 
2.3.6.1 Iniferter (Sodium N- (dithiocarboxy) sarcosine) preparation 
A method for the synthesis of a hydrophilic iniferter species outlined by 
previous PhD work in this lab was followed (44,45). Sodium hydroxide   
2.25 g (56.2 mmol) was added to 20 ml water which was then cooled to 
10°C. Sarcosine 5 g (56.1 mmol) was added to this cooled solution. Carbon 
disulphide 5.6 ml (93 mmol) was then dissolved in ethanol 15 ml. Whist 
maintaining the temperature at 10°C, this carbon disulphide/ethanol 
solution was slowly added to the sarcosine solution. The product was then 
stirred gently at 10°C for 30 minutes followed by gentle stirring at room 
temperature for a further 30 minutes. Extraction using chloroform (50 mls 
x 3) was followed by rota-evaporation until caramel-like oil was formed. 
This was further rota-evaporated using multiple aliquots of ethanol (10 ml) 
until it formed a honeycomb-like structural appearance. The product was 
stored in a desiccator box at -4°C and protected from light.  
2.3.6.2 Iniferter attachment to modified Merrifield resin 
The iniferter coupling required a 10-20 fold molar excess of the iniferter to 
resin free chloromethyl groups. For 500 mg of 0.5 mol equivalent resin 
(0.75 mmol chloride), 3.1 g (15 mmol) of iniferter was used (20 fold excess). 
The coupling reaction was carried out under three conditions: water 15 ml; 
water/MeOH (70/30 v/v %) 15 ml; and MeOH/DMF (70/30 v/v %) 15 ml. All 
reactions were gently stirred overnight at 40°C and protected from light at 
all times. Samples were washed and filtered with DI water and ethanol and 
left to dry overnight under vacuum at 40°C. Thereafter, all samples were 
analysed with FTIR and elemental analysis. 
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2.3.6.3 Alkyne PMB attachment to iniferter coupled resin 
Using the method described in section 2.3.4.3, PMB was attached to 
iniferter coupled resin. All samples were washed, filtered and dried as 
described in section 2.3.4.3. The resultant resins therefore had both 
iniferter and PMB attached to the surface and were therefore used for 
ongoing polymerisation experiments. 
2.3.6.4 Polymerisation of iniferter coupled resin 
a. Polymerisation time point experiment 
The 0.5 mol equivalent azide converted resin, coupled with iniferter and 
alkyne PMB, was used in a polymerisation time point experiment. Resin (50 
mg) was suspended in 4 ml of DI water in a polymerisation vial. The 
monomers were then added: AAm 70 mg (1 mmol) plus MBAam 7.5 mg 
(0.05 mmol). Seven samples were prepared, to correspond with 7 
polymerisation time points (0, 20, 40, 60, 80, 100 and 120 minutes), three 
repeats of each. Samples were sparged with nitrogen for 7 minutes and 
then stirred gently under UV light of 100 mw/cm2/325 nm at a distance of 
20 cm for the range of irritation times outlined above. Following irradiation 
all samples were washed and filtered with DI water 100 ml, 100 ml DI 
water/ methanol (50/50 v/v%), 100 ml and methanol 100 ml. Samples were 
dried overnight under vacuum at 40 °C.  A sample from each time point 
was analysed by FTIR. 
b. Binding Assay 
Resins (5 mg) prepared in section 2.3.6.4 (a) were incubated with 1 µg ml-1 
LPS in WFI overnight (prepared in triplicate). Following incubation all 
samples were filtered through Whatman 1 paper, the resultant filtrate was 
analysed with fluoroscopy.  
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2.3.7 Imprinting Methods 
2.3.7.1 Preparation of imprinted and non-imprinted polymer 
The resin used for these experiments was the 0.5 mol equivalent 
azidomethyl resin (50% of chloromethyl groups converted to azide groups), 
alkyne PMB attached to these azide groups and iniferter species attached 
to the remaining chloromethyl groups. 
The molecularly imprinted polymer (MIP) was prepared as follows: resin 
(100mg) was suspended in 20ml of DI water, LPS (400 µg /0.04 µmol) was 
added and the reaction was stirred gently at room temperature for four 
hours, monomers were then added (AAm 350 mg (5 mmol) and MBAam 
37.5 mg (0.25 mmol)) and the reaction was sparged with nitrogen for 7 
minutes.  
The non-imprinted polymer (NIP) was prepared as follows: resin (100mg) 
was suspended in 20ml of DI water and this was stirred gently at room 
temperature for four hours, monomers were then added (AAm 350 mg (5 
mmol) and MBAam 37.5 mg (0.25 mmol)) and the reaction was sparged 
with nitrogen for 7 minutes.  
Both MIP and NIP preparations were stirred gently under UV light of 
100mw/cm2/325 nm at a distance of 20 cm for 60 minutes. Following 
polymerisation, samples were filtered and washed with DI water (100 ml; 
x3). The samples were then washed with the following (x3): 1% sodium 
deoxycholate (100 ml), followed by a second wash and filter with DI water 
(100 ml) and a final wash with 100 ml water/methanol (50/50 v/v %) 
followed by methanol (100 ml) prior to drying overnight under vacuum at 
40°C.  
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2.3.7.2 Binding assay 
The following resins were prepared for overnight incubation with LPS (5 mg 
each, 1 µg LPS, 4 repeats of each):  
 MIP: 0.5 mol equivalent azidomethyl resin, iniferter attached, 
alkyne PMB attached, prior incubation with LPS, polymerisation and 
washing with sodium deoxycholate;  
 NIP: 0.5 mol equivalent azidomethyl resin, iniferter species 
attached, alkyne PMB attached, no prior incubation with LPS, 
polymerisation and washing with sodium deoxycholate;  
 Resin A (RA): 0.5 mol equivalent azidomethyl resin, iniferter species 
attached, alkyne PMB attached;  
 Resin B (RB): 0.5 mol equivalent azidomethyl resin, iniferter species 
attached;  
 Resin C (RC): 50% azide modified Merrifield resin, iniferter species 
attached, and polymerisation. 
 
Polymerisation conditions were standardised for all samples that required 
it (MIP, NIP and Resin C- stirred gently under UV light of 100mw/cm2/     
325 nm at a distance of 20 cm for 60 minutes). Following overnight 
incubation all samples were filtered through Whatman 1 paper, 
fluorescence spectroscopy was then performed on the resultant filtrate. 
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2.4 Results and discussion 
2.4.1 Preparation of modified Merrifield Resin 
2.4.1.1 Azidomethyl resin 
Successful generation of azidomethyl resin was demonstrated with FTIR 
analysis. Shown in figure 2.4 are the transmittance spectra obtained via 
FTIR analysis of plain (unmodified, black trace) Merrifield resin and 1 mol 
equivalent azidomethyl resin (red trace). The spectrum obtained by FTIR 
for 1 mol equivalent azidomethyl resin gave a distinct stretch at    2100 cm-1 
which corresponded to presence of an azide group. Spectra of a control 
resin (unmodified Merrifield resin) lacked this band at 2100 cm-1. 
 
Figure 2.4: FTIR spectra for 1 mol equivalent azidomethyl 
resin (red) compared to plain (unmodified) Merrifield resin 
(black).  A stretch is seen at Vma x/ cm
- 1  
2100 (N=N=N; dashed 
red circle) in the modified azidomethyl resin and is not 
present in the plain resin.   
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With evidence of successful substitution of chloride groups with azide 
functionality, a library of resins with differing azide conversion rates were 
synthesised.  The resultant FTIR spectra for these resins are shown in figure 
2.5, where a gradual step-wise increase in the peak area of the stretch at 
2100 cm-1 is demonstrated.  
 
 
Figure 2.5: FTIR spectra for azidomethyl resins produced 
through the reaction of Merrifie ld resin with varying 
concentrations of sodium azide.  The area of interest Vma x/ 
cm
- 1  
at 2100 is il lustrated and representative of azide moiety 
(N=N=N). Spectra are shown for the following resins: 0.2 mol 
equivalent ( indicates 20% of the molar concentrati on of 
chloride groups was added in azide ), 0.4; 0.5; 0.6; 0.8 and 1 
mol equivalent.   
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The synthesised resins, the FTIR analysis of which are shown in figures 2.4 
and 2.5, were the product of a nucleophilic substitution reaction (figure 
2.6). Sodium azide is a water soluble salt of the azide ion, a nucleophilic 
linear species with high affinity for electrophilic sites (46).  
 
 
 
Figure 2.6: Schematic of the nucleophilic substitution 
reaction of sodium azide and an alkyl halide. Shown is a 
chloromethyl group (plus aromatic hydrocarbon) 
representative of the functional group of Merrifield resin. 
The nucleophilic sodium azide ion attacks  the electrophilic 
species.   
In their exhaustive 2005 review, Brӓse et al. describe the varied reactions 
of organic azides. Dedicating a section to classic nucleophilic substitution 
reactions, they indicated sodium azide is the most commonly used azide 
source (47). Using sodium azide, other groups have synthesised 
azidomethyl polystyrene for diverse applications. For example, in a recent 
paper by Slini et al., the synthesis of azidomethyl polystyrene for the 
preparation of engineered polymers for use in de-pollution applications 
(attached chelating agents) is described (48). This group achieved a 99% 
substitution rate (azide groups for chloromethyl groups) using a 1:7.32 
molar ratio of chloride to azide. Similarly, Ouerghui et al. describe the 
synthesis of azidomethyl polystyrene in their 2014 paper, again achieving 
high conversion rates by using a 1:5 molar ratio of chloride to azide (49). 
However, the graduated, controlled conversion of a selected proportion of 
chloromethyl groups to azide groups rather than the blanket conversion of 
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all chloromethyl groups is not heavily represented in the literature. 
Although, work from this laboratory has shown the  controlled azidomethyl 
resin synthesis as part of Merrifield resin bifunctionalisation technique (9).  
Conversely, FTIR analysis can be used to show a reduction in azide groups 
as a reaction proceeds. In recent work by Albuszis et al., effective photo-
crosslinking of microspheres via the exploitation of azide functionality was 
demonstrated with FTIR spectra showing a decrease in the azide stretch as 
azide groups were consumed during the reaction (50). 
2.4.1.2 Preparation of alkyne PMB and coupling to azidomethyl resin 
Click Chemistry is an umbrella term to describe a group of neat chemical 
reactions that generate products efficiently by joining together small units. 
This study utilises a copper catalysed azide-alkyne cycloaddition reaction, 
which Sharpless once described as the ‘cream of the crop’ of Click 
Chemistry reactions (43). Strictly speaking, this study uses a variant of this 
reaction as first described by Sharpless; a copper catalyst is employed, and 
therefore it is not a true Huisgen Cycloaddition. The method using a copper 
catalyst was first described in 2002 and allows the reaction to continue 
without the use of extremely high temperatures (51). 
Figure 2.7 shows the reaction schematic for the preparation of alkyne PMB. 
This step was necessary prior to the alkyne ‘click’ reaction with azide. 
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Figure 2.7: Reaction schematic of preparation of alkyne PMB.  
The epoxide ring of glyc idyl propargyl ether comes under 
nucleophilic attack by a free amine group of PMB (Dab -5 
position) leading to opening of the ring and adoption of a 
more stable bond angle configuration.   
Figure 2.8 shows the ‘click’ reaction between alkyne groups (PMB) and 
azide (converted Merrifield resin). The azidomethyl resin and modified 
alkyne PMB react under conditions of copper (II) sulphate catalysis. 
Therefore using this click method, PMB is successfully anchored to the 
azidomethyl polystyrene. As the ratios of azide groups are pre-determined, 
so is the loading of PMB onto the resin. 
 
Figure 2.8: Schematic of attachment of alkyne PMB to azide 
modified resin.  R: polystyrene group of Merrifield resin; R’:  
PMB; RT: room temperature.   
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Figure 2.9 shows FTIR spectra comparing azidomethyl resin (0.5 molar 
equivalent) with (red) and without (black) PMB coupling. A decrease in the 
peak area of the azide stretch at    2100 cm-1 is demonstrated in the spectra 
for PMB- coupled resin compared to the resin lacking PMB.  
 
Figure 2.9: Comparison FTIR spectra for 0.5 mol equivalent 
azidomethyl resin (black) and alkyne PMB deri vatised 0.5 mol 
equivalent azidomethyl resin (red).  Reduction in peak area at 
Vma x/ cm
- 1
 2100 (azide peak, N=N=N) of red spectra is 
demonstrated. A small amino stretch is present at   3200-
3400cm
- 1
 in red spectra from peptide.  
It may be expected that the azide peak would be absent from the PMB 
resin as the azide groups are used in the azide- alkyne click reaction. This is 
not the case, although a reduction in peak area of approximately 50% is 
observed. This is likely due to solvent dependent resin swelling behaviour 
and the difference between reaction conditions for azide coupling (organic) 
and those for alkyne PMB coupling (aqueous). To ensure a maximum 
amount of available azide groups, the coupling reaction to attach alkyne 
PMB resin took place in DMF; a solvent that encourages significant swelling 
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of Merrifield resin. However, the attachment of PMB takes place in water 
where the degree of resin swelling is markedly reduced. Therefore, 
although a molar excess of PMB is used in the attachment reaction, due to 
the restricted swelling of the resin, a proportion of azide moieties were 
likely unavailable for PMB coupling. FTIR results shown in figure 2.9 
suggested the continued availability of azide groups despite introduction of 
alkyne PMB. 
The paramount importance of resin swelling in solvents was noted by 
Merrifield himself (1), who along with others (52,53) reported 
experimental outcome differences in solid phase peptide synthesis (SPPS) 
using Merrifield resin dependent on choice of solvent. For example, in their 
1998 paper, Santini et al. produced swelling data for a library of resins, 
including Merrifield resin, using a simple method of measuring the volume 
of swollen resin beads following one hour of solvent submergence. Santini 
et al. showed swelling of Merrifield resin in methanol of 1.8 ml g-1.  The 
authors conclude with proposal of three SPS solvent classifications: 
swelling greater than 4.0 ml g-1 classed as a good solvent; swelling of 2.0 to 
4.0 ml g-1 a moderate solvent and a swelling volume of less than 2.0 ml g-1 is 
a poor solvent and should not be used for SPPS (54). The swelling of 
Merrifield resin in DMF has also been reported by several groups. Using the 
same methods as Santini’s group, Vanini and colleagues reported swelling 
in DMF of three Merrifield resins of increasing chloride loading of 2, 5 and 
10 %. Swelling volumes were 4.0 ml g-1, 3.7 ml g-1 and 3.0 ml g-1 
respectively (55). Therefore, by Santini’s classifications DMF is a moderate 
solvent. With a more automated method of investigating swelling, 
Rodionov et al. in their swellographic study paper also report Merrifield 
resin/DMF swelling volumes that correlate with other authors (56). 
Therefore, even in methanol the swelling of Merrifield resin is far lower 
than other solvents. In aqueous environments, however, Merrifield resin 
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becomes compacted with less binding site availability and those that are 
reside mainly on the resin surface.  
2.4.2 Binding experiments with PMB modified resin  
2.4.2.1 Polymyxin loading and LPS binding to PMB resin  
A set of azidomethyl resins with a range of azide conversion (0.2, 0.4, 0.6, 
0.8 and 1 mol equivalent resins) were coupled with alkyne PMB. These 
resins were then tested to establish LPS binding performance. In all binding 
experiments the molar equivalence of the azidomethyl resin relates to a 
chloride loading of 0.5 mmol (250 mg Merrifield resin). By integrating the 
data from a FTIC LPS calibration curve (figure 2.10), the amount of LPS 
bound to the resin under investigation could be plotted against free LPS 
concentration. Moreover, this allowed the calculation of Bmax and Kd values 
for each tested resin; Bmax refers to the maximum binding capacity of the 
resin and is expressed in nmol (of LPS) per mg of resin and Kd reflects the 
concentration of LPS (in µM) at which 50 % of the receptor sites for LPS 
binding are occupied. 
 
Figure 2.10: Typical FITC-LPS calibration curve.  [y= 5787.8x + 
274.5. R
2
= 0.999].   
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Figure 2.11 shows results from the first two binding studies using the lower 
molar equivalent azidomethyl/PMB resins (0.2 and 0.4 mol equivalent). 
 
 
Figure 2.11: Binding curves of 0.2 mol equivalent (A) and 0.4 
mol equivalent (B)  azidomethyl resin/LPS binding experiment.  
 
Note the lack of distinct curve shown in graph A, indicating a lack of specific 
binding taking place for this resin/LPS interaction. Error bars are also wide 
reflecting a wide range of values obtained between replicates, more 
pronounced for higher free LPS concentrations. The isotherm from analysis 
of 0.4 mol equivalent azidomethyl resin (graph B) also lacks the 
morphology of an efficient binding system, however error bars are smaller. 
Calculating Bmax and Kd was possible for this isotherm only, however values 
were magnitudes greater than for other resins (Bmax: 0.183 nmol mg
-1; Kd: 
2.325 µM). 
Figure 2.12 shows the binding curves for the remainder of the tested resins 
(PMB resins modified from 0.5, 0.7, 0.8 and 1 molar equivalent resins).  
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Figure 2.12: Binding isotherms from LPS/PMB modified resin binding experiments.  A:  Binding isotherm from analysis of 0.5 
mol equivalent azidomethyl resin/LPS binding experiment (B ma x : 0.103 nmol  mg
- 1
;  Kd:  0.328 µM); B:  0.7 mol equivalent 
azidomethyl resin/LPS binding (B ma x:  0.0722 nmol  mg
- 1
; Kd:  0.197 µM); C:  0.8 mol equivalent azidomethyl resin/LPS binding 
(Bma x: 0.170 nmol mg
- 1
; Kd: 0.534 µM); D: 1 mol equivalent azidomethyl resin/LPS binding (B ma x : 0.216 nmol mg
- 1
; Kd: 0.95 
µM).  
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Figure 2.13 compares the binding isotherms from analysis of 0.5 mol 
equivalent azide converted resin/LPS binding experiment (black trace) and 
1 mol equivalent azidomethyl resin (red trace). 
 
Figure 2.13: Binding isotherm from analysis of 0.5 mol 
equivalent azidomethyl resin/LPS binding experiment and 1 
mol equivalent azide converted resin.  Black: 0.5 mol 
equivalent azidomethyl resin B ma x: 0.103 nmol/mg; Kd: 0.328 
µM. Red: 1 mol equivalent  azidomethyl resin Bma x : 0.216 
nmol/mg; K d: 0.950 µM.   
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The binding performance data (kd and Bmax values) for all tested resins are 
shown in table 2.2.  
Table 2.2:  Table of results from binding isotherms of resin 
library binding to LPS. 
 
Azidomethyl resin 
(% azide modification) 
 
Apparent Bmax 
(nmol/mg resin) 
 
Apparent Kd 
(µM) 
 
20 
 
N/A 
 
N/A 
40 0.183 2.325 
50 0.103 0.328 
70 0.072 0.197 
80 0.170 0.534 
100 0.216 0.950 
 
Results from figures 2.11, 2.12 and 2.13, together with binding data shown 
in table 2.2 show a diverse range of binding performance, suggesting  
binding to LPS was dependent on azidomethyl resin composition (and 
hence alkyne PMB loading). At lower rates of azidomethyl conversion (0.2 
and 0.4 mol equivalent) data did not form a curved isotherm expected of a 
single-site specific binding system. The graphs were fitted using non-linear 
regression modelling (single-site binding). The binding in these systems 
appeared linear indicating probable nonspecific binding at sites with 
affinity and capacity for LPS but which are separate from the receptor sites 
of interest (57). Possible extra sites of interaction include free chloromethyl 
moieties or uncoupled azide sites. 
With the exception of the 0.7 mol equivalent resin, Bmax values shown in 
table 2.2 follow an upward trend as the azide conversion increases, with 
Bmax for the 1 mol equivalent resin displaying a value around twice that for 
the 0.5 mol equivalent resin. Bmax reflects the total density of receptor 
sites; therefore this doubling of Bmax as the theoretical number of PMB 
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binding sites doubles is encouraging. However, Kd values, which represent 
the concentration of free LPS at which 50 % of the PMB receptor sites are 
occupied, follow an upward trend. This indicates a possible decrease in 
affinity as the resins have increased alkyne PMB coupling. The literature 
reports several methods of investigating the PMB/LPS interaction affinity at 
equilibrium, however, results broadly correlate. Recent work with a 
fluorescent probe modified PMB has generated Kd values of 0.3 µM (58) 
and 0.5 µM (59). These correlate well with earlier work using a slightly 
different PMB fluorescent modification giving Kd values in the range of     
0.4 to 1.5 µM (60).  Previous titration calometric studies have also yielded 
association constants (dependent on LPS type) of 1.8 to 2.3 µM (61). 
However, results from isothermic titration calorimetry methods reported 
by Soon and colleagues as part of their work with new fluorescent PMB 
probes, reported results fitted to a two-site binding system as they failed 
to sit favourably in a single-site model. In this study the Kd values obtained 
for the two binding sites were initially 0.5 µM and then 0.08 µM (59). Kd 
results obtained by this work described in this chapter generally correlate 
with previous studies which is encouraging. Therefore, that baseline 
affinity for LPS of PMB has apparently been unhindered by any coupling 
process when attached to azidomethyl resin, or by prior alkyne attachment 
processes. The ability to bind LPS with the same level of affinity has, in the 
most part, been preserved. 
2.4.3 Polymerisation Experiments 
Iniferter (Sodium N- (dithiocarboxy) sarcosine) synthesis  
The synthesis of a hydrophilic iniferter species enabled the progression of 
polymerisation experiments under aqueous conditions. Aqueous 
conditions are desirable when working with biological templates and LPS is 
no exception. LPS tends to form micelles in most solvents secondary to its 
amphiphilic structure (62). Santos et al. investigated the aggregation of LPS 
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using light scattering spectroscopy and found the LPS serotype Escherichia 
coli  026:B6 begins to aggregate at a concentration of 14 µg ml-1 (in water, 
37 degrees celsius) (63). However, Santos et al. described two stages of LPS 
behaviour below this concentration. Immediately prior to this aggregation 
concentration, LPS forms pre-aggregate oligomers and prior to this remains 
at a monomer arrangement. Therefore, LPS monomers are possible under 
aqueous conditions at concentrations lower than the CMC (critical micelle 
concentration). 
Figure 2.14 shows the reaction for hydrophilic iniferter synthesis (sodium 
N-(dithiocarboxy) sarcosine).  
 
Figure 2.14 Reaction schematic of iniferter synthesis.  
 
2.4.3.1 Iniferter/resin coupling  
a. FTIR results 
The swelling of Merrifield resin was also a consideration during the 
attachment of iniferter. Therefore, attachment of iniferter to both plain 
Merrifield resin and synthesised azidomethyl resin was carried out in 
aqueous and organic conditions. Resins were then analysed with FTIR.  
The IR transmittance spectra obtained for a set of modified 0.5 mol 
equivalent resins (50 % azide conversion) are shown in figure 2.15. 
Comparison was made between azidomethyl resin with iniferter attached 
in water (black spectra, top); azidomethyl resin with iniferter attached in 
water/methanol (70/30 v/v %, green spectra, middle) and azidomethyl 
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resin with iniferter attached in methanol/DMF (70/30 v/v %, red spectra, 
bottom). 
 
Figure 2.15: FTIR analysis of azidomethyl resin (0.5 mol 
equivalent resin) with iniferter attached under varied 
conditions.  Black: iniferter attached in water; green: iniferter 
attached in water/MeOH; red: iniferter attached in 
MeOH/DMF. There are differences in the spectra obtained 
from the resin with iniferter attached  in methanol/DMF: a 
greater peak area of stretch seen at Vmax/cm
- 1
 1610 (C=C; red 
dashed circle), a significant extra stretch can also be seen at 
Vma x/cm
- 1
 1380 (C-H; blue dashed circle), a t hiocarbonyl  
stretch at V ma x/cm
- 1
 1030 (C=S; red black circle) is also 
evident and supplemental small extra peaks are 
demonstrated at  V ma x/cm
- 1
 1220 and V ma x/cm
- 1
 1106. Spectra 
off-set for clarity.   
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b. Elemental analysis  
Table 2.3 shows elemental analysis results for iniferter modified resins.  
Table 2.3: Elemental analysis results from a series of 
prepared resins.  A: 0.5 mol equivalent resin, iniferter 
attached in water; B:  0.5 mol equivalent resin, iniferter 
attached in water/methanol (70/30 v/v %); C:  0.5 mol 
equivalent resin, iniferter attached in methanol/DMF (70/30 
v/v %) 
 
Sample 
 
C 
% (mmol g
-1
) 
 
H 
% (mmol g
-1
) 
 
N 
% (mmol g
-1
) 
 
S 
% (mmol g
-1
) 
 
A 
 
80.32 (66.93) 
 
7.81 (78.1) 
 
3.02 (2.16) 
 
0 (0) 
B 79.92 (66.60) 7.48 (74.8) 2.89 (2.06) 0 (0) 
C 60.31 (50.26) 6.64 (66.4) 5.4 (3.86) 8.98 (2.81) 
 
Elemental analysis data shown in table 2.3 partially correlates with FTIR 
findings. For example, resin C (iniferter attached in DMF/MeOH) shows the 
greatest sulphur content indicating a greater degree of iniferter coupling. 
This finding is supported by FTIR spectra (figure 2.15) that shows an 
increased stretch strength at a Vmax/cm
-1 1030 (C=S) and Vmax/cm
-1 1650 
(C=O) compared to other resins.  
What is interesting however is the lack of sulphur detection on resins A and 
resin B. These resins are iniferter coupled resins with iniferter attached in 
water and water/MeOH respectively. Therefore, it is possible the amounts 
of iniferter present were below the levels of detection for elemental 
analysis (detection limit <0.1%). However, it is likely that no iniferter was 
attached to these resins. 
Overall, FTIR and elemental analysis results were mixed. Presence of 
thiocarbonyl groups on iniferter coupled resins regardless of coupling 
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reaction conditions was encouraging; however a stronger thiocarbonyl 
stretch signal was seen from the resin that was coupled with iniferter in a 
methanol/DMF mix.  
2.4.3.2 Polymerisation with iniferter modified resin 
a. Polymerisation time point experiment 
Once iniferter is coupled to resin, it can be further modified with PMB and 
following incubation with monomers polymer growth can be evaluated. 
The monomers used in this study were acrylamide (AAm) and N-N’-
Methylenebisacrylamide (MBAam), a choice based on extensive work in 
the imprinting of LPS carried out in this laboratory. Furthermore, several 
other research groups have demonstrated successful initiation and control 
of polyacrylamide polymerisation with thiocarbamate based iniferters 
(37,64,65).  
Demonstrating the presence of polymer growth on the modified resins, 
figure 2.16 shows FTIR spectra from three modified resins that were 
subjected to polymerisation conditions for 30 minutes (black spectrum) 
and 90 minutes (red spectrum) compared to a modified resin that was not 
placed under polymerisation conditions (purple spectrum). 
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Figure 2.16: FTIR spectra of resins following iniferter 
attachment different polymerisation  times (0,  30 and 90 
minutes).  
The FTIR spectra in figure 2.16 for resins with polymerisation time of 30 
and 90 minutes demonstrated a stretch at    1690 cm-1. This stretch is 
absent from the spectra for the resin that was not subjected to 
polymerisation conditions. Furthermore, a small stretch is seen at 3200-
3400 cm-1 in the 30 and 90 minutes polymerisation time resins compared 
to the resin with no polymerisa on  me. This stretch at    1690 cm-1 is 
indicative of the carbonyl group of the monomer and the stretch at 3200-
3400 cm-1 represents amide groups. However, demonstrated by a stretch 
at    1030 cm-1, indicative of a thiocarbonyl group, there is evidence of 
remaining iniferter species on all three resins.  
The efficiency of the LPS binding interaction is dependent on the 
availability of PMB; therefore uncontrolled overgrowth of polymer during 
the imprinting process would hinder this interaction. Controlled polymer 
growth during the molecular imprinting process is an important 
consideration and underpins the choice of polymerisation method. 
Iniferter driven RDRP has been shown to produce homogenous polymers of 
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low polydispersity indices and furthermore has been shown to produce 
MIPs with improved performance compared to those produced with 
alternative polymerisation techniques (26,30). Shown in figure 2.17 is the 
theoretical result of polymer overgrowth on LPS binding experiments.  
 
 
Figure 2.17: Schematic of theoretical result of polymer 
overgrowth during surface molecular imprinting.  1.)  A 
functionalised azidomethyl resin is shown with 50% 
chloromethyl groups converted to azide, and the remainder 
left to couple with iniferter. Alkyne PMB then att aches to 
azide functional groups and functional monomers added. 2.)  
Polymerisation is initiated by iniferter species and the 
polymer grows on the surface of the functionalised resin. The 
polymer has stopped growing to allow sufficient exposure of 
PMB groups making them available for LPS interaction. 3.)  
Polymer overgrowth has occurred. Notice how PMB is now no 
longer easily accessible for LPS binding.   
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However, under growth of polymer could have also caused issues with LPS 
binding. Inadequate polymer growth would lead to an ineffective 
imprinting process as the template/monomer interaction would be 
hindered and therefore formation of LPS binding sites would become an 
issue.  
b. LPS binding 
An LPS binding experiment was carried out to evaluate dependence of 
resin binding to LPS on the length of time the sample resin was subjected 
to polymerisation conditions. The resins used in this experiment were 0.5 
mol equivalent azidomethyl resins, alkyne PMB coupled, iniferter attached 
in water and monomers added. Resins were subjected to polymerisation 
times from zero to 120 minutes.  
Figure 2.18 shows the respective binding capability (expressed as percent 
bound) of prepared resins with differing polymerisation times. If 
overgrowth did occur it would be expected that binding to LPS would 
plateau or even decrease as the polymerisation time increased.  
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Figure 2.18: Graph showing LPS binding to seven resins which 
had polymerised for different lengths of t ime.  
Optimal binding capability is demonstrated by the resin that was exposed 
to polymerisation conditions for 50 minutes. There is then a slight decline 
in binding capability across the resins that polymerised for 60, 80 and 100 
minutes. A marginal increase is then seen (however, wide error bars noted) 
in binding ability of the resin polymerised for 120 minutes. This may be due 
to polymer overgrowth preventing the successful binding of available PMB 
binding sites and LPS. Also clear is the sub-optimal binding demonstrated 
by the resins with the shortest polymerisation times (0 and 20 minutes), 
suggesting the presence of polymer itself is advantageous to LPS binding 
capability.  
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2.4.4 Imprinting Methods 
2.4.4.1 Preparation of imprinted and non-imprinted polymer: binding 
assay 
A typical calibration curve used for the calculation of LPS concentration in 
resultant binding study filtrate is shown in figure 2.19. 
 
Figure 2.19: Calibration curve for imprinting binding studies.  
Line fit by l inear regression (y= 14238x + 152.9; R
2
= 1).  
Shown in figure 2.20 are the binding study data for a set of modified resins 
following overnight incubation with known concentrations of FTIC labelled 
LPS. The tested resins shown in figure 2.20 include imprinted and non 
imprinted resins, a resin with PMB coupled and no iniferter, a resin with 
iniferter and no PMB and an iniferter and polymer modified resin. 
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Figure 2.20: Comparison of overall binding ability to L PS of 
synthesised resins.  MIP:  0.5 molar eq azidomethyl resin 
coupled with PMB and iniferter, LPS present during 
polymerisation process; NIP : 0.5 molar eq azidomethyl resin 
coupled with PMB and iniferter, no LPS present during 
polymerisation process; Resin A:  0.5 molar eq azidomethyl 
resin with PMB attached; Resin B:  0.5 molar eq azidomethyl 
resin coupled with iniferter; Resin C:  0.5 molar eq 
azidomethyl resin coupled with iniferter and subjected to 
polymerisation.   
 
Shown in figure 2.20 is a significant difference in binding ability seen 
between systems that were alkyne PMB coupled and systems that lacked 
alkyne PMB. It is likely that the measured difference in binding capability of 
the resins is a result of the mere presence of PMB, regardless of imprinting 
processes the resin was subjected to. 
A disappointing finding is that the best performance is seen in the resin 
subjected to no imprinting or polymerisation conditions (Resin A). This 
resin demonstrates similar binding to the resin used on the polymerisation 
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time point experiment once the polymerisation time had reached 50 
minutes (figure 2.18). Furthermore, the composition of the resin used in 
the time point experiment reflected that of the NIP, apart from the NIP 
washing stage (1% sodium deoxycholate (100 ml), x3) and at 60 minute 
polymerisation time (the same polymerisation time used for NIP synthesis) 
the binding performance of these two resins was similar. However, if the 
NIP had been subjected to a polymerisation time of 50 minutes it may have 
achieved binding levels comparable with Resin A. Ten minutes of extra 
polymer growth time seemed to affect resin LPS binding capability. 
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2.5 Chapter conclusions 
2.5.1 General conclusions 
Results from this chapter demonstrated that azidomethyl resin synthesis to 
a predefined azide: chloride ratio is achievable. A set of resins were 
produced that demonstrated a stepwise increase in the strength of an 
indicative azide moiety stretch on FTIR analysis. Peak areas of the azide 
FTIR stretches increased from 202 (arbitrary units) for the resin with a 
predicted 0.2 molar equivalent (20% of the molar concentration of the 
Merrifield resin chloride groups was added in azide) to a peak area of 1005 
(arbitrary units) for the predicted 1 molar equivalent resin (indicates 100% 
of the molar concentration of the Merrifield resin chloride groups was 
added in azide). Furthermore, the ongoing functionalisation of azidomethyl 
resin was possible with the attachment of modified PMB to azide moieties. 
Reflecting successful attachment of PMB to bifunctionalised Merrifield 
resin, the binding ability of PMB/azidomethyl complexes has also been 
demonstrated and associated with reasonable binding performance data. 
For example, LPS binding isotherm analysis of the 0.5 molar equivalent 
azidomethyl resin (with alkyne PMB attachment) demonstrated an 
apparent Bmax and Kd of 0.103 nmol/mg of resin and 0.328 µM, 
respectively. In comparison, binding data analysis for the 1 molar 
equivalent azidomethyl resin (with alkyne PMB attachment) showed an 
apparent Bmax of 0.216 nmol/mg of resin and an apparent Kd of 0.950 µM. 
Therefore, improved apparent LPS binding data was produced using 
functionalised resin with greater PMB attachment. 
Imprinting of biological macromolecules is notoriously difficult (66,67). 
Issues of mass transfer simply due to template size are sometimes an 
insurmountable problem. The development of surface imprinting has 
previously led to the successful MIP synthesis for large proteins (68) and 
other large biological macromolecules (69). However, the successful 
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imprinting of LPS via surface imprinting methods was not achieved in the 
experiments described in this chapter. Binding data analysis of produced 
LPS MIP and NIP were disappointing. Comparison of LPS binding of MIP and 
NIP did not suggest successful imprinting as binding performance was 
similar with the MIP binding; therefore, alternative strategies for molecular 
imprinting were investigated. 
2.5.2 Rationale for next chapter 
The use of a Merrifield resin solid support was questionable and the 
behaviour of Merrifield resin (and any modified resin) in solvents was a 
problem. Organic conditions rendered the resin in a desirable swollen state 
for coupling and polymerisation stages but aqueous conditions were 
desirable for any ongoing reactions with LPS. Furthermore, the role of PMB 
necessitated further investigation.  
Chapter three therefore explores the modification of PMB structure that 
allowed synthesis of a polymerisable PMB (p-PMB) which further facilitated 
alternative imprinting methods that negated the use of separate solid 
support.  
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3.1 Introduction 
3.1.1 Chapter outline 
This second experimental chapter outlines work with the peptide antibiotic 
polymyxin B (PMB) to facilitate molecular imprinting without the need of a 
solid support (Merrifield resin). This chapter describes methods of PMB 
structure manipulation to render it polymerisable (p-PMB) with 
subsequent synthesis of a polymyxin B polymer. Polymyxin is introduced in 
section 3.1.2 with subsequent explanation of the important PMB/LPS 
interaction.  
3.1.2 Polymyxin’s structure 
The Polymyxins are a group of naturally occurring peptide antimicrobials, 
the most studied being polymyxin B (PMB) and colistin (Polymyxin E). PMB 
is isolated from Bacillus Polymyxa, a strain of the bacillus genus and was 
originally named ‘Aerosporin’ by Ainsworth et al. in 1947 (1,2), the potent 
anti Gram-negative activity of Polymyxin was clear at this early stage (1).  
Shown in figure 3.1 is the structure of PMB, comprising a positively charged 
cyclic peptide ring and a fatty acid tail. The peptide ring contains seven 
amino acid residues, with a further two 2,4- diaminobutyric acid (Dab) and 
one Threonine (Thr) within the fatty acid tail.  
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Figure 3.1: PMB structure. In polymyxin B1 R= CH 3 and in 
polymyxin B2, R= H.DAB: γ - diaminobutric acid; Thr: 
threonine (C4H9NO 3); Phe: phenylalanine (C 9H11NO2); Leu: 
leucine (C6H1 3NO3). Positively charged cyclic rin g confers 
overall charge of +5. The fatty acid tail provides 
hydrophobicity.  
3.1.3 Polymyxin/LPS interaction 
The interaction between PMB and LPS has been investigated since the 
1950s and an extensive review published in 1956 by Newton focused 
heavily on the interaction of polymyxin with the cell wall of Gram-negative 
bacteria (3). Newton’s work also provided the first evidence of interaction 
between polymyxin and a ‘membrane underlying the bacterial cell wall’ (3). 
Since the 1950s, many investigative techniques have since been used to 
explore PMB/LPS interaction and recent examples of work in this area 
include use of computational modelling (4), NMR analysis (5), SPR analysis 
(6,7), dynamic light scattering (8) and the use of zeta potentials (8). 
Understanding this interaction may help address problems like polymyxin 
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toxicity, bacterial polymyxin resistance or the development of future 
peptide antibiotics. Furthermore, there are distinguishing features 
between the interaction of polymyxin with free LPS and interaction at LPS 
attached to Gram-negative bacteria cell walls. 
3.1.3.1 Free LPS 
NMR studies have provided a vast amount of information relating to the 
interaction of PMB and LPS and elucidated important structural 
considerations. Studying conformational changes of free PMB compared to 
PMB-LPS complexes using solution-state NMR allowed Pristorsek et al. to 
construct a molecular model for PMB/LPS interaction that showed both 
electrostatic and hydrophobic interactions serve to stabilise the PMB-LPS 
complex (9,10). Furthermore, modelling studies have shown a distinct 
conformational change of LPS upon interaction with PMB that results in 
increased separation of LPS polar and hydrophobic areas (9,10). This 
accentuates the amphiphilic nature of the LPS; a characteristic that is 
widely regarded of utmost importance in the interaction with PMB (11). 
As a result of interaction with free LPS, polymyxin B has been shown to 
promote LPS aggregation, disrupting LPS/TLR-4 binding and reducing the 
subsequent cascade of LPS triggered cytokine release from macrophages 
(8). Furthermore, it is proposed that in an aggregated cluster LPS is 
amenable to phagocytosis by macrophages; effectively sequestering LPS 
from the circulation (8,12). In their 2012 paper, Domingues et al. used 
biomembrane modelling and dynamic light scattering techniques to study 
PMB/LPS interaction. They showed that at relatively high LPS 
concentrations (0.3 - 3 mg ml-1), PMB causes the aggregation of LPS, 
forming clusters of the magnitude of 60 -100 nm width  (8). This interaction 
as described by Domingues et al. is shown in figure 3.2.  
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Figure 3.2: Demonstration of PMB interaction with LPS 
aggregates as proposed by work from Domingues and 
colleagues. 1.)  PMB introduced to circulation; 2.)  Interaction 
of PMB and aggregates of LPS (LPS micelles) causes further 
aggregation forming ‘clumps’ of LPS and finally 3.)  These 
aggregates fai l to elicit  a response from the cell via TLR4 
therefore reducing the release of sepsis mediators. Adapted 
from (8).  
Using X-ray diffraction techniques, Howe et al. tracked diffraction pattern 
changes in the aggregate structures of two LPS subtypes (LPS-R45 and LPS-
R595 from Proteus mirabilis and Salmonella minnesota, respectively) with 
and without PMB present (13). Aggregate pattern changes associated with 
a change from unilaminar to multilaminar structures were observed on the 
addition of PMB (13), demonstrating a PMB induced conformational 
change in LPS aggregates. However, the concentrations of LPS used by both 
Domingues and Howe were many magnitudes greater than found in the 
circulation of patients with sepsis (milligrams compared to picograms per 
ml (14)).  
3.1.3.2 Cell wall interaction 
The combination of electrostatic and hydrophobic interactions forms a 
widely accepted model for the interaction of PMB and Gram-negative 
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bacteria cells (11,15). Initially, the positive overall charge of PMB reliably 
allows the drug’s accumulation at the anionic bacterial membrane. 
Thereafter, further electrostatic interaction between the positively charged 
Dab residues of PMB and the negatively charged lipid A portion of LPS 
disrupts stabilising bridges of divalent cations that would normally serve to 
stabilise the outer cell membrane (11,15–17). This disruption is the catalyst 
for cell death as the increased permeability allows leakage of bacterial cell 
contents whist also allowing the influx of host serum complement 
(11,18,19). Furthermore, this action brings the PMB fatty acid tail into close 
contact with the outer membrane and this inserts itself into the cell, 
expanding (and further disrupting) the cell wall (11,20,21). NMR studies 
have shown the N-terminal fatty acid chain of PMB moves independently 
of the PMB peptide core, providing a flexibility that aids cell insertion 
(11,22,23). In their 2015 computational biology paper, Berglund et al. 
mapped the interaction of PMB1 with both the outer and the inner cell 
membrane of Escherichia coli. In agreement with previous work (11,24,25), 
they observed the importance of Dab residues to the interaction with the 
bacterial outer cell membrane and describe how PMB ‘anchors’ itself to the 
membrane via this electrostatic Dab interaction with LPS lipid head groups 
(4). Interestingly, this group also showed that within 16 milliseconds of 
PMB1/LPS interaction, PMB1 aggregates in the LPS headgroup region of 
the Escherichia coli outer membrane; forming a micelle-like structure (4). 
The cell wall defects forged by polymyxin facilitate further drug uptake 
hence the widely used term ‘self promoted uptake’ is used to summarise 
the mode of action of PMB (20). Figure 3.3 shows these PMB/LPS cell wall 
interaction events. 
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Figure 3.3: Simplified schema of the interac tion of PMB at 
the cell wall of  Escherichia coli .  1.)  PMB in close proximity to 
the bacterial outer cell wall, the posit ive charge of PMB and 
the negative charge of the cell wall are shown. 2.)  Cell wall  
disruption caused by an initial electrostatic interaction 
between the positively charged Dab residues (PMB) and the 
negatively charged lipid A portion of LPS. Cell wall disruption 
follows as the hydrophobic tail  of PMB inserts itself into the 
bacterial cell. 3.)  Having successfully rendered the bacterial 
outer cell walls and inner membrane unable to maintain an 
effective barrier,  both inward flux of host cell complement 
and outward flow of bacterial cell contents occur.  
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In addition to its direct antibacterial action, PMB also exhibits potent anti-
endotoxin activity and the release of factors such as TNF- α and interleukin-
1 activated by LPS has been shown to be inhibited by PMB and colistin (26). 
Tsuzuki and colleagues suggest this is secondary to inhibition by PMB of the 
NF-kB pathway with demonstration of an immediate decrease in NF-kB 
binding activity when PMB was added to LPS activated human blood 
mononuclear cells in vitro (27). However, in high concentrations PMB has 
previously been shown to conversely stimulate the NF-kB pathway in 
monocytes and increase the production of TNFα (28). 
3.1.4 Polymyxin B structure manipulation 
The initial interaction between PMB and the cell membrane of bacteria is 
dependent on an overall positive charge of PMB (attributed to positively 
charged amine groups) and a negatively charge portion of LPS (KDO-Lipid A 
region) (29). Therefore, in order to maintain this interaction, PMB must 
carry a positive charge and it has been shown that reducing the available 
number of amine groups in PMB structure dramatically affects the affinity 
of LPS binding (11). Furthermore, structural variants of PMB that lack 
certain Dab residues show decreased levels of insertion into bacterial cell 
membranes (both LPS and peptidoglycan monolayer) (30). An example is 
polymyxin B nonapeptide (PMBN) that lacks the fatty acid and the terminal 
dab residue of PMB (31). This PMB structural manipulation historically 
demonstrated a decrease in antimicrobial action (32) however, findings in 
successive years reported potential, indirect PMBN antimicrobial activity. 
For example, a bacterial ‘sensitisation’ effect of PMBN was demonstrated 
by Vaara and Vaara in the 1980s who found the susceptibility of Escherichia 
coli (using a smooth strain resistant to the hydrophobic antibiotics 
erythromycin, clindamycin, rifampicin and fusidic acid) to certain 
hydrophobic agents was markedly increased following the addition of 
PMBN. These findings are credited to the increased permeability of 
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bacteria cells caused by PMBN, facilitating the influx of other antibiotics 
(33). Moreover, the addition of PMBN to the same strain of Escherichia coli 
sensitised the bacteria to serum complement (33). Further work confirmed 
the susceptibility of other strains of Gram-negative bacteria (strains of 
Klebsiella pneumonia, Salmonella tryhimurium and Pseudomonas 
aeruginosa amongst others)  to erythromycin, fusidic acid and novobiocin 
when PMBN was introduced (34). Building on a body of investigative work 
on PMBN, the Vaara group have worked on a library of PMB derivative 
antibiotics with varied structure manipulations (35–37). Recently, one such 
derivate compound (denoted by NAB739) that possesses the same cyclic 
portion of PMB but the linear diaminobutyryl-theronyl-diaminobutyryl 
residue is substituted by threonyl-D-serinyl (therefore carrying only three 
positive charges), has been investigated. Findings initially showed 
comparable results of NAB739 and PMB when looking at the action against 
15 Escherichia coli strains with similar MIC50 obtained (0.5-1 µg ml
-1 and                  
0.25-1 µg ml-1, respectively) (38). Furthermore, ongoing work from this 
group continued to demonstrate NAB739’s ability to inhibit the growth of 
other Gram-negative species, the closest comparable action seen against K. 
pneumonia (MIC90 of 2 mg l
-1 compared to 1 mg l-1) (39). In 2017 the Vaara 
group also published work about another PMB derivative, NAB815 that has 
only two positives charges in its cyclic portion (40), this compound 
demonstrated impressive MICs compared to PMB.  
3.1.5 Clinical use of PMB 
3.1.5.1 General overview 
In the clinical setting, PMB has been shown to moderate adverse clinical 
conditions in septic shock such as hypotension and acidosis (41,42). 
Despite this, use of PMB declined following findings from large clinical 
studies in the 1970s that investigated polymyxin related nephrotoxicity and 
neurotoxicity. However, the advent of multi-drug resistant Gram-negative 
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bacteria in some countries has led to the resurgence of polymyxin use 
(17,43). In their 2006 systematic review, Falagas and Kasiakou reviewed 
both old and new evidence regarding polymyxin toxicity (44). Incidence of 
nephrotoxicity taken from older studies was up to 36%, whereas more 
recent studies found much lower incidence, around 15%. However, studies 
are still emerging that document the renal cellular damage caused by PMB 
(45) and the dose dependent nature of PMB renal toxicity (46). Similarly, 
discrepancy exists between old and new studies looking at neurotoxicity; 
Falagas and Kasiakou highlight that no episodes of significant neurotoxicity 
have appeared in the literature for at least the last 15 years.  
Interestingly, antimicrobial activity has been demonstrated with PMB 
immobilised on Agarose beads; demonstrating effective antimicrobial 
potency with cell membrane disruption alone without the need to directly 
enter the bacterial cell (10). Incorporation of polymyxin into carrier 
compounds, such as liposomes, has also shown benefit and effective 
antimicrobial activity against Pseudomonas aeruginosa has been 
demonstrated using liposomal PMB (47). These findings are relevant to this 
work as there is theoretical potential for synthesised polymerisable 
polymyxin to be used in LPS sequestration applications, such as in adapted 
extracorporeal circuits.  
3.1.5.2 Polymyxin in extracorporeal circuits 
In 2011, Onaizi & Leong discussed relevant issues in the attachment 
strategies of antimicrobial peptides to medical device surfaces in their 
extensive review (48). With focus on antimicrobial peptides, the paper 
looked at both the advantages of combating infection secondary to biofilm 
formation on medical devices, and the pitfalls. Importantly, the review 
highlighted the contribution to antimicrobial resistance that an increased 
availability of antimicrobial peptide coatings could bring to the population. 
Antimicrobial resistance is a major global health concern and medical 
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devices that contribute to this growing problem have no place in modern 
medicine. However, the burden of sepsis is ever present and considering 
the wealth of investigative work on extracorporeal strategies, such devices 
may have a place in the treatment of patients. 
Patients with sepsis commonly require the use of extracorporeal systems 
to undertake the role of failing kidneys (figure 3.4).  
 
 
Figure 3.4: Simplified schematic of a CVVH circuit (continuous 
veno-venous hemofiltration).  The patient is attached to the 
extracorporeal circuit via large cannulae placed into a major 
vein (internal jugular or femoral veins for example). B lood is 
then pumped from the patient and  is passed over 
membranous circuit components which serve as surrogate 
kidneys for the filtration of blood. Following fi ltration, waste 
filtrate is discarded and blood is pumped back to the patient.  
The membrane unit is representative of a possible point o n 
the circuit where specialised components could be util ised. 
For example, the addition of PMB coated membranes in 
circuitry al lowing the sequestration of LPS.  
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Also commonplace in some countries is the use of more specialised 
extracorporeal filter system designs specifically for the removal of 
endotoxin. In Japan the use of such devices has been part of the critical 
care approach in sepsis for over 20 years (49). The key part of the 
specialised design of these systems is polymyxin, and the attachment of 
PMB to specifically designed extracorporeal endotoxin removal cartridges 
(Toraymyxin®- Spectral Medical INC) (49,50).  
By the early 2000s small trials looking at such extracorporeal devices for 
the treatment of sepsis were frequently appearing in the literature. Many 
desirable features were highlighted by these studies including improved 
cardiovascular parameter profile (51), improved oxygenation of study 
patients (52,53) and, importantly, the apparent decrease in mortality 
(15,16) . Larger randomised control trials was a natural next step, ushered 
in by analysis of these preceding smaller trials (54). Published in 2009, the 
EUPHAS clinical trial (Early Use of Polymyxin B Hemoperfusion Abdominal 
Septic shock) (55) was a multicentre randomised controlled trial that 
included 64 patients from ten centres around Italy. This preliminary study 
showed a decrease in 28 day mortality rate in patients randomised to 
receive PMB hemoperfusion therapy (34% vs 53%). Commencing in 2014, 
the EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in 
a Randomised controlled trial of Adults Treated for Endotoxemia and 
Septic shock) was designed to further investigate the use of this specialised 
therapy for patients with sepsis (56). Interim analysis following 
randomisation of 184 patients lead to key recommendations including the 
increase in power to 650 patients (from 360) leading to the expansion to 60 
centres, also the exclusion criteria of a MODS (multiple organ dysfunction 
score) greater than or equal to nine being added, essentially excluding all 
but the sickest of patients. Unfortunately, results published in 2018 
showed no difference in 28 day mortality between patients in the 
treatment group to those in the control group (57). However, an 
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interesting paper reporting on an exploratory post hoc analysis of the 
EUPHRATES data showed a statistically significant increase in mortality in 
the treatment group when analysis was focussed on the sickest patients 
(high MODS sores) with moderate endotoxin activity assay (EAA) levels 
(58). Extracorporeal PMB systems also reduce other circulating bio-
molecules in addition to LPS that may be beneficial in the treatment of 
sepsis. For example, PMB sequestration cartridges can also reduce serum 
levels of the chemokine IL-8 (52), IL-6 (59), IL-18 (60) and anandamide (61). 
The stratification of patients with sepsis to treatment arms tailored to their 
own therapeutic responses may, in the future, include use of 
extracorporeal PMB devices to sequester LPS. Indeed, this is already 
employed in parts of the world.  
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3.2 Aims and Objectives 
The main aim of this chapter was to investigate the feasibility of the 
manufacture of a polymer, using a polymerisable PMB, capable of binding 
to LPS. 
Key objectives of this chapter were as follows: 
1. Successful synthesis of a modified PMB with methacrylate groups 
attached to structure. 
2. Subsequent successful integration of this synthesised modified PMB 
(denoted p-PMB (polymerisable PMB)) into a bulk polymer. 
3. Demonstrate efficient binding capability of this synthesised p-PMB 
polymer to LPS. 
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3.3 Materials and Methods 
3.3.1 Materials 
The polymyxin B used in all experiments was from Enzo (Exeter, UK). All LPS 
used was FITC- labelled Escherichia coli 0111:B4 LPS (Sigma-Aldrich). All 
other chemicals purchased from Sigma-Aldrich (Poole, UK). All organic 
solvents were of HPLC grade and were obtained from Fisher Scientific, 
(Loughborough, UK). 
3.3.2 Analysis 
3.3.2.1 Mass spectrometry 
Mass spectrometry analysis used Quattro Ultima Mass Spectrometer 
(Waters Micromass, Elstree, Herts, UK). 
3.3.2.2 Nuclear Magnetic Resonance 
Nuclear magnetic resonance performed using Bruker Avance 500Mhz 
multi-nuclear gradient NMR (Bruker, Coventry, UK). All predictive NMR 
data generated from ChemDraw Professional® software. 
3.3.2.3 Fluorescence  
Fluorescence analysis was undertaken using a FLUOstar OPTIMA 
platereader (BMG Labtech GmbH, Ortenburg, Germany). The florescence 
properties of the FITC labelled Escherichia coli 0111: B4 LPS used in all 
binding experiments was as follows: excitation wavelength of 485 nm and 
emission wavelength 520 nm (λex 485 nm/ λem 520 nm). Analysis of binding 
performance data obtained from fluorescence analysis was carried out 
with GraphPad Prism® V8 software (Bmax and Kd values from single-site 
specific binding curve fitting algorithm). 
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3.3.2.4 HPLC 
Thermo Scientific Products (Paisley, UK) automated HPLC system was used. 
Column: C18, 4.6 x 250 mm, 5µm. Two mobile phases were used - A: 99% 
ACN; 0.1% TFA and B: 99% DI water; 0.1% TFA – and a gradient elution 
employed (98% A: 2% B at time zero to 2% A: 98% B at 30 minutes). Flow 
rate: 1.8 ml min-1; injection volume: 200 µl; UV detection: 215 nm. 
3.3.3 General method overview 
The aim was to synthesise a PMB analogue that could polymerise. This was 
achieved with the substitution (to a varying degree) of PMB amine groups 
for methacrylate groups. Structure modification of PMB produce 
polymerisable PMB (p-PMB) via two routes is described. Section 3.3.5 
describes the reaction of PMB and methacryloyl chloride and section 3.3.6 
describes the reaction of PMB and glycidyl methacrylate. The different 
modification routes (figure 3.5) leave the resultant p-PMB with different 
molecular structures, which is important when analysing the mass 
spectrometry data.  
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Figure 3.5:  Reaction schematic of two possible routes to the 
structural manipulation of PMB to substitute free amine 
groups for methacrylate groups.  The left arm of the 
schematic shows the reaction of PMB with methacryloyl 
chloride. Shown on the right arm of the schematic is a second 
process using glycidyl methacrylate.  
3.3.4 Plain PMB analysis 
Plain PMB (as purchased from Enzo®) was analysed by mass spectrometry 
and NMR. These results were then used to compare synthesised PMB 
products from methacryloyl chloride and glycidyl methacrylate 
experiments.  
3.3.5 Methacryloyl chloride experiments 
3.3.5.1 Synthesis of polymerisable polymyxin (p-PMBMC) 
Into a small, two-necked, round bottomed flask, 5 ml of deionised water 
was added to 300 mg of PMB (0.25 mmol) and sonicated until a clear 
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solution obtained. The mixture was then cooled on ice. Whilst still on ice 
the following were added simultaneously in a dropwise fashion: 2 ml 1% 
sodium hydroxide, 2 ml dichloromethane containing 24.4 µl (0.25 mmol) 
methacryloyl chloride. This remained on ice and was stirred gently for 90 
minutes.  
Following 90 minutes stirring on ice the organic phase was extracted from 
the aqueous with deionised water and dichloromethane. Both aqueous and 
organic phases were sampled for analysis by thin layer chromatography, 
mass spectrometry and NMR. Aqueous phase (containing product) was 
freeze dried to fine white powder, this was stored at 4 °C.  
Furthermore, 10 mg of aqueous phase freeze dried powder (post 
extraction and post lyophilisation) was dissolved in 2 ml DI water/1 ml 
MeOH (sonicated) and analysed with HPLC. Timings of major peaks were 
noted and samples were taken from the HPLC run and were then analysed 
by mass spectrometry. 
Methacryloyl chloride experiments were not taken any further; thereafter, 
glycidyl methacrylate methods to synthesise polymerisable polymyxin and 
associated control polymers were the focus. The experimental section 3.4.3 
details findings from methacryloyl chloride experiments and therefore 
dictated the decision to continue only with the alternative experimental 
arm (glycidyl methacrylate experiments). Results in section 3.4.3 will show 
an inefficient process of synthesising single or double methacrylate 
substituted PMB in comparison to the results from glycidyl methacrylate 
experiments detailed in section 3.4.4. 
 
 Chapter Three: Polymerisable Polymyxin Experiments  
116 
 
3.3.6 Glycidyl methacrylate experiments 
3.3.6.1 Synthesis of polymerisable polymyxin (p-PMBGMA) 
Polymyxin B 300mg (0.25 mmol) was added to 20 ml of methanol. Glycidyl 
methacrylate 35.5 mg (0.25 mmol) was then added to give a 1:1 molar 
ratio of PMB: glycidyl methacrylate. Sealed in a freeze-drying vial, the 
reaction was stirred gently at 40°C in a water bath overnight. This was 
repeated using a 1:2 molar ratio of PMB: glycidyl methacrylate (300mg 
PMB (0.25 mmol); 71 mg (0.5 mmol) glycidyl methacrylate). The reaction 
was rotavap dried and resultant white powder was analysed with NMR and 
MS.  
3.3.6.2 Polymer production  
a. p-PMBGMA composite polymers 
Two polymers containing p-PMBGMA were synthesised (denoted p-PMBGMA 
Polymer A and p-PMBGMA Polymer B). Polymer A: p-PMBGMA 100 mg; AAm 
216 mg (3.04 mmol); MBAam 56 mg (0.36 mmol); azo initiator (2’2’ Azo (2-
methyl-propionamide) dihydrochloride/AAPH) 3.6 mg in DI water 800 µl. 
Polymer B: p-PMBGMA 100 mg; AAm 144 mg (2.03 mmol); MBAam 84 mg 
(0.55 mmol); AAPH 3.6 mg in DI water 800 µl.  Each sample was sparged 
with nitrogen for 7 minutes and samples were then stirred gently under UV 
light of 100mw/cm2/325 nm at a distance of 20 cm for one hour. Following 
irradiation all samples were washed and filtered in the following sequence: 
MeOH 15 ml (x2); 50/50 DI water/MeOH 15 mls (x2); MeOH 15 mls. 
Samples were dried overnight under vacuum at 40°C.   
b. Matched (control) polymers 
Two matched polymers were synthesised that did not contain p-PMBGMA
 . 
Matched polymer A: AAm 1.2 g (16.90 mmol); MBAam 0.3 g (1.95 mmol); 
AAPH 3.6 mg in DI water 800 µl. Matched polymer B: AAm 0.918 g (12.91 
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mmol); MBAam 0.54 g (3.51 mmol); azo initiator 3.6 mg in DI water 800 µl. 
Each sample was sparged with nitrogen for 7 minutes. Samples were then 
stirred gently under UV light of 100mw/cm2/ 325 nm at a distance of 20cm 
for one hour. Following irradiation all samples were washed and filtered in 
the following sequence: MeOH 15 ml (x2); 50/50 DI water/MeOH 15 ml 
(x2); and MeOH 15 ml. Samples were dried overnight under vacuum at 
40°C.  
Table 3.1 shows the composition of polymers described in this method 
section.  
Table 3.1: Composit ion of polymers used in glycidyl 
methacrylate experiments .  (Polymer (m) denoting the 
matched polymer to that particular p -PMBG MA  polymer).  
  
p-PMBGMA 
mg (mmol) 
 
AAm 
mg (mmol) 
 
MBAam 
mg (mmol) 
 
Polymer A 
 
100 (0.74) 
 
216 (3) 
 
56 (0.3) 
Polymer A (m) Nil 1200 (16) 300 (2) 
Polymer B 100 (0.74) 144 (2) 84 (0.5) 
Polymer B (m) Nil 918 (13) 540 (3.5) 
3.3.6.3 Polymer/LPS binding Studies 
Both p-PMBGMA polymers and matched (non p-PMBGMA ) were tested for 
FITC-LPS binding capability. Dried polymer (10 mg) was incubated with 
known concentrations of LPS in a glass vial. Concentrations of LPS were as 
follows (volume 1ml water for injection): blank (water for injection only); 
0.1 µ ml-1; 1 µ ml-1; 2 µ ml-1; 4 µ ml-1; 6 µ ml-1; 8 µ ml-1 and 10 µ ml-1. Three 
repeats of all concentrations were prepared. Samples were sealed and 
shaken gently overnight. Following overnight incubation all samples were 
filtered via a mixed cellulose filter and filtrate was analysed with 
fluorescence spectroscopy using a 96 well plate. The florescence properties 
 Chapter Three: Polymerisable Polymyxin Experiments  
118 
 
of the FITC labelled Escherichia coli 0111: B4 LPS used in all binding 
experiments was as follows: excitation wavelength of 485 nm and emission 
wavelength 520 nm (λex 485 nm/ λem 520 nm). 
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3.4 Results and Discussion 
3.4.1 Plain PMB analysis 
The Polymyxins are a naturally derived group of peptides; therefore, 
multiple closely related structural species occur. In 1981, Elverdam and 
Lund published chromatography separation work that isolated 13 
components from PMB and colistin (62). Furthermore, in 2001 Orwa et al. 
looked solely at PMB and isolated seven components using a poly (styrene-
divinyal benzene) semi-preparative column (63).  
PMB from Enzo® is composed of three forms of PMB (PMB1, B2 and B3). 
The minor structural differences derive from the fatty acid component. As 
shown in figure 3.6,  the fatty acid component for B1 is 6-methyloctanoic 
acid, for B2 it is 6- methylheptanocic acid and for B3 the fatty acid 
component is octanoic acid (17). 
 
 
Figure 3.6:  Schematic representation of the variable fatty 
acid portion of different varieties of PMB.  PMB1 contains the 
fatty acid 6-methyaloctanoic; PMB2 contains 6 -
methyalhepanocic and B3 contains the fatty acid portion 
octanoic acid.  
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Purchased PMB was analysed by mass spectrometry (figure 3.7) and NMR 
(figure 3.9). Despite the purchased PMB being a mixture of polymyxin B1, 
B2 and B3 (MW 1203.5, 1287.53 and 1287.55 gmol-1 respectively), the 
abundance of PMB1 is evident from the mass spectrometry analysis (peak 
at 1203.7, figure 3.7). 
 
 
Figure 3.7: Mass spectra for polymyxin B sulphate as 
purchased from  Enzo®.  M/Z 1203.7 represents PMB1. 
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NMR data from purchased PMB analysis is shown in figure 3.9 and is similar 
to that obtained from a digital prediction model (figure 3.8). 
 
 
 
Figure 3.8: Predicted 
1
H NMR for PMB1 as generated by 
ChemDraw®. 
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Figure 3.9: 1H NMR (500MHz,D 2O) of PMB sulphate.  δ=0.605 
ppm (d,1H); δ=0.681(d, 1H); δ=0.794 ppm (m,2H); δ=1.104 
ppm (m, 1H); δ=1.178 ppm (d, 2H); δ= 1.27 ppm (m, 2H); δ= 
1.494 ppm (m, 1H); δ= 1.93 (m, 1H); δ= 2.07 ppm (m, 1H); δ= 
2.206 ppm (m, 1H); δ= 2.293 ppm (m, 2H); δ= 2.942 ppm (m, 
1H); δ= 3.093 ppm (m, 4H); δ= 4.142 ppm (m, 1H); δ= 4.236 
ppm (m, 2H); δ= 4.305 ppm (m, 1H); δ= 4.482 ppm (m, 2H); 
δ= 7.233 ppm (d, 2H); δ= 7.332 ppm (m, 3H).  
3.4.2 Theoretical resultant polymerisable PMB structure 
3.4.2.1 Structure schematic 
The theoretical resultant structures of p-PMBMC and p-PMBGMA are shown 
in figure 3.10.  
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Figure 3.10: Schematic representation of structure 
modification of PMB.  A.)  Structure of plain PMB; B.)  PMB 
following reaction with methacryloyl chloride; C.)  PMB 
following reaction with glycidyl methacrylate. Modification 
circled in red.  
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3.4.2.2 Molecular weights 
The successful conversion of PMB to a polymerisable PMB via the 
substitution of one or two of the free amine groups to methacrylate groups 
was the desired outcome. The small difference in attachment of 
methacrylate group between the structures shown in figure 3.10B and 
3.10C is reflected in a molecular weight difference. These structures could 
therefore be compared with mass spectrometry analysis of the resultant 
polymerisable PMB.  
Drawing B in figure 3.10 shows the theoretical structure of a resultant p-
PMB following reaction of PMB and methacryloyl chloride, a weight of       
68 g mol-1 is added to the molecular weight of PMB of 1203.7 g mol-1  giving 
a p-PMBMC weight of 1271.7 g mol
-1. Drawing C in figure 3.10 shows the 
theoretical structure of a resultant p-PMB following reaction of PMB and 
glycidyl methacrylate and results in an additional weight of 142 g mol-1 
giving a p-PMBGMA weight of 1345.7 g mol
-1. 
3.4.2.3 Relative free amine reactivity 
In figure 3.11, PMB Dab residue positions are highlighted with their 
associated identifying number.   
 
Figure 3.11: PMB structure.  In polymyxin B1 R= CH 3 and in  
polymyxin B2, R= H. Dab residue posit ion identifiers are 
shown. 
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Therefore, the theoretical PMB derivative structures shown in figure 3.10 
demonstrate modifications to the Dab-5 residue. In their 1998 paper, 
Weinstein and colleagues investigated selective modifications of PMB to 
give tetra-boc derivatives, with antimicrobial activity of the derivatives also 
investigated (64).  As part of this work, Weinstein et al. protected the most 
reactive amine group via protonation with a strong acid, whilst other free 
amine groups were BOC protected. Of the tetra-boc derivatives they 
synthesised, the structure with the protonated amine group at position 
Dab-5 (most reactive) was abundant (64). Furthermore, recent extensive 
investigative work by Gallargo-Godoy et al. concerning the antimicrobial 
action of PMB analogues alluded to relative importance of Dab residue 
position for the maintenance of antimicrobial function (65). They 
demonstrated Dab-5 and Dab-9 alteration had the greatest effect on PMB 
potency (Dab-5 more so), whereas Dab-8 and Dab-3 alterations had 
minimal effect (65).   
3.4.3 Methacryloyl Chloride Experiments 
3.4.3.1 Synthesis of polymerisable polymyxin (p-PMBMC) 
a. General overview 
Carl Schotten was a German chemist who, along with Eugen Baumann,  
described the Schotten–Baumann reaction in 1884 (66). It was described as 
a method to circumvent the formation of carboxylic acids formed via OH   
attack on acyl chlorides during the formation of amides from acyl chlorides 
and amines in the presence of base (base added to neutralise the HCl 
formed) (67). The method necessitates the use of a two-phase system of 
water and DCM. Figure 3.12 shows a simplified schematic of a Schotten-
Baumann reaction. 
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Figure 3.12:  Simplified schema of a Schotten -Baumann 
reaction.  
Schotten-Baumann conditions are regularly used by polymer chemistry 
groups as a reliable way of synthesising specialist monomers (68,69). For 
example, in their 2004 paper Emilitri and colleagues used Schotten-
Baumann conditions to synthesise two bisarylamide monomers (for 
subsequent polymerisation into polymers containing disulphide linkages on 
their backbone) (68), demonstrating successful monomer synthesis, and 
subsequent polymer assembly, from a cystamine dihydrochloride and 
acryloyl chloride reaction. Moreover, in 2010 Boehner et al. achieved high 
yields of acrylamide from the coupling of an amine and acryloyl chloride 
under Schotten-Baumann conditions as part of a complex process to graft 
gel spots of a tetrafluorophenol polymer onto glass (69). 
Similarly, the method used to synthesise p-PMBMC via reaction of PMB and 
methacryloyl chloride (section 3.3.5.1) uses Schotten-Baumann conditions 
to attach methacrylate groups to free PMB amine groups. With the 
addition of base (1% NaOH), hydrogen chloride (reaction by-product) is 
neutralised during the reaction. Figure 3.13 shows the mechanism for the 
methacryloyl chloride and PMB reaction. 
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Figure 3.13: Methacryloyl chloride/PMB reaction .  1.)  
Nucleophilic attack on carbon by lone pair on nitrogen atom 
from free PMB amine group (Dab -5 posit ion); 2.)  Reformation 
of oxygen double bond and loss of chloride, removal of one 
hydrogen from the nitrogen is seen (removed by chloride 
ion); 3.)  Formation of product.  
b. Mass spectrometry results 
The reaction to synthesise polymerisable PMB from methacryloyl chloride 
and PMB involved extraction steps using DI water and DCM. MS analysis of 
both extraction phases is shown in figures 3.14 (DI water) and 3.15 (DCM). 
Results were compared to those obtained for plain PMB (shown in figures 
3.7 and 3.9).  
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Figure 3.14: Mass spectrometry of aqueous phase of 
extraction stage of methacryloyl chloride experiments.  M/z 
1271.6: single substituted PMB; m/z 1203.6: plain PMB with 
no substitution; m/z 1339.6: double substituted PMB; m/z 
1407.4: triple substituted PMB.  
Figure 3.14 shows a base peak at m/z of 1271.6 that represented single 
substituted PMB (1203.6 plus molecular weight of methacrylate group 68). 
Thereafter, m/z 1203.6 represented plain PMB with no substitution; m/z 
1339.6 represented double substituted PMB (1203.6 plus 136); and m/z 
1407.4 represented triple substituted PMB (1203.6 plus 204). These results 
were encouraging as the desired outcome was a dominance of single, 
double or triple substituted PMB. 
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MS analysis of DCM extraction phase is shown in figure 3.15. 
 
Figure 3.15: Mass spectrometry results from a sample taken 
from the organic phase of the extraction step (methacryloyl 
chloride experiments).   
There is no evidence of the presence of plain (un-reacted PMB) or PMB 
with any degree of modification from the MS result shown in figure 3.15. 
However, of note in this spectrum is the repeating mass increase of m/z 
100, from 922.1 to 1722. This distinctive pattern could reflect repeating 
units of the same molecular weight that occurs with polymer formation. 
With a molar mass of 100.12 gmol-1, a poosibility is the presence of methyl 
methacrylate in the organic phase. 
 Chapter Three: Polymerisable Polymyxin Experiments  
130 
 
Mass spectrometry results shown in figures 3.14 and 3.15 suggested p-
PMBGMA product was present in the post-extraction aqueous phase. The 
aqueous phase was then freeze dried overnight giving a fine white powder 
and the organic phase was discarded. However, further sample purification 
was indicated to improve outcome from any further experiments in which 
this modified PMB was used to make a polymer. 
c. HPLC analysis 
In an attempt to further purify the aqueous phase of this experiment, and 
obtain product with a greater percentage of di or tri substituted PMB, 
freeze-dried aqueous extract (10 mg) was dissolved in 2 ml DI water/1 ml 
MeOH (sonicated) and analysed with HPLC (figure 3.16). Timings of major 
peaks were noted and fractions were collected from the HPLC run at these 
times. These fractions were analysed by mass spectrometry and resultant 
spectra are shown in figures 3.17, 3.18 and 3.19. 
 
 
Figure 3.16: HPLC chromatogram for p -PMBMC  aqueous phase.  
Fractions were then siphoned corresponding with the timings 
of major peaks and analysed by mass spectrometry.  
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Shown in figure 3.17 is the mass spectrometry data from analysis of a 
fraction siphoned from the HPLC analysis run at 11 minutes and 27 
seconds.  
 
 
Figure 3.17: Mass spectrometry analysis of product retrieved 
at 11 minutes, 27 seconds from start of HPLC run.   
Major peaks are seen at m/z 1565.7; m/z 1669.5; m/z 1475.5; m/z 1271.8 
and m/z 1774.4. Unfortunately mass calculations for PMB methacrylate 
products from methacryloyl chloride/PMB experiments do not correspond 
with any of these m/z values. However, minor peaks are seen in the 
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spectra at m/z 1203.5 and 1271.5, representing un-reacted (plain) PMB and 
single substituted PMB respectively. 
Figure 3.18 shows the mass spectrometry data from analysis of a fraction 
siphoned from the HPLC analysis run at 12 minutes and 9 seconds.    
 
 
Figure 3.18: Mass spectrometry analysis of product retrieved 
at 12 minutes, 9 seconds from start of HPLC run.   
The base peak at m/z 1225.7 represents unmodified PMB plus sodium and 
m/z 1203.5 represents unmodified PMB. This particular fraction therefore 
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contained plain, unmodified PMB (no free amine groups substituted for 
methacrylate groups). 
Shown in figure 3.19 is the mass spectrometry data from analysis of a 
fraction siphoned from the HPLC analysis run at 12 minutes and 33 
seconds.  
 
Figure 3.19: Mass spectrometry analysis of product retrieved 
at 12 minutes 30 seconds from start of HPLC run.  
A major peak at m/z 1271.5 is single substituted PMB and m/z 1293 is 
single substituted PMB plus sodium. Therefore, this fraction contained 
predominately single substituted PMB. 
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A significant change in the absorption of UV at 215 nm dependent on the 
modifications to PMB carried out in these experiments is unlikely. 
Therefore the peak at 12 minutes 33 seconds on the HPLC spectra shown in 
figure 3.16 likely corresponds, as the size of the peak suggests, to the least 
abundant product in the sample tested. The mass spectrometry analysis 
results shown in figures 3.16, 3.17 and 3.19 demonstrated spectra 
pertaining to the peak at 12 minutes 33 seconds was the only fraction that 
showed desired product in significant abundance. Therefore, the majority 
of the sample analysed by HPLC contained undesired products.  
In conclusion, although it would seem product was in the aqueous phase 
and that further purification may be possible, results did not show the 
abundance of single or double substituted PMB that would be desirable to 
take forward to the bulk polymer stage. Therefore, an alternative strategy 
to the synthesis of a modified p-PMB was investigated and reactions with 
glycidyl methacrylate were undertaken and p-PMBMC was not taken 
forward to the polymerisation stage. 
3.4.4 Glycidyl methacrylate experiments 
3.4.4.1 Polymerisable polymyxin B synthesis 
a. General overview 
Glycidyl methacrylate is an epoxide. Epoxides are three-membered cyclic 
ethers and exhibit a high degree of ring strain and therefore react readily 
with nucleophiles in ring-opening reactions that give rise to more stable 
bond angles (67,70,71). Examples of epoxides and their reactions with 
nucleophiles are shown in figure 3.20. 
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Figure 3.20: Epoxides and their reaction with nucleophiles.  
1.)  Example of an epoxide showing 60  bond angles. This bond 
arrangement is di erent from the 109  bond angle seen in an 
ideal tetrahedron, therefore a high degree of ring strain is 
present (67). 2.)  Structure of glycidyl methacrylate, the 
epoxide ring is circled. 3.)  The reaction between an epoxy 
and a nucleophile containing a hydroxyl, carboxyl or amine 
group (epoxide ring opening reactions).  Normal bond angles 
are restored during this reaction. (Diagram 3 adapted from 
(67), page 435).  
The reactivity of epoxides is exploited by polymer chemists to functionalise 
polymers and several extensive reviews on the post-polymerisation 
functionalisation of polymers indicate the usefulness of epoxides for 
production of diverse polymer end-products (72–74). For example, In their 
2013 paper, McEwen and colleagues synthesised a range of functionalised 
poly (glycidyl methacrylate) polymers via epoxide ring opening reactions 
using primary and secondary amines (71). A further example is the work of 
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Potén et al., who described the fluorophore functionalisation of glycidyl 
methacrylate based monoliths for the detection of hydrogen peroxide in 
their 1996 paper (75). More recently, Kimmins et al. successfully 
immobilised the analytical enzyme proteinase K via a ring-opening reaction 
following amine functionalisation of glycidyl methacrylate emulsion-
templated porous polymers (76).  
In this experimental section the ring opening of glycidyl methacrylate 
epoxy group via nucleophilic attack by an amine was used to successfully 
substitute methacrylate groups into the PMB structure (figure 3.21).  
 
Figure 3.21: Schematic of the reaction to synthesi sed 
polymerisable polymyxin B using glycidyl methacrylate.  
Epoxide ring comes under nucleophilic attack by free amine 
group of PMB (Dab-5 position) leading to opening of r ing and 
adoption of a more stable bond angle configuration.  
b. Mass spectrometry results 
Shown in figures 3.22 and 3.23 are the MS spectra from analysis of the 
resultant product from glycidyl methacrylate /PMB experiments. Figure 
3.22 shows initial analysis of a 1:1 molar ratio reaction of PMB/glycidyl 
methacrylate. 
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Figure 3.22: Mass spectrometry of plain polymyxin B sulphate 
reacted with glycidyl methacrylate to give a polymerisable 
PMB (using a 1:1 molar ratio GMA:PMB).  M/z 1203.9 base 
peak: plain PMB (no methacrylate group attached); m/z 
1345.9: single substituted PMB (substitution of one amine 
group to methacrylate group).  
Results demonstrated in figure 3.22 were disappointing. The abundant 
peak at m/z of 1203.9 was associated with as-purchased PMB, suggesting 
no reaction of free amine groups with glycidyl methacrylate. A smaller peak 
relative to this base peak at m/z 1345.9 corresponded to the expected 
molecular weight of PMB plus one methacrylate group. The experiment to 
produce a p-PMB using reaction with glycidyl methacrylate was therefore 
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repeated using an increased concentration of glycidyl methacrylate to give 
the molar ratio of PMB : GMA of 1:2. Figure 3.23 shows analysis of a 1:2 
molar ratio reaction of PMB/glycidyl methacrylate. 
 
 
Figure 3.23: Mass spectrometry of plain polymyxin B sulphate 
reacted with glycidyl methacrylate to give a polymerisable 
PMB (using a 1:2 (PMB: GMA) molar ratio).  M/z 1203.7: non- 
substituted PMB; m/z 1345.7: single substituted PMB; m/z 
1487.6: double substituted PMB.    
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Results shown in figure 3.23 were more encouraging than those shown in 
figure 3.22. The base peak remained representative of plain as-purchased 
PMB (m/z 1203.7); however, the species in secondary abundance (m/z 
1345.7) represented a double substituted PMB (two amine groups 
modified with methacrylate functionality). The risk with this approach is 
the conversion of too many free amine groups; as discussed previously, the 
preservation of at least 3 amino groups is vital to ensure PMB retains LPS 
binding ability (11). The spectrum in figure 3.23 demonstrated the 
presence of PMB with more than the desired number of amine groups 
substituted: m/z 1629.5 represented a triple substituted species and m/z 
1771.9 represented a quadruple substituted species. However, these are 
less abundant in comparison to the double substituted species.  
c. NMR results 
Glycidyl methacrylate structure and predicted 1H NMR spectra are shown 
in figure 3.24. Thereafter; 1H NMR results are shown for plain as-purchased 
glycidyl methacrylate (figure 3.25). 
 
 
Figure 3.24: Predicted 
1
H NMR for glycidyl methacrylate as 
generated by ChemDraw® 
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Figure 3.25: 
1
H NMR (500MHz, D 2O) for glycidyl methacrylate .  
δ = 1.7474 (t, 3H); δ =2.45  (q, 1H); δ =2.62 (t, 1H); δ = 3.03 
(m, 1H); δ = 3.787 (q, 1H); δ = 4.264 (d,d, 1H); δ = 5.407 (s, 
1H); δ = 5.938 (s, 1H).  
Shown in figure 3.26 is the 1H NMR analysis of product from PMB/glycidyl 
methacrylate reaction to synthesise a polymerisable polymyxin B (p-
PMBGMA ). 
 Chapter Three: Polymerisable Polymyxin Experiments  
141 
 
 
Figure 3.26: 
1
H NMR (500 MHz, D2O) spectra of p-PMBG MA  
(from PMB /GMA reaction 1:2 molar ratio)  for comparison, 
the inlay shows NMR spectra for plain PMB. δ= 0.893ppm 
(m,4H); δ= 1.31 ppm (m, 15H); δ= 1.967 ppm (s, 30H); δ= 
2.691 ppm (q, 5H); δ= 2.855 ppm (t,  5H); δ= 3.39 ppm (s, 8H); 
δ= 3.474 ppm (d,d, 5H); δ= 3.606 ppm (m, 3H); δ= 3.99 ppm 
(q,3H); δ= 4.155 ppm (m, 5H); δ= 4.23 ppm (m, 5H); δ= 4.495 
ppm (d, 3H); δ= 4.52 ppm (d, 3H); δ= 5.671 ppm (d, 4H); δ= 
6.157 ppm (s, 4H); δ= 7.299 ppm (m, 5H).    
Shown in figure 3.26 are additional signals at ~ 5.7 and 6.2 ppm in the 1H 
NMR spectra from p-PMBGMA compared to that of the plain, as purchased 
PMB. These signals represent a methacrylate group. These signals are also 
absent from the predictive 1H NMR spectra for plain PMB1 shown in figure 
3.8. The remaining NMR spectra from the p-PMBGMA shown in figure 3.26 is 
comparable to that of the plain PMB. 
Overall, NMR analysis supported mass spectrometry analysis findings and 
showed modification of PMB structure by the addition of methacrylate 
groups had been achieved. With encouraging mass spectrometry and NMR 
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data this synthesised p-PMBGMA was taken forward and integrated into a 
polymer. 
3.4.4.2 p-PMBGMA composite Polymer synthesis and LPS binding Studies 
Having established the attachment of one or more methacrylate groups to 
PMB via the glycidyl methacrylate reaction, p-PMBGMA was used as a 
monomer to synthesise a p-PMBGMA polymer. Two p-PMBGMA polymers 
were synthesised, denoted polymer A and B. Furthermore, matched 
polymers to A and B were synthesised that did not contain p-PMBGMA. The 
composition of these polymers is shown in table 3.2.  
Table 3.2: Composit ion of polymers used in glycidyl 
methacrylate experiments.  (Polymer (m) denoting the 
matched polymer to that particular p -PMBG MA  polymer).  
  
p-PMBGMA 
mg (mmol) 
 
AAm 
mg (mmol) 
 
MBAam 
mg (mmol) 
 
Polymer A 
 
100 (0.74) 
 
216 (3) 
 
56 (0.3) 
Matched polymer A Nil 1200 (16) 300 (2) 
Polymer B 100 (0.74) 144 (2) 84 (0.5) 
Matched Polymer B  Nil 918 (13) 540 (3.5) 
 
Thereafter, a series of binding experiments to test polymer LPS binding 
capability were carried out. Binding isotherms were obtained from filtrate 
analysis of samples incubated with the p-PMBGMA polymers (A and B) and 
their corresponding matched polymers. All polymers (10 mg) were tested 
over a FTIC-LPS concentration range of 0.1 to 10 mcg ml-1.  Shown in figure 
3.27 is a typical calibration curve (post-filtering) obtained for analysis of 
purchased FITC-LPS. 
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Figure 3.27: FITC-LPS calibration curve used for p -PMBGM A  
and plain (matched) polymer binding studies.  y=58992.9x + 
375; R2= 0.999.  
Figure 3.28 shows the binding isotherms from analysing filtrate following 
incubation of p-PMBGMA polymer A compared to matched polymer A.  
 
Figure 3.28: Binding isotherms showing amount of FITC 
labelled Escherichia coli 0111:B4 LPS bound to 1 mg of 
polymer at differing concentrations of LPS for p -PMBG MA  
Polymer A and matched polymer A.   
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Note the straight isotherm seen for the matched Polymer A suggesting 
tendency toward non–specific binding (Bmax and Kd ambiguous). However, a 
curve is seen in the isotherm depicting binding in the p-PMB polymer 
system with a Bmax value of 0.055 nmol/mg polymer and Kd of 0.354 µM. 
The curve obtained for Polymer A, albeit slight, was encouraging in 
comparison to the straight line seen for the control polymer (matched 
polymer A) suggesting a degree of specific binding of LPS to the PMB 
polymer. Considering the main composite difference between these two 
polymers is the presence of p-PMBGMA , results initially indicate a polymer 
had been synthesised capable of binding to LPS. However, the binding 
performance figures are lower than expected for an efficient p-PMB 
polymer system considering the affinity of PMB for LPS and suggest a re-
design of the polymer was necessary or the initial synthesis of p-PMBGMA 
was the issue. 
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Figure 3.29 shows the binding isotherms from analysing filtrate following 
incubation of p-PMBGMA polymer B compared to matched polymer B. 
 
Figure 3.29: Binding isotherms showing amount of FITC 
labelled Escherichia coli  0111:B4 LPS bound to 1 mg of 
polymer at differing concentrations of LPS for p-PMBG MA  
Polymer B and matched polymer B . 
The binding data shown in figure 3.29 was more promising than that for 
Polymer A. For p-PMB polymer B a curved binding isotherm was 
demonstrated with a derived apparent Bmax value of 0.133 nmol/mg 
polymer and apparent Kd of 0.074 µM. Figure 3.30 shows a comparison of 
the binding isotherms for both p-PMBGMA polymers. 
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Figure 3.30: Comparison of LPS binding of both tested p -
PMBGM A polymers. Both p-PMBG MA  containing polymers 
demonstrate curved binding isotherms.  
There is a marked difference in the binding performance between the 
polymers containing p-PMBGMA. The Bmax values for p-PMBGMA Polymers A 
and B (0.069 and 0.133 nmol per mg polymer, respectively) show a 
significant difference in the binding site density between the two polymers. 
The Kd values are also different, showing that p-PMBGMA Polymer B, with a 
lower Kd of 0.074 µM, has higher affinity for LPS than p-PMBGMA Polymer A 
with a Kd 0.327 µM.  
This is interesting considering the mass of p-PMBGMA used in the synthesis 
of both Polymer A and Polymer B was the same. However, both polymers 
were designed with different degrees of crosslinking, and this variable may 
explain the observed difference in polymer binding performance. The 
greater degree of crosslinking seen in Polymer B (AAm: MBAam 4:1) 
compared to Polymer A (10:1) ensured the successful integration of p-
PMBGMA into the polymer matrix and therefore more reliable availability of 
PMB/LPS binding sites. Furthermore, increased crosslinking may have 
decreased steric hindrance, allowing the large LPS molecules greater access 
to PMB binding sites. Given that the initial interaction of LPS and PMB is 
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electrostatic, the relative surface charge of the two polymers was a 
determinant in this binding performance difference. However, AAm and 
MBAam are non-ionic monomers and polyacrylamide matrix is un-charged; 
if desired charge is often introduced to polyacrylamide with secondary 
monomers, acrylic acid for example confers a negative charge (77). 
Conversely, introducing p-PMBGMA as a co-monomer introduced a positive 
charge (with valence dependent on the degree of methacrylate 
substitution of the p-PMBGMA). During polymerisation it was hypothesised 
that p-PMBGMA with the greater number of substituted methacrylate 
groups would be integrated into the crosslinked polymer matrix before 
those with a lower number of methacrylate groups. Therefore, p-PMBGMA 
with less methacrylate substitution (and hence more available amide 
groups, and a greater positive charge) would be available for LPS binding. A 
reduction in crosslinking would therefore increase the chance of a polymer 
with only p-PMBGMA with lower LPS binding ability integrated as a co-
monomer. 
The performance of the matched (control) Polymers A and B is also 
different. Matched polymer A demonstrated a straight binding isotherm 
compared to the curved isotherm generated by matched polymer B. 
Similar to its p-PMBGMA counterpart, matched Polymer B has a higher 
degree of crosslinking when compared to matched polymer A (acrylamide 
to MBA ratios of 3:1 compared to 8:1) suggesting that despite the lack of 
integrated p-PMBGMA the polymer still demonstrated LPS binding ability 
dependent on degree of crosslinking.  
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3.5 Chapter conclusions 
3.5.1 General conclusions 
The overarching aim was to produce a polymer from a custom-made 
monomer of modified PMB. The staged approach included the 
optimisation of two key processes, firstly the successful modification of 
PMB structure to attach methacrylate groups and secondly, the integration 
of modified PMB into a polymer.  
The experiments to synthesise p-PMB via the methacryloyl chloride route 
yielded product with predominance of PMB with high degrees of 
methacrylate substitution and were therefore not taken onto the 
polymerisation stage.  Experiments to synthesise p-PMB focused on 
controlled substitution of methacrylate for amine groups as interaction of 
PMB and LPS depends on the presence of at least two PMB amine groups 
(11,30,31). Therefore, the polymerisable polymyxin from the glycidyl 
methacrylate experiments was further utilised in p-PMBGMA polymer 
synthesis.  
These polymers were tested to assess binding capability to LPS and binding 
studies showed the potential specific binding of LPS to this bulk polymer 
due to integration of p-PMBGMA into the polymer structure. The p-PMBGMA 
polymer with the best performance in these studies demonstrated a Bmax 
of 0.133 nmol/mg polymer and a Kd of 0.074 µM. 
3.5.2 Rationale for next chapter 
Moving forward, the aim was to produce an imprinted p-PMB polymer 
bead that would potentially act as a MIP for LPS detection. However, it has 
been demonstrated that LPS is not a suitable template for conventional 
molecular imprinting strategies, therefore techniques that circumvent 
problems associated with the imprinting of biological macromolecules 
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were needed. One such approach was to localise the template at a surface 
via chemical immobilisation at a solid-solvent interface (surface imprinting 
on a solid support) and this was explored in chapter two. Another approach 
was molecular imprinting via self-assembly at a solvent-solvent interface. 
Therefore, a solvent-solvent interface system designed to facilitate both 
the self assembly stage of molecular imprinting and the polymerisation 
stage was needed. This work involved the integration of a microfluidic 
system (providing the solvent-solvent interface) into a microwave delivery 
system (providing the polymerisation stage).  
Microfluidic system development is described in chapter four and the 
microwave delivery system is described in the final experimental chapter, 
chapter five. 
  
 Chapter Three: Polymerisable Polymyxin Experiments  
150 
 
3.6 References 
1.  Ainsworth GC, Brown AM, Brownlee G. ‘Aerosporin’, an Antibiotic 
Produced by Bacillus aerosporus Greer. Nature. 1947 Aug 
23;160(4060):263–263.  
2.  Langlykke RGBF. Antibiotic activity of Bacillus polymyxa. J Bacteriol. 
1947 Jul 1;54(1):24.  
3.  Newton BA. THE PROPERTIES AND MODE OF ACTION OF THE 
POLYMYXINS. Bacteriol Rev. 1956 Mar;20(1):14–27.  
4.  Berglund NA, Piggot TJ, Jefferies D, Sessions RB, Bond PJ, Khalid S. 
Interaction of the Antimicrobial Peptide Polymyxin B1 with Both 
Membranes of E . coli : A Molecular Dynamics Study. PLOS Comput 
Biol. 2015 Apr 17;11(4):e1004180.  
5.  Mares J, Kumaran S, Gobbo M, Zerbe O. Interactions of 
Lipopolysaccharide and Polymyxin Studied by NMR Spectroscopy. J 
Biol Chem. 2009 Apr 24;284(17):11498–506.  
6.  Thomas CJ, Surolia A. Kinetics of the interaction of endotoxin with 
polymyxin B and its analogs: a surface plasmon resonance analysis. 
FEBS Lett. 1999 Feb 26;445(2–3):420–4.  
7.  Thomas CJ, Surolia N, Surolia A. Surface plasmon resonance studies 
resolve the enigmatic endotoxin neutralizing activity of polymyxin B. J 
Biol Chem. 1999 Oct 15;274(42):29624–7.  
8.  Domingues MM, Inácio RG, Raimundo JM, Martins M, Castanho 
MARB, Santos NC. Biophysical characterization of polymyxin B 
interaction with LPS aggregates and membrane model systems. 
Biopolymers. 2012;98(4):338–44.  
9.  Pristovsek P, Kidric J. Solution structure of polymyxins B and E and 
effect of binding to lipopolysaccharide: an NMR and molecular 
modeling study. J Med Chem. 1999 Nov 4;42(22):4604–13.  
10.  Pristovsek P, Kidric J. The search for molecular determinants of LPS 
inhibition by proteins and peptides. Curr Top Med Chem. 
2004;4(11):1185–201.  
11.  Velkov T, Thompson PE, Nation RL, Li J. Structure—Activity 
Relationships of Polymyxin Antibiotics. J Med Chem. 2010 Mar 
11;53(5):1898–916.  
 
 Chapter Three: Polymerisable Polymyxin Experiments  
151 
 
12.  Domingues MM, Castanho MARB, Santos NC. rBPI 21 Promotes 
Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by 
(Hemi)fusion of PG-Containing Membranes. PLOS ONE. 2009 Dec 
22;4(12):e8385.  
13.  Howe J, Andrä J, Conde R, Iriarte M, Garidel P, Koch MHJ, et al. 
Thermodynamic Analysis of the Lipopolysaccharide-Dependent 
Resistance of Gram-Negative Bacteria against Polymyxin B. Biophys J. 
2007 Apr 15;92(8):2796–805.  
14.  Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, et al. 
Relationship between plasma levels of lipopolysaccharide (LPS) and 
LPS-binding protein in patients with severe sepsis and septic shock. J 
Infect Dis. 1999 Nov;180(5):1584–9.  
15.  Powers J-PS, Hancock REW. The relationship between peptide 
structure and antibacterial activity. Peptides. 2003 Nov;24(11):1681–
91.  
16.  Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: 
Mechanisms, frequency and treatment options. Drug Resist Updat. 
2010 Aug;13(4–5):132–8.  
17.  Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment 
of multidrug-resistant pathogens: a critical review. J Antimicrob 
Chemother. 2007 Dec 1;60(6):1206–15.  
18.  Teuber M, Bader J. Action of polymyxin B on bacterial membranes. 
Arch Microbiol. 1976 Aug 1;109(1–2):51–8.  
19.  Rosenthal KS, Storm DR. Disruption of the Escherichia coli outer 
membrane permeability barrier by immobilized polymyxin B. J 
Antibiot (Tokyo). 1977 Dec;30(12):1087–92.  
20.  Hancock RE. Peptide antibiotics. The Lancet. 1997 Feb 
8;349(9049):418–22.  
21.  Clausell A, Garcia-Subirats M, Pujol M, Busquets MA, Rabanal F, Cajal 
Y. Gram-negative outer and inner membrane models: insertion of 
cyclic cationic lipopeptides. J Phys Chem B. 2007 Jan 25;111(3):551–
63.  
22.  Meredith JJ, Dufour A, Bruch MD. Comparison of the structure and 
dynamics of the antibiotic peptide polymyxin B and the inactive 
nonapeptide in aqueous trifluoroethanol by NMR spectroscopy. J Phys 
Chem B. 2009 Jan 15;113(2):544–51.  
 Chapter Three: Polymerisable Polymyxin Experiments  
152 
 
23.  Bruch MD, Cajal Y, Koh JT, Jain MK. Higher-Order Structure of 
Polymyxin B:  The Functional Significance of Topological Flexibility. J 
Am Chem Soc. 1999 Dec 1;121(51):11993–2004.  
24.  Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion 
of bacterial lipopolysaccharides. Immunochemistry. 1976 
Oct;13(10):813–8.  
25.  Kanazawa K, Sato Y, Ohki K, Okimura K, Uchida Y, Shindo M, et al. 
Contribution of each amino acid residue in polymyxin B(3) to 
antimicrobial and lipopolysaccharide binding activity. Chem Pharm 
Bull (Tokyo). 2009 Mar;57(3):240–4.  
26.  Evans ME, Feola DJ, Rapp RP. Polymyxin B Sulfate and Colistin: Old 
Antibiotics for Emerging Multiresistant Gram-Negative Bacteria. Ann 
Pharmacother. 1999 Sep 1;33(9):960–7.  
27.  Tsuzuki H, Tani T, Ueyama H, Kodama M. Lipopolysaccharide: 
neutralization by polymyxin B shuts down the signaling pathway of 
nuclear factor kappaB in peripheral blood mononuclear cells, even 
during activation. J Surg Res. 2001 Sep;100(1):127–34.  
28.  Bl J, S S, M CN, Aj K, Bj P. Polymyxin-B stimulates tumor necrosis 
factor-alpha production by human peripheral blood mononuclear 
cells. Int J Artif Organs. 1998 May;21(5):269–73.  
29.  Rifkind D. Studies on the interaction between endotoxin and 
polymyxin B. J Infect Dis. 1967 Dec;117(5):433–8.  
30.  Clausell A, Pujol M, Alsina MA, Cajal Y. Influence of polymyxins on the 
structural dynamics of Escherichia coli lipid membranes. Talanta. 2003 
Jun 13;60(2–3):225–34.  
31.  Vaara M. Polymyxin B nonapeptide complexes with 
lipopolysaccharide. FEMS Microbiol Lett. 1983 Apr;18(1–2):117–21.  
32.  Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide 
antibiotics. Annu Rev Biochem. 1977;46:723–63.  
33.  Vaara M, Vaara T. Sensitization of Gram-negative bacteria to 
antibiotics and complement by a nontoxic oligopeptide. Nature. 1983 
Jun 9;303(5917):526–8.  
34.  Viljanen P, Vaara M. Susceptibility of gram-negative bacteria to 
polymyxin B nonapeptide. Antimicrob Agents Chemother. 1984 
Jun;25(6):701–5.  
 Chapter Three: Polymerisable Polymyxin Experiments  
153 
 
35.  Vaara M, Siikanen O, Apajalahti J, Fox J, Frimodt-Møller N, He H, et al. 
A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and 
Carries Only Three Positive Charges Has Strong Synergism with Agents 
Excluded by the Intact Outer Membrane. Antimicrob Agents 
Chemother. 2010 Aug;54(8):3341–6.  
36.  Vaara M. Polymyxins and their novel derivatives. Curr Opin Microbiol. 
2010 Oct;13(5):574–81.  
37.  Vaara M. Novel derivatives of polymyxins. J Antimicrob Chemother. 
2013 Jun;68(6):1213–9.  
38.  Vaara M, Fox J, Loidl G, Siikanen O, Apajalahti J, Hansen F, et al. Novel 
polymyxin derivatives carrying only three positive charges are 
effective antibacterial agents. Antimicrob Agents Chemother. 2008 
Sep;52(9):3229–36.  
39.  Vaara M, Sader HS, Rhomberg PR, Jones RN, Vaara T. Antimicrobial 
activity of the novel polymyxin derivative NAB739 tested against 
Gram-negative pathogens. J Antimicrob Chemother. 2013 
Mar;68(3):636–9.  
40.  Vaara M, Vaara T, Tyrrell JM. Structure–activity studies on polymyxin 
derivatives carrying three positive charges only reveal a new class of 
compounds with strong antibacterial activity. Peptides. 2017 
May;91:8–12.  
41.  Flynn PM, Shenep JL, Stokes DC, Fairclough D, Hildner WK. Polymyxin 
B moderates acidosis and hypotension in established, experimental 
gram-negative septicemia. J Infect Dis. 1987 Nov;156(5):706–12.  
42.  Baldwin G, Alpert G, Caputo GL, Baskin M, Parsonnet J, Gillis ZA, et al. 
Effect of polymyxin B on experimental shock from meningococcal and 
Escherichia coli endotoxins. J Infect Dis. 1991 Sep;164(3):542–9.  
43.  Velkov T, Roberts KD, Nation RL, Thompson PE, Li J. Pharmacology of 
polymyxins: new insights into an “old” class of antibiotics. Future 
Microbiol. 2013 Jun;8(6):711–24.  
44.  Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review 
of the evidence from old and recent studies. Crit Care Lond Engl. 2006 
Feb;10(1):R27.  
45.  Vattimo M de FF, Watanabe M, Fonseca CD da, Neiva LB de M, Pessoa 
EA, Borges FT. Polymyxin B Nephrotoxicity: From Organ to Cell 
Damage. PLOS ONE. 2016 Aug 17;11(8):e0161057.  
 Chapter Three: Polymerisable Polymyxin Experiments  
154 
 
46.  Elias LS, Konzen D, Krebs JM, Zavascki AP. The impact of polymyxin B 
dosage on in-hospital mortality of patients treated with this antibiotic. 
J Antimicrob Chemother. 2010 Oct 1;65(10):2231–7.  
47.  Alipour M, Halwani M, Omri A, Suntres ZE. Antimicrobial effectiveness 
of liposomal polymyxin B against resistant Gram-negative bacterial 
strains. Int J Pharm. 2008 May 1;355(1–2):293–8.  
48.  Onaizi SA, Leong SSJ. Tethering antimicrobial peptides: current status 
and potential challenges. Biotechnol Adv. 2011 Feb;29(1):67–74.  
49.  Tani T, Shoji H, Guadagni G, Perego A. Extracorporeal removal of 
endotoxin: the polymyxin B-immobilized fiber cartridge. Contrib 
Nephrol. 2010;167:35–44.  
50.  Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: 
endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial Off 
Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther. 2003 
Feb;7(1):108–14.  
51.  Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, et al. 
Endotoxin removal by direct hemoperfusion with an adsorbent 
column using polymyxin B-immobilized fiber ameliorates systemic 
circulatory disturbance in patients with septic shock. Am J Kidney Dis 
Off J Natl Kidney Found. 2002 May;39(5):937–47.  
52.  Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early 
hemoperfusion with an immobilized polymyxin B fiber column 
eliminates humoral mediators and improves pulmonary oxygenation. 
Crit Care. 2005;9(6):R653–61.  
53.  Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, et 
al. Direct hemoperfusion using a polymyxin B immobilized column 
improves acute respiratory distress syndrome. J Clin Apheresis. 
2002;17(2):97–102.  
54.  Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et 
al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a 
systematic review. Crit Care Lond Engl. 2007;11(2):R47.  
55.  Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. 
Early use of polymyxin B hemoperfusion in abdominal septic shock: 
the EUPHAS randomized controlled trial. JAMA. 2009 Jun 
17;301(23):2445–52. 
 
 Chapter Three: Polymerisable Polymyxin Experiments  
155 
 
56.  Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP. 
The EUPHRATES trial (Evaluating the Use of Polymyxin B 
Hemoperfusion in a Randomized controlled trial of Adults Treated for 
Endotoxemia and Septic shock): study protocol for a randomized 
controlled trial. Trials. 2014;15:218.  
57.  Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall 
JC, et al. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day 
Mortality in Patients With Septic Shock and Elevated Endotoxin Level: 
The EUPHRATES Randomized Clinical Trial. JAMA. 2018 Oct 
9;320(14):1455–63.  
58.  Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli 
M. Polymyxin B hemoperfusion in endotoxemic septic shock patients 
without extreme endotoxemia: a post hoc analysis of the EUPHRATES 
trial. Intensive Care Med. 2018 Dec 1;44(12):2205–12.  
59.  Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, 
et al. Treatment of severe sepsis and septic shock by CHDF using a 
PMMA membrane hemofilter as a cytokine modulator. Contrib 
Nephrol. 2010;166:73–82.  
60.  Nakamura T, Kawagoe Y, Suzuki T, Shoji H, Ueda Y, Kobayashi N, et al. 
Changes in plasma interleukin-18 by direct hemoperfusion with 
polymyxin B-immobilized fiber in patients with septic shock. Blood 
Purif. 2005;23(6):417–20.  
61.  Kohro S, Imaizumi H, Yamakage M, Masuda Y, Namiki A, Asai Y, et al. 
Anandamide absorption by direct hemoperfusion with polymixin B-
immobilized fiber improves the prognosis and organ failure 
assessment score in patients with sepsis. J Anesth. 2006;20(1):11–6.  
62.  Elverdam I, Larsen P, Lund E. Isolation and characterization of three 
new polymyxins in polymyxins B and E by high-performance liquid 
chromatography. J Chromatogr. 1981 Nov 20;218:653–61.  
63.  Orwa JA, Govaerts C, Busson R, Roets E, Van Schepdael A, 
Hoogmartens J. Isolation and structural characterization of polymyxin 
B components. J Chromatogr A. 2001 Apr 6;912(2):369–73.  
64.  Weinstein J, Afonso A, Moss E, Miller GH. Selective chemical 
modifications of polymyxin B. Bioorg Med Chem Lett. 1998 Dec 
1;8(23):3391–6.  
65.  Gallardo-Godoy A, Muldoon C, Becker B, Elliott AG, Lash LH, Huang JX, 
et al. Activity and Predicted Nephrotoxicity of Synthetic Antibiotics 
Based on Polymyxin B. J Med Chem. 2016 Feb 11;59(3):1068–77.  
 Chapter Three: Polymerisable Polymyxin Experiments  
156 
 
66.  Schotten C. Ueber die Oxydation des Piperidins. Berichte Dtsch Chem 
Ges. 1884 Jul 1;17(2):2544–7.  
67.  Clayden J, Greeves N, Warren S, Wothers P. Organic Chemistry. 
Oxford ; New York: OUP Oxford; 2001. 1512 p.  
68.  Emilitri E, Ranucci E, Ferruti P. New poly(amidoamine)s containing 
disulfide linkages in their main chain. J Polym Sci Part Polym Chem. 
2005 Apr 1;43(7):1404–16.  
69.  Boehner CM, Marsden DM, Sore HF, Norton D, Spring DR. High 
throughput ‘catch-and-release’ synthesis within spatially discrete gel 
arrays. Tetrahedron Lett. 2010 Nov 10;51(45):5930–2.  
70.  Kolb HC, Finn MG, Sharpless KB. Click Chemistry: Diverse Chemical 
Function from a Few Good Reactions. Angew Chem Int Ed Engl. 2001 
Jun 1;40(11):2004–21.  
71.  McEwan KA, Slavin S, Tunnah E, Haddleton DM. Dual-functional 
materials via CCTP and selective orthogonal thiol-Michael 
addition/epoxide ring opening reactions. Polym Chem. 2013 Mar 
19;4(8):2608–14.  
72.  Matyjaszewski K, Tsarevsky NV. Nanostructured functional materials 
prepared by atom transfer radical polymerization. Nat Chem. 2009 
Jul;1(4):276–88.  
73.  Peters EC, Svec F, Fréchet JMJ. Rigid Macroporous Polymer Monoliths. 
Adv Mater. 1999 Oct 1;11(14):1169–81.  
74.  Gauthier MA, Gibson MI, Klok H-A. Synthesis of Functional Polymers 
by Post-Polymerization Modification. Angew Chem Int Ed. 2009 Jan 
1;48(1):48–58.  
75.  Pontén E, Viklund C, Irgum K, Bogen ST, Lindgren ÅN. Solid Phase 
Chemiluminescence Detection Reactors Based on in Situ Polymerized 
Methacrylate Materials. Anal Chem. 1996 Jan 1;68(24):4389–96.  
76.  Kimmins SD, Cameron NR. Functional Porous Polymers by Emulsion 
Templating: Recent Advances. Adv Funct Mater. 2011;21(2):211–225.  
77.  Verheyen E, Schillemans JP, van Wijk M, Demeniex M-A, Hennink WE, 
van Nostrum CF. Challenges for the effective molecular imprinting of 
proteins. Biomaterials. 2011 Apr;32(11):3008–20.  
Chapter 4: Molecular Imprinting studies without a solid support: Microfluidic applications 
 
157 
 
Chapter 4. Towards molecular 
imprinting without a solid 
support:  Microfluidic system 
development 
 
 
  
Chapter 4: Molecular Imprinting studies without a solid support: Microfluidic applications 
 
158 
 
4.1 Introduction 
4.1.1 Chapter outline 
This experimental chapter introduces a strategy for molecular imprinting at 
a liquid/liquid interface. It describes the initial stages of a microfluidic 
system development to establish an organic/aqueous interface within a 
generated segmented flow.  
4.1.2 General principles of microfluidics 
4.1.2.1 Overview 
Microfluidics (MF) describes the strategic flow manipulation of small 
volumes of fluid (10-8 to 10-11L) (1). MF systems therefore comprise of 
multiple components all designed for the throughput of fluids on a small 
scale. Owing to the desirable handling of small volumes of fluid, MF 
technology has multiple applications in a diverse range of scientific fields. 
For example, MF systems are used for the handling of single cells for 
analysis in cell biology (2,3), the separation of DNA for analysis (4), the 
encapsulation of biological material (5,6), complex immunoassays (7,8), 
and for drug development (9,10).  
The foundation of modern microfluidics is work from the late 1970s when, 
in 1979, the concept of a ‘lab-on-a-chip’ was realised with the manufacture 
of a miniature gas chromatography device chemically etched into silicon 
(11). Lab-on-a-chip refers to technology capable of laboratory grade 
analysis undertaken by a device on a miniscule scale (12) and it is an 
important facet of MEMS (micro-electro-mechanical systems). Lab-on-a-
chip is also interchanged with the term micro Total Analysis Systems 
(µTAS); all of which labour the important point of miniaturisation.  
Sophisticated MF systems now exist demonstrating countless combinations 
of channel geometry to allow processing of small fluid volumes (13). 
Furthermore, systems often integrate components such as separators, 
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filters and pumps. Components can also be added for specific analytical 
purpose and in this project a microwave resonator cavity as a specialised 
method of polymerisation was eventually included. In their 2017 
comprehensive review of microfluidics for the chemical and biological 
sciences, Chiu et al. outlined their perceived future for microfluidic 
technology. They provided vast evidence for the field of microfluidics 
fulfilling expectations seeded in the 1990s (improved analytical 
performance, functionality and economics) and predicted that greater and 
greater numbers of ‘microfluidic-embedded’ instruments would be 
available in the future (14). 
A key consideration in the application of MF systems is the difference in 
fluid behaviour on the micro when compared to the macro scale. The 
interplay of forces (section 4.1.2.2) and dimensionless parameters (section 
4.1.2.3) that dictate fluid flow through small channels are important in the 
understanding of flow manipulation. 
4.1.2.2 Forces  
When immiscible fluids like water and chloroform meet in a macrofluidic 
setting, the fluids will separate dictated by their respective densities. 
Forces such as gravity and inertial force are therefore important in the 
observation of fluid behaviour. This is a more tangible situation; the notion 
of gravity being responsible for observations is familiar. However, on the 
microscale forces dependent on volume (gravity, inertia) are insignificant in 
comparison to surface forces (surface tension, shear stresses). This is 
because forces dependent on characteristic length scale (which signifies 
magnitude) change in their relative contribution to fluid behaviour as the 
magnitude of the system decreases (as in microfluidics) (15).  
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This shift can be explained by microfluidics scaling laws that express the 
variation in physical phenomena as the characteristic length scale of a 
system (denoted l) changes (equation 4.1) (15).  
                                                                                                        (4.1a) 
                                                                                                              (4.1b) 
              
             
   
  
  
  
 
 
                                                                                   (4.1c) 
Scaling laws shown in equations 4.1a, b and c demonstrate that forces 
dependent on volume (proportional to l3) decrease to a greater degree 
than surface forces (proportional to l2) when length scale is reduced. 
4.1.2.3 Dimensionless parameters 
Fluid flow in microfluidic systems is governed by physical phenomena that 
are described by a group of dimensionless parameters (15). These 
parameters can also be expressed as ratios between forces, length scales 
or other quantities of the relevant physical properties (15). Perhaps the 
two most important of these dimensionless parameters is the Reynold’s 
Number and the capillary number. 
a. Reynold’s number: 
The Reynold’s number describes the relative contribution of inertial forces 
and viscous forces and is a key parameter in the characterisation of viscous 
flow.  
    
   
 
                                                                                                              (4.2) 
In equation 4.2 ρ: fluid density (kg m-3); v: characteristic velocity (m s-1); l: 
characteristic length scale (m); η: dynamic viscosity (Pa. s).  
On the macroscale, when Reynold’s number is low, viscous forces 
dominate over inertial forces and flow is laminar as opposed to turbulent. 
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Conversely, flow of two miscible fluids in microfluidic systems occurs in 
parallel, with the fluids demonstrating low Reynold’s numbers (indicating 
the relative unimportance of inertial forces and predominance of laminar 
flow (16,17)). However, immiscible fluids bring another force into 
consideration as surface tension also contributes to fluid behaviour. The 
capillary number highlights the importance of surface tension. 
b. Capillary number:  
The capillary number describes the relationship between viscous force and 
surface tension. 
    
  
 
                                                                                                               (4.3) 
In equation 4.4 η: dynamic viscosity (Pa. s); v: velocity (m s-1); γ: surface 
tension (interfacial tension) (N m-1). Practically speaking, microfluidic 
systems tend to demonstrate capillary numbers between 10-4 and 10-1 (18) 
and these low Ca values indicate that interfacial tension dominates viscous 
stresses in MF systems (19). Furthermore, spheres are more likely to form 
under these conditions as drops attempt to minimise surface area (18,20). 
The capillary number therefore defines flow characteristics for multiphase 
flow, where the constraints forced upon two mixing phases by surface 
force combined with viscous forces give rise to droplet formation (21). 
4.1.3 Droplet formation in microfluidic systems 
4.1.3.1 General overview 
The formation of droplets is often the primary aim in MF system design and 
is a discipline in of itself with many extensive reviews dedicated solely to 
this aspect of MF technology (22–26). Control of both morphology and 
polydispersity of droplets are often the focus of droplet microfluidics 
studies. Factors such as liquid flow speeds (27–30), channel geometries 
(25,31,32) and external physical factors (exposure to electricity (33) and 
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temperature manipulation (30) for example) have all been investigated 
when exploring droplet formation.  
4.1.3.2 Geometries and droplet formation 
The formation of droplets of a desired geometry hinges on the way in 
which two (or more) streams of liquids are introduced within the MF 
system. This is commonly the most complex element of any MF system 
from a design perspective and groups routinely design ever more elaborate 
MF systems to fit their purpose (34,35). For example, microfluidic Large 
Scale Integration (mLSI) describes the development of MF systems with 
hundreds or thousands of integrated micromechanical valves (36), allowing 
the multiplexing of biological assays. 
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Shown in figure 4.1 are the three geometric configurations that dominate 
droplet formation dynamics:  t-junction, flow focusing and co-flow.  
 
 
Figure 4.1: Schematic representation of the three main 
microfluidic configurations for droplet forming junctions.  The 
t-junction represented by the top diagram is the 
configuration used in this study. Diagram adapted from (37).  
In this study a t-junction was used to generate segmented flow, therefore 
further discussion focuses on this geometry.  
4.1.3.3 The t-junction 
The two main advantages of t-junctions are the ease in which they can be 
fabricated (allowing the relatively straightforward process of on-bench 
design and manufacture) and predictable droplet formation owing to pre-
determined channel geometries (32,38). The main determinant of the size 
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of droplets formed within a microchannel system is the geometry of the    
t-junction (9). 
Shown in figure 4.2 are the two principle flow configurations seen at a t-
junction. The t-junction design in this study channelled the continuous flow 
via the horizontal channel and the dispersed phase via the perpendicular 
channel. This cross-flow arrangement distinguishes it from a perpendicular 
flow system where continuous phase flows via the perpendicular channel 
and the dispersed phase via the horizontal channel.  
 
 
 
Figure 4.2: Schematic representation of cross -flow and 
perpendicular flow t -piece designs.  A.) Cross-flow design; the 
dispersed phase is introduced to the continuous ste am. B.)  
Perpendicular flow; in this design the continuous phase is 
introduced to the dispersed phase.  
There are also two main distinct flow regimes observed in the formation of 
droplets at a t-junction: squeezing and dripping (figure 4.3). Squeezing 
occurs when the droplet occupies the entirety of the main channel and 
dripping occurs when the droplet only occupies a proportion of this 
channel width (39). Furthermore, the regimes can be classified according to 
calculated capillary number of the continuous phase (Ca <0.002 for 
squeezing and Ca 0.01- 0.3 for dripping (40)).  
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Figure 4.3: Demonstration of squeezing and dripping flow 
regimes through a microfluidic co -flow t-junction. Adapted 
from (37).  
In 2001, Thorsen et al. neatly described, via mathematical models, the 
formation of a droplet at a t-junction (29). Thorsen et al. looked at the size 
of droplets obtained from a variety of flow speeds and concluded that 
droplet break off was dictated by a balance of the shear stress exerted on 
the droplet by the continuous phase and the interfacial tension between 
the two phases (29). A scaling model for the prediction of droplet size is 
also proposed in this paper, referring to the space between the droplet and 
the channel wall, therefore indicating the applicability of this model to the 
dripping regime of droplet formation. However, when alternative flow 
regimes occur, (squeezing) the model proposed by Thorsen et al. becomes 
inaccurate. In a squeezing scenario modelling papers from Garstecki (23) 
and Menech (24), for example, are more relatable. These authors both 
stress the importance of relative hydrostatic pressures of the continuous 
phase and dispersed phase in droplet break off. Furthermore, both 
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highlight the importance of the capillary number for the continuous phase 
when establishing the mechanism of droplet formation. 
4.1.3.4 Droplets to beads 
A logical step from the production of droplets is the eventual production of 
solid beads and microfluidic systems are well placed to efficiently produce 
beads of a pre-determined size (41). The use of microfluidics to prepare 
polymer particles in particular is the subject of many review articles (41–
44). In their comprehensive 2008 review of microfluidic assisted synthesis 
of polymer particles, Chang & Serra highlighted how microfluidics is the 
only way to prepare certain polymer particles (varying morphologies, novel 
multi-component polymer particles, Janus particles) (41). Despite this, in 
his 2006 overview of microfluidics, George Whitesides commented that 
chemical synthesis has perhaps not exploited MF technology to its full 
potential in comparison with other disciplines (45). Aside from use in the 
production of polymer beads, MF technology has been used to successfully 
synthesise beads of varied materials including alginate (46), hydrogel (47) 
silica (48) and gold (49). 
4.1.4 Microfluidic applications 
4.1.4.1 Imprinting at a liquid/liquid interface 
As introduced in chapters one and two, traditional molecular imprinting 
methods often use a bulk imprinting approach in which a target molecule 
(template) is ‘imprinted’ into a polymer matrix  (50). However, this results 
in a polymer in ‘bulk’ form and milling is required to give fine, often 
heterogeneous, particles (51). Therefore, molecular imprinting technology 
(MIT) has developed alternative polymerisation methods to facilitate the 
manufacture of stable, uniform polymer beads and successful imprinting 
strategies have been demonstrated using emulsion polymerisation (52–55).  
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An emulsion is the stable dispersion of one fluid in another immiscible fluid 
(56), therefore emulsion polymerisation describes the suspension of 
organic monomers in an aqueous phase (oil-in-water), or vice-versa in 
reverse-phase emulsion polymerisation (57). It is used in industry to make 
large batches of latex for example (used for multiple coating and covering 
applications) (58). Furthermore, emulsion polymerisation techniques have 
been used by molecular imprinters to facilitate the imprinting of template 
molecules at the interface of dispersed phase (the bead) and continuous 
phase (51,59,60). For example, recently Liang et al. described the 
generation of molecularly imprinted polymer microspheres for the 
detection of malachite green (a carcinogenic dye also used in aquaculture 
as an antimicrobial) (51) using emulsion polymerisation with the template 
in the oil phase.  
 
Using MF technology to generate emulsions offers several advantages to 
traditional techniques. For example, in most conventional emulsion 
techniques a degree of agitation is needed to promote the formation of an 
emulsion; if this is not uniform across large mixtures, polydisperse 
emulsions result (61). Smaller scale microfluidic techniques can offer a 
more controlled agitation environment, furthermore they provide the 
advantage of carefully crafting one bead at a time, further reducing 
polydispersity (56,62). It follows therefore that multiphase microfluidics as 
a discipline is well placed to facilitate molecular imprinting at an oil/water 
interface (63,64). 
4.1.4.2 Microfluidics and molecular imprinting  
Integrating molecular imprinting and microfluidics can be broadly 
categorised as either direct manufacture of molecularly imprinted beads or 
a MIP integrated into an MF system for analytical purpose. The former 
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category reflects the molecular imprinting process taking place at a 
liquid/liquid interface, a strategy employed in this study.  
Work from Takimoto et al. in 2015 is an example of imprinting at a 
liquid/liquid interface. Their paper described the synthesis of imprinted 
submillimeter microgels capable of human serum albumin detection using 
a water-in-oil arrangement via fabricated microfluidic channels. 
Interestingly, in contrast to this study, where the MF system was designed 
for in-situ polymerisation of beads, Takimoto’s work describes 
polymerisation of droplets outside of an MF system via 
photopolymerisation over 24 hours (63). In contrast, and exemplifying  the 
latter category of MIP integrated into MF systems,  Huang et al. described 
a microfluidic system designed with a MIP film integrated for use in an SPR 
(Surface Plasmon Resonance) detection system for progesterone (65). 
Furthermore, Birnbaumer et al., in their 2009 paper, integrated a virus 
detection system into an MF channel using a MIP capable of detecting viral 
binding events (66). Integrated MIP/MF systems have also previously been 
developed for drug detection. For example, systems for the detection of 
morphine (an opioid analgesic) (67) and propofol (an intravenous general 
anaesthetic agent) (68) have both been developed. 
4.1.4.3 Microfluidics and biotechnology 
a. General overview 
The scale of analytes associated with biomedical technology such as 
individual cells or pathogens makes microfluidics a useful tool owing to its 
relative size. In Yeo’s comprehensive 2010 review paper, microfluidics in 
biotechnology is explored under a wide range of subheadings from 
pathogen detection to protein manipulation, demonstrating the 
comprehensive array of biomedical uses for microfluidic technology (69). A 
wide range of biomedical devices therefore utilised MF technology (for 
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example, the ubiquitous analysis strips used for blood glucose testing) and 
microfluidic bioanalysis as a thriving discipline (70). An interesting 
application of MF in bioanalysis is in point-of-care diagnostics and the use 
of point-of-care testing for the diagnosis of infection is a particular area of 
growth in this field (71). 
b. Microfluidics and point-of-care diagnostics 
The ability for both healthcare professionals to achieve laboratory based 
diagnostics using a portable device is the aim of point of care diagnostics. 
Furthermore, the end user (patient) can also use such devices to carry out 
testing at home for a variety of chronic and acute conditions, facilitating 
patient-centred healthcare (71). In a recent comprehensive review of MF 
technology in point-of-care testing, Pandey et al. also highlighted the 
potential of MF technology to facilitate diagnostics for non-invasive 
biosensors using bodily fluids such as sweat or saliva (72). Devices utilising 
this non-invasive approach have several advantages over those requiring 
blood (ease of patient use and decreased discomfort of testing for example 
(72)) and are therefore an interesting sub-field of MF driven point-of-care 
diagnostics.  
Micro and nano fluidics are therefore popular techniques employed by 
many scientific groups for a diverse range of disciplines. Moreover, small 
scale fluidics can be integrated into complex systems for biomedical and 
sensing applications and provides the key phenomena underpinning ‘lab-
on-a-chip’ technology. Therefore, the scope for integration of MF systems 
into detection devices for biomarkers is wide.  
  
Chapter 4: Molecular Imprinting studies without a solid support: Microfluidic applications 
 
170 
 
4.2 Chapter aims and objectives 
The overarching chapter aim was to manufacture a microfluidic system to 
manipulate the interaction of two immiscible fluids in order to promote a 
stable imprinting environment with the end result of polymer bead 
production. 
Key objectives in this chapter were as follows: 
1. To establish the optimal t-junction design integral to the 
microfluidic system to promote segmented flow. 
2. To establish optimal respective flow rates for aqueous and organic 
fluids, constituting the dispersed and continuous phases 
respectively. 
3. To use the designed microfluidic system as a platform for the 
investigation of MF system polymerisation capability. 
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4.3 Materials and Methods 
4.3.1 Materials 
All organic solvents were of HPLC grade and were obtained from Fisher 
Scientific, (Loughborough, UK) unless otherwise stated. All 
polytetrafluroroethylene (PTFE) and PET tubing was from Fisher Scientific; 
prefabricated T-junction fitting (PTFE), zero volume connectors (PTFE) and 
standard connector fittings and ferrules all Upchurch Scientific (Silsden, 
UK). Glass syringes: SGC Analytical Science (Trajan Scientific, Milton Keynes, 
UK); Syringe drivers: kd Scientific (MA, USA);  
4.3.2 Analysis 
Multizoom upright microscope: Nikon AZ 100; high speed camera: AOS 
Technologies AG (Baden, Switzerland).  
4.3.3 General method overview 
Described herein are method development stages in the design of a 
microfluidic system capable of generating segmented flow. The overall aim 
of immiscible fluid interaction was to produce aqueous ‘packets’ (water 
soluble monomer solution containing initiator) travelling in a continuous 
flow of organic solvent (figure 4.4). Furthermore, the aim was for these 
‘packets’ to adopt the geometrically stable shape of a sphere, creating a 
stable environment for molecular imprinting at a liquid-liquid interface. 
 
 
Figure 4.4: Simplified diagram demonstrating desired MF 
segmented flow pattern.  
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Microfluidic system development took part in three distinct stages:  
1. System A development and testing (prefabricated t-junction 
testing),  
2. System B development and testing (micromilled t-junction testing), 
3. Development of MF system B with integration of a polymerisation 
point.  
4.3.4 Microfluidic system development: systems A & B common 
components 
4.3.4.1 Tubing 
PTFE tubing with fixed external diameter of 1/16 inch (1.59 mm) was used 
in the MF system construction. Tubing internal diameter was 100 µm 
initially and then connected via a zero volume connector to a larger 
internal diameter of 250 µm. Tubing was connected to t-junction and zero 
volume connectors (PTFE) and standard connector fittings and ferrules. 
4.3.4.2 Syringe drivers 
Two syringe drivers were needed for the system, one for the aqueous 
phase and one for the organic phase. Both were programmable digital 
syringe drivers for syringe sizes 10 µl to 140 ml. 
4.3.4.3 Syringes 
Glass SGE Analytical Science syringes, 5 ml or 10 ml were used for all 
experiments. 
4.3.5 Microfluidic system development: System A 
4.3.5.1 Pre fabricated t-junction 
A purchased prefabricated t-junction was used to establish segmented flow 
in microfluidic system A. Manufactured in ethylene tetrafluoroethylene 
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(ETFE), it was made to fit tubing of external diameter 1/16 inch (1.59 mm) 
and had an internal though-hole diameter of 0.5 mm.  
4.3.5.2 Immiscible fluid interaction: system A 
Continuous (chloroform) and dispersed phases (monomer solution) were 
pumped into the microfluidic system with syringe drivers capable of 
generating a wide range of flow rates. Observations were made 
systematically to ascertain the optimum dispersed/aqueous (Qd) and 
continuous/organic flow rate (Qc) combination that would result in 
spherical bead formation. A variety of flow speeds were investigated, 
however the following combinations resulted in representative bead 
morphology for different classifications of aqueous packet shape: Qd:       
1.5 ml hr-1 with a Qc: 1.5 ml hr
-1; Qd: 1.5 ml hr
-1 with a Qc: 2 ml hr
-1, and 
finally,  Qd: 1.5 ml hr
-1 with a Qc: 3 ml hr
-1. 
4.3.6 Microfluidic system development: System B 
4.3.6.1 Micromilled t-junction 
To improve the system described in section 4.3.5, a t-junction with 
rectangular cross sectioned channels was designed on SolidWorks™ CAD 
software. This design was then milled onto a PTFE disc using a micro milling 
machine. Offering several advantages over the original t-junction, this 
milled PTFE chip had pre-determined planar geometry and allowed direct 
observation of droplet formation at the junction using a high speed 
camera. 
4.3.6.2 Immiscible fluid interaction: system B 
Using the micromilled t-junction, observational data was collected 
pertaining to immiscible fluid interaction at the t-junction. All observations 
were made via a high speed camera experimental set up which is shown in 
figure 4.5. 
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Figure 4.5: Experimental set -up for the fi lming and 
photographing of microfluidic flow via a micromilled t -piece.  
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Data collected included general aqueous packet appearance and inter-
packet distance for the organic and aqueous flow speed combinations 
shown in table 4.1.  
Table 4.1: Table showing all combinations of organic and 
aqueous phase flow speeds used in observational data 
experiments.  
Test 
number 
 
Qc 
(organic) 
ml hr
-1
 
 
Qd 
(aqueous) 
ml hr
-1
 
Test 
number 
 
Qc 
(organic) 
ml hr
-1
 
 
Qd 
(aqueous) 
ml hr
-1
 
 
1 
 
1 
 
0.5 
 
13 
 
5 
 
2.5 
2 1 0.25 14 5 1.25 
3 1 0.1 15 5 0.5 
4 2 1 16 6 3 
5 2 0.5 17 6 1.5 
6 2 0.2 18 6 0.6 
7 3 1.5 19 10 2.5 
8 3 0.75 20 20 2.5 
9 3 0.3 21 20 10 
10 4 2 22 30 10 
11 4 1 23 35 10 
12 4 0.4 24 50 10 
 
4.3.7 Integration of polymerisation point 
4.3.7.1 General overview 
Final iterations of the designed MF system included a ‘polymerisation 
point’. This involved the design of a portion of the MF system capable of 
polymerising aqueous beads flowing through the system. Experiments 
were carried out with direct, volumetric heating by submergence of MF 
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tubing in a water bath and with an integrated UV light exposure. Finally, 
the integration of microwave resonator was investigated. 
4.3.7.2 Volumetric heating 
Initial polymerisation studies used a water bath to directly heat a length of 
MF system tubing. PTFE tubing, 210 cm (ID 250 µm; volume 47.1 ml), was 
coiled around a water bath allowing complete submergence under water. 
This water was heated to 55   C. Segmented flow was established (using 
system A) with a Qd: 1.5 ml hr
-1 and a Qc: 3 ml hr
-1 and fluid flowed through 
the water bath that remained at 55   C.  
4.3.7.3 UV-initiated polymerisation 
A UV LED bulb (10 mm size; dominant wavelength 400- 405 nm; intensity 
80-120 mcd) was attached to a power source and mounted onto a 
prefabricated t-junction as to deliver UV light to the perpendicular flow 
stream. Segmented flow was established (using system A) with a Qd:         
1.5 ml hr-1 and a Qc: 3 ml hr
-1. 
4.3.7.4 Microwave-initiated polymerisation 
This chapter gives an overview of experiments preceding the introduction 
of microwave-initiated polymerisation. Chapter five (Molecular imprinting 
without a solid support: microwave-initiated polymerisation) gives a 
detailed account of experiments using a hybrid MF/microwave 
polymerisation system. 
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4.4 Results and discussion 
4.4.1 Microfluidic system development: system A 
4.4.1.1 Prefabricated t- junction 
Shown in figure 4.6 is the pre-fabricated t-junction used for MF system A.  
Blue dye was added to the aqueous phase allowing observation of droplet 
formation and downstream segmented flow. 
 
Figure 4.6: A.)  Photograph of f irst iteration of t -piece used in 
MF system A.  B.)  Black dashed l ine: flow direction continuous 
phase (organic); blue dashed l ine : flow direction dispersed 
phase (aqueous). This is a cross flow t -junction configuration.  
4.4.1.2 Immiscible fluid interaction: system A (Pre-fabricated t-junction 
testing) 
Direct observation could be made of bead formation at this t-junction and 
by using a blue dye in the aqueous phase, subsequent bead shape within 
downstream MF tubing was observed. Figure 4.7 shows the formation of 
segmented flow at the pre-fabricated junction.  
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Figure 4.7: Formation of beads at the pre-fabricated t -
junction. A.)  Dispersed phase has approached the t -junction; 
B.)  Continuous phase flow has started to drag the emerging 
dispersed phase along the perpen dicular flow path; C.)  Pinch 
off is seen, giving a packet of aqueous phase travelling in a 
continuous organic phase.  
Further observations were then made of downstream bead appearance at 
various flow speeds of the dispersed and continuous phases. Figure 4.8 
shows three examples of how differing respective flow speed ratios 
generated aqueous packets (again shown in blue) of differing shape and 
with variable inter-packet space. 
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Figure 4.8: Bead appearance depending on relative speeds of 
aqueous (Qd) and organic (Qc) phases. A.)  phases are flowing 
at the same rates. B.)  Organic phase was flowing at 2 ml  hr
- 1
,  
aqueous phase 1.5 ml  hr
- 1
.  C.)  Organic phase was flowing at   
3 ml hr
- 1
,  aqueous phase 1.5 ml  hr
- 1
.   
When the aqueous and organic phases are flowing at the same rate a slug 
appearance was seen with small inter-bead distances (figure 4.8 a). 
However, when the organic phase was set to flow at 2 ml hr-1, a rate 
approximately 33% greater than the dispersed aqueous phase that was 
flowing at 1.5 ml hr-1, the packets remained slug-like but decreased in 
width (figure 4.8b). When the continuous organic phase (3 ml hr-1) was 
flowing at twice the speed of the dispersed aqueous phase (1.5 ml hr-1). 
The dispersed aqueous packets adopted a spherical shape. 
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Despite the documented generation of spherical beads at continuous and 
dispersed flow rates of 3 and 1.5 ml hr-1 respectively, there were 
limitations of this prefabricated t-junction. Importantly, the findings shown 
in figure 4.8c were not reliably reproduced. Good runs of spherical beads 
were often interspersed with more chaotic appearance of slugs and a 
variable inter-sphere distance. It was possible these findings were 
secondary to syringe drivers or choice of syringe; however, once these 
issues were resolved the droplet formation remained erratic. Moreover, 
any dead space volume at the connection between the t-junction and the 
MF tubing could potentially disrupt droplet formation. If droplets are given 
the opportunity to collect at the junction between two MF components 
(the t-junction and the tubing) this could cause disconnect between the 
bead morphology formed at the t-junction and what is observed 
downstream. Therefore, rather than a pre-fabricated, purchased MF 
component, a t-piece was specifically designed and manufactured (system 
B). 
4.4.2 Microfluidic system development: system B 
4.4.2.1 Micromilled t-junction manufacture 
An improved t-junction was designed and manufactured by micromilling a 
CAD drawing design onto a PTFE disc. Figure 4.9 shows CAD drawings from 
the t-junction design. The diagrams indicate the path taken by the 
programmed milling (the channel width is dictated by the choice of milling 
tool).  
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Figure 4.9: 2d, bird’s eye view of Solidworks CAD drawing for 
the design of the micromilled t -junction. A.)  Design of inlet 
and outlet holes. B.)  Design of channels.  C.)  Channels and 
holes integrated. D.)  Appearance of complete drawing for 
micromilled t-junction. The formation of the holes in the 
brass manifold is shown in picture D, demonstrating ideal 
placement for the viewing of droplet formation at the t -
junction. Channel width: 200 µm; channel depth 200 µm. 
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Figure 4.10a and 4.10b show the measurements of the pattern milled onto 
the PTFE disc. Figure 4.10b shows an example of a milled inlet (indicated by 
the black circle in 4.10a) and the relevant dimensions. 
 
Figure 4.10: Micromilled pattern measurements wit h all  
measurements shown in mm. A.)  Global picture of pattern 
that was micromilled onto a PTFE disc. B.)  As indicated by the 
black circle on A, a close-up of a milled inlet is shown 
(measurements in mm) 
The design shown in figures 4.9 and 4.10 were then milled onto a PTFE 
disc. This was subsequently held in a brass manifold, specifically designed 
for the integration of MF tubing. The finished, milled, PTFE disc and the 
brass manifold with the disc in situ are shown in figure 4.11. 
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Figure 4.11: Photograph showing micromilled PTFE chip in 
situ  held in a brass manifold.  
Figure 4.12 is a schematic representation of the manifold cross section 
showing the layered components that comprised the design. The chip is 
held in place sandwiched between a hydrophobic perfluoralkoxy alkane 
(PFA) film layer and the brass manifold. A quartz disc sits between the 
upper manifold and the PFA film.  
 
 
Figure 4.12: Schematic showing a cross section of the brass 
manifold holding system for the micromilled PTFE chip.  PTFE: 
polytetrafluroethelene; PFA: perfluoralkoxy alkane.  
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4.4.2.2 Immiscible fluid interaction: system B 
a. Observational data 
A set of observational data (table 4.2) was collected for a range of aqueous 
and organic flow rates via the micromilled t-junction. The flow rates of the 
continuous and dispersed phases were systematically changed and 
resultant droplet formation was observed. 
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Table 4.2: Observational data from flow experiments (system 
B).  
Test 
number 
 
Qc 
(organic) 
ml  hr
-1
 
 
Qd 
(aqueous) 
ml hr
-1
 
Observations 
 
 
1 
 
 
1 
 
 
0.5 
 
 
 
Slugs; pronounced inter-slug space. Figure: 
4.14 
2 1 0.25 
Slug appearance; pronounced inter-slug 
space 
3 1 0.1 Slow flow, slugs, pronounced inter-slug space 
4 2 1 Slug appearance 
5 2 0.5 Slug appearance 
6 2 0.2 
Spheres formed, increased inter-sphere 
spacing 
7 3 1.5 Good spherical formation. Figure 4.15 
8 3 0.75 Spheres formed 
9 3 0.3 Increased spacing 
10 4 2 Good sphere formation 
11 4 1 Good sphere formation 
12 4 0.4 Spheres, increased inter-sphere space 
13 5 2.5 Good sphere formation 
14 5 1.25 Good sphere formation 
15 5 0.5 Spheres, increased inter-sphere space 
16 6 3 Good sphere formation 
17 6 1.5 Good sphere formation 
18 6 0.6 Good sphere formation 
19 10 2.5 Good sphere formation 
20 20 2.5 Good sphere formation 
21 20 10 Spherical shape lost- slug appearance 
22 30 10 Spherical shape lost, ‘string-of-pearls’  
23 35 10 ‘String-of-pearls’; Figure 4.16a 
24 50 10 Stratification present;  Figure 4.16b 
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Observation of bead morphology, inter-bead separation distance and any 
resultant break up/coalescence was noted. The appearance of the aqueous 
phase as it travelled in the continuous phase could be broadly described 
under four headings: slugs, spheres, ‘string-of-pearls’ and stratified. ‘String-
of-pearls’ or beads-on-a-string are terms that aptly describe the 
characteristic flow pattern observed, and are used interchangeably by 
several groups when describing segmented flow through MF systems when 
distinct bead separation is lost (73–75). Figure 4.13 demonstrates these 
four resultant slug appearances in relation to respective aqueous and 
organic flow speeds. 
 
Figure 4.13: Relationship between respective flow rates of 
aqueous and organic flow rates and appearance of resultant 
beads.  
At low flow rates of both organic and aqueous phases, the aqueous 
segments travelling in the organic continuous phase had a slug appearance. 
When the organic flow rate reached 4ml hr-1, aqueous phase appearance 
began to change and spheres were formed. At higher flow rates distinct 
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shape aqueous packets were lost and appearance moved towards 
stratified. 
b. Photographic results 
The experimental set up for the filming of bead formation by a high speed 
camera is shown in figure 4.5, this allowed for direct observation of flow 
rate effects on the morphology of subsequent segmented flow. Images 
shown in figures 4.14 were taken at continuous flow speed of 1 ml hr-1 and 
a dispersed flow speed of 0.5 ml hr-1. 
 
 
Figure 4.14: High speed camera pictures of flow through 
micromilled t-junction (shutter speed 1/1000).  Pictures taken 
at continuous flow speed of 1 ml  hr
- 1
 and a dispersed flow 
speed of 0.5 ml hr
- 1
.  A.)  Tip of the dispersed phase enters the 
continuous phase channel; B.)  The droplets starts to grow; 
C.)  E longation of the droplet  continues giving a slug-l ike 
appearance.  
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Captured images in figure 4.14 demonstrate the formation of a slug-like 
aqueous packet travelling in the organic continuous phase. This was not 
the desired spherical conformation, therefore investigation continued of 
dispersed and continuous flow speed ratios. For example, figure 4.15 
shows pictures taken at continuous phase flow speed of 3 ml hr-1 and a 
dispersed phase flow speed of 1.5 ml hr-1. 
 
Figure 4.15: High speed camera pictures of flow through 
micromilled PTFE t -junction (shutter speed 1/1000).  Pictures 
taken at continuous flow speed of 3 ml  hr
- 1
 and a dispersed 
flow speed of 1.5 ml  hr
- 1
.  A.)  Tip of the dispersed phase 
enters the continuous phase channel; B.)  The droplets starts 
to grow; C.) Elongation of the droplet; D.)  The neck of the 
droplet breaks. (Contrast darkened post production).  
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Figure 4.15 shows a representation of droplet formation beginning to form 
the desired spherical geometry. In figure 4.15a the tip of the dispersed 
phase can be observed entering the main MF channel, containing 
continuous phase. Thereafter, in figure 4.15b, the droplet starts to grow 
and begins to fill the main channel; in 4.15c elongation of the droplet can 
be observed with associated thinning of the neck connecting it to the 
stream of dispersed phase liquid. Finally, in 4.15d, the neck of the droplet 
breaks and it continues downstream as the neck retreats into the feeder 
channel.  
Shown in figure 4.16 are high speed camera images from experiment run 
using high flow rates. 
 
Figure 4.16: High speed camera pictures of segmented flow 
at higher flow speeds.  A.)  Continuous flow speed: 35 ml  hr
- 1
;  
dispersed flow speed: 10 ml  hr
- 1
; B.)  Continuous flow speed: 
50 ml hr
- 1
; dispersed flow speed: 10 ml  hr
- 1
.  
Figure 4.16a shows an image captured at a continuous phase flow speed of 
35 ml hr-1 together with a dispersed phase flow speed of 10 ml hr-1. The 
distorted pinch off can be observed as the dispersed phase meets the 
continuous, giving a ‘string of pearls’ appearance. Figure 4.16b shows an 
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image captured at continuous phase flow speed of 50 ml hr-1 and dispersed 
flow speed of 10 ml hr-1. In this image two streams flowing in parallel 
(stratified) can be observed, with the dispersed (aqueous) phase occupying 
the top of the tubing as it appears in the picture. 
c.   Capillary number calculations 
The capillary number is a dimensionless parameter that describes the 
relationship between viscous forces and surface tension (19). Both viscous 
force and surface tension become important in multiphase flow on a 
microscale and at small capillary numbers (dominant interfacial tension) 
plugs start to take on a spherical shape (20). 
Capillary numbers for selected continuous phase flow speeds were 
calculated and are shown in table 4.3. These continuous phase flow speeds 
are representative of the flow speeds shown in figures 4.14 to 4.16.  
Table 4.3: Table showing continuous phase ( Qc)  capillary 
numbers (Ca) for the flow speeds demonstrated in figures 
4.15 to 4.17. 
*calculated for flow speed through 200 µm channel; 
**calculated with denominator of interfacial tension 
chloroform/water of 32.8 mN m
- 1
.  
 
Qc ml hr
-1
 
 
*Velocity ms
-1
 
 
**Ca 
 
1 
 
0.008 
 
1.3 x 10
-4
 
3 0.026 4.3  x 10
-4
 
35 0.309 5.1  x 10
-3
 
50 0.442 7.2  x 10
-3
 
 
 
 
Chapter 4: Molecular Imprinting studies without a solid support: Microfluidic applications 
 
191 
 
d.   General discussion 
Results from immiscible fluid experiments generally correlate with those 
from the seminal work from Thorsen, showing a decrease in droplet size as 
the flow rate of the continuous phase increased (29). This observation has 
since also been made by several groups investigating droplet dynamics at t-
junctions (27,28,30).  
In this work the manufactured t-junction encourages the ‘squeezing’ 
regime of droplet formation as Win = Wout (Win refers to the width of feeder 
channel and Wout to the width of main channel; shown in figure 4.17). 
 
Figure 4.17: Formation of a droplet at the micromilled t -
junction. W i n: width of feeder channel carrying the dispersed 
(aqueous) phase; W o u t: width of main channel carrying the 
continuous (organic) phase. In the micromilled PTFE chip 
used in this study, W i n  = Wo ut  (both 200 µm).  
Furthermore, as shown in table 4.3, the capillary numbers of the 
continuous phase are low, also facilitating the ‘squeezing’ flow dynamic 
(23,24). In this scenario the droplet fills the main channel as it forms, 
distinguishing it from the ‘dripping’ regime when droplets release from the 
feeder channel before they get big enough to obstruct it (37). 
As a droplet formed at the micromilled t-junction in microfluidic system B, 
the growth of the droplet impeded the flow of organic continuous phase 
around it. Dynamic pressure then increased downstream of the droplet 
and eventual pinch off was forced (20). Dynamic pressure (q) is dependent 
on both density of the fluid and the flow speed, however, from the 
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equation shown (4.6) flow speed (v) has greater influence than viscosity 
(ρ): 
   
 
  
                                                                                                              (4.4) 
Therefore the greater the speed of continuous phase, the greater the 
dynamic pressure that builds up and influences neck pinch off of the 
developing droplet.  
When modelling this squeezing regime of droplet formation Guilliot and 
Colin investigated conditions for parallel flow of two phases in microfluidic 
channels. However, they demonstrated parallel flow streams when the 
flow rate of the dispersed phase became greater than the flow speed for 
the continuous phase (76). Moreover, Guilliot and Colin showed the 
importance of respective phase viscosities and showed that as the viscosity 
of the dispersed phase increased, the velocity of the dispersed needed to 
encourage parallel flow decreased (76). However, results in figure 4.16b 
show the transition to parallel co-flow at a dispersed flow rate at only 20% 
of the continuous flow rate (Qc 50 ml hr
-1; Qd 10 ml hr
-1) this is due to the 
difference in dynamic viscosity between organic and aqueous phases, 0.54 
and 0.89 mPa s-1 (41) respec vely (at 25   C). In Guilliot and Colin’s paper 
the dynamic viscosity ratio of organic phase: aqueous phase was 1:0.4 
(compared to 1:1.65 in this study). Therefore, this work demonstrates that 
parallel flow appears more readily achievable at lower flow speeds with 
higher dynamic viscosity ratios. At high viscosity ratios the emerging 
dispersed phase droplet will experience less shear stress on the interface 
between itself and the continuous phase than if the viscosities between 
the two phases were similar. Therefore, this increased stability of the 
dispersed phase allows the formation of parallel flow at lower flow speeds 
(78,79). 
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4.4.3 Integration of polymerisation point 
4.4.3.1 Water bath heating 
The use of conventional, volumetric heating using a water bath to initiate 
polymerisation within the MF tubing was unsuccessful. Segmented flow 
was established through the MF system and this was subsequently passed 
through a water bath heated to 55◦ C and polymerisation of the aqueous 
packets within the MF tubing was absent over repeated attempts.  
4.4.3.2 UV-initiated polymerisation 
Attempts to initiate polymerisation with UV exposure were unsuccessful. 
No polymerisation was evident and this was also abandoned (along with 
conventional heating) as a method for polymerising monomer beads within 
MF tubing. 
UV-initiated polymerisation within microfluidic systems requires optically 
clear polymer (PDMS (polydimethylsiloxane) for example) or glass 
channels. PDMS is transparent from 240 to 1100 nm (7,80) making it 
possible to couple PDMS with UV light sources. Therefore groups working 
with the UV curing or gelation of polymers and hydrogels in MF systems 
often use PDMS components (81–83). However, PDMS exhibits 
unfavourable behaviour when exposed to certain solvents, making the use 
of PDMS in this study unviable. PDMS swells in non polar solvents such as 
chloroform (34) whereas PTFE is highly compatible with both chloroform 
and toluene (both used as organic phases in this study) (84).  
4.4.3.3 Microwav- initiated polymerisation 
Attempts to reliably polymerise aqueous packets in PTFE tubing using both 
volumetric heating and UV-initiated polymerisation were unsuccessful. 
Therefore, an alternative method of achieving in-situ polymerisation by 
dielectric heating was investigated. The use of microwaves for organic 
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synthesis reactions is a well established (85) and microwave-initiated 
polymerisation is a notable branch of this discipline (86,87). However, the 
integration of microfluidics and microwave-initiated in-situ polymerisation 
is relatively under-represented in the literature. A stepwise approach from 
the use of an adapted domestic microwave to a cavity resonator was used 
and the polymerisation of dispersed aqueous beads within PTFE tubing was 
eventually achieved.  
 
Hybrid MF/microwave system development and polymer bead generation 
is the subject of chapter five and a detailed look at the field of microwave 
assisted organic synthesis reactions is given in this chapter.  
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4.5 Chapter Conclusions 
4.5.1 General conculsions 
The general aim of this chapter was to create a stable environment for 
liquid/liquid interface imprinting. Once optimisation of MF system 
components was undertaken (manufacture of t-junction), systematic 
testing of micromilled t-junction gave an optimal flow speed ratio of 
continuous to dispersed flow speeds for the production of spherical 
aqueous dispersed phase.  
Undocumented work in the course of this project looked at the feasibility 
of emulsion polymerisation methods which also promoted molecular 
imprinting at a liquid/ liquid interface. However, this largely unsuccessful 
work provided outward focus on alternative ways to promote liquid/liquid 
interaction. Therefore, the discipline of microfluidics as a more efficient 
way to produce polymer beads whilst exploiting advantages of liquid/liquid 
interface imprinting was investigated. Furthermore, the scale of MF 
systems developed in this chapter allowed microwave integration; this was 
not possible with emulsion techniques.  
In conclusion, this chapter demonstrates the initial stages of developing a 
microfluidic/microwave hybrid system for the production of polymer 
beads.  
4.5.2 Rationale for next chapter 
Chapter five expands on microwave-initiated polymerisation, taking the 
microfluidic system described in this chapter to a point where the 
manufacture of imprinted polymer beads was possible. 
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5.1 Introduction 
5.1.1 Chapter outline 
This final experimental chapter outlines the integration of microwave 
delivery into an established microfluidic system in order to polymerise 
aqueous monomer beads. In addition, microwave sensing technology is 
used to characterise reactants and to provide insight into the 
polymerisation process.  
5.1.2 Microwaves 
Heat application to stimulate chemical reactions remains an integral part of 
laboratory chemistry. In order to hasten reactions that are slow or 
impossible at room temperature, the use of microwaves is an efficient way 
of providing heat (1). Described as the Bunsen burner of the 21st century 
(2), microwaves are electromagnetic waves with a frequency between 1 
and 30 GHz (3) and consist of an electric field (E field) and a magnetic field 
(H field)  (figure 5.1). Microwave ovens (domestic and laboratory) operate 
at an allocated frequency of 2.45 GHz; therefore avoiding interference with 
mobile phone and telecommunication frequencies. 
 
Figure 5.1: Electric (E field) and magnetic (H field) 
components of microwaves.  
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Application of microwaves causes a rapid, volumetric heating that is 
dependent on the materials’ ability to convert electromagnetic energy into 
heat (4). In comparison, conventional heating relies on conduction and 
describes the transfer of heat at rates dictated by the temperature 
gradients between two bodies (5). In addition to the regular use of 
microwaves in the domestic setting, the use of microwave irradiation has 
gained popularity as a laboratory aid to organic synthesis (2,6,7). The use of 
microwaves to initiate organic reactions has several advantages over 
conventional heating methods; for example, shorter reaction times (8,9), 
noncontact heating (10) and increased yields of purer products (11) have 
all been demonstrated with microwave use. A summary of advantages of 
microwave heating in organic synthesis reactions is shown in table 5.1. 
Table 5.1: Advantages of microwave heating compared to  
conventional heating techniques.  Adapted from Sosnik (12).  
Property 
 
Conventional conductive 
heating 
Microwave heating 
 
Heating rate 
 
Slow 
 
Fast 
 
Max. Reaction temp Limited by solvent BP Not limited by solvent 
boiling point 
 
Reaction time Long Short 
 
Homogeneity of 
heating 
 
Low High 
 
Yield 
 
Low 
 
High 
 
Secondary products 
 
High 
 
Low 
 
Solvent-free 
conditions 
 
Difficult Easy 
 
Reproducibility 
 
Low 
 
High 
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5.1.3 Microwave reactors: general introduction 
5.1.3.1 Overview 
The emergence of microwave-assisted organic synthesis in the 1980s was 
initially reliant on the use of domestic microwave ovens; however, these 
devices are often not suitable for laboratory work (13). The main issue with 
using domestic ovens for organic synthesis reactions is the inherent lack of 
precise control over their operation (14). For example, accurate 
temperature control and temperature detection is difficult, leading to 
uneven heating and inaccurate temperature profiling of reactions. 
Furthermore, concerns regarding safety of such devices, particularly with 
the use of organic solvents, has limited their use in the laboratory setting 
(15). The recognisable domestic microwave has therefore been largely 
superseded by devices specifically designed for scientific use (11,16). This 
study, for example, used a domestic microwave for initial polymerisation 
experiments and graduated to a single mode cavity resonator specifically 
designed for precise laboratory use.  
The increased popularity of custom-made microwave resonators has 
revolutionised on-bench organic synthesis. Microwave units for laboratory 
use now range from machines that look much like domestic ovens to 
bespoke cavity resonators (11,13,16); examples of resonators are shown in  
figure 5.2. 
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Figure 5.2: Custom made microwave cavity resonators used in 
the Centre for High Frequency Engineering at Cardiff 
University’s School of Engineering.  Each has a resonant 
frequency shown under each picture.  
5.1.4 Microwave reactors: operational overview 
5.1.4.1 Introduction 
Three major components constitute a microwave processing system: a 
source for electromagnetic field generation; a transmission line to carry the 
electromagnetic radiation to an applicator (waveguide); and finally a cavity 
(i.e. applicator) where microwaves interact with a material (17,18). Cavity 
design determines the microwave field distribution so therefore cavity 
resonators used for delivery of microwaves to a loaded sample are 
designed to facilitate accurate and efficient delivery of microwaves to that 
particular sample. An important consideration is also the use of a 
monomodal or mulitimodal microwave processing system. 
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5.1.4.2 Multimodal vs monomodal 
In microwave systems electromagnetic waves propagate in hollow tubes, 
called waveguides, which transmit energy from the microwave source. 
Microwaves can travel in waveguides using many different modes, the 
term ‘mode’ referring to motion patterns sinusoidal waves (17,18). The 
cavity is then a resonant length of this waveguide, which is usually 
rectangular (as in a microwave oven) or cylindrical in cross section. 
Domestic microwaves are commonly multimodal; indicating the microwave 
source in domestic ovens excites multiple resonant modes simultaneously. 
This ‘scattergun’ approach of multiple excited modes creates an inefficient 
heating environment, however, this is desirable for heating food as 
domestic microwaves are minimally affected by the dielectric properties of 
materials placed in their cavity (1).  However, bespoke resonant cavities for 
laboratory use are generally single-mode devices (monomodal) (11). Single-
mode systems generate microwaves by exciting one resonant mode only 
and instead of multiple ‘hot spots’ of electric field found in domestic multi-
mode ovens, single-mode cavities have just one E-field spot within the 
cavity where the microwave field strength is highest (13). This allows the 
efficient delivery of microwaves- a desirable quality in organic synthesis 
application. Comparison of mono and multimodal operation is shown in 
figure 5.3. 
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Figure 5.3: Microwave resonators.  A.)  A multimodal 
microwave processing system representing common domestic 
microwave operation. The microwave source (magnetron) 
propagates waves using multiple modes. B.)  A monomodal 
microwave processing system representing a system 
specifically designed for precise laboratory organic synthesis.  
In monomodal systems the magnetron will propagate waves 
in one mode only. Adapted from (19).  
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5.1.4.3  Quality factor 
The operation of a microwave cavity is governed by the theory of 
electromagnetic resonance. A microwave cavity will have a natural 
oscillating frequency (resonant frequency), this describes the frequency 
adopted by an object as determined by its physical characteristics (dictated 
by object size) (1,19). A resonant system will also have a quality factor, 
referred to as the Q factor.  The Q factor is a dimensionless parameter 
defined as the ratio between energy stored in the system and the energy 
losses of the system in one cycle (equation 5.1). A high Q factor indicates 
that a high amount of the energy will be dissipated in the sample, values 
around 10,000 are considered high for a microwave cavity, operating 
around 2.45 GHz (18).  
   
  
  
                                                                                                                (5.1) 
f0 corresponds to the resonant frequency at maximum peak height and ∆f 
represents the width of the resonance curve at half maximum. In figure 5.4 
two resonant peaks of different morphology are shown. The lower 
amplitude resonance represents a strongly damped system and will have a 
lower Q than the higher amplitude resonance.   
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Figure 5.4: Schematic demonstrating differences in Quality 
(Q) factor of two resonant systems.  
This Q factor can be given as Q0 (Q factor of an empty cavity) and Qs (Q 
factor when the sample is loaded into cavity). A key element of 
investigating microwave E-field interaction with a material is dielectric 
permittivity measurement. In order to use a resonator system for accurate 
perturbation measurements to determine the permittivity, the Q factor of 
the system needs to be measured with and without the sample in situ, and 
therefore the resonant frequency shift can be measured (20,21). 
Permittivity is decribed in more detail in section 5.1.5.1. 
5.1.4.4 Cavity resonator used in this chapter 
From the cavity resonators shown in figure 5.2, resonator B was used for 
experiments described in this chapter. Cavity resonator B is a cylindrical 
cavity with inner height 4 cm and inner radius 4.6 cm, made from 
aluminium (a high conductivity metal, giving high Q of the empty cavity). 
The specific mode this cavity operates in is denoted TM010, meaning 
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Transverse Magnetic mode with a cylindrical mode number given as a 
suffix. These numbers correspond to the field pattern within cavity. 
Electromagnetic fields are distributed in one of three ways: transverse 
electric (TE), transverse magnetic (TM) or transverse electric and magnetic 
(TEM) (18). Transverse electric indicates electric field is perpendicular to 
the direction of wave propagation and conversely, transverse magnetic 
indicates the magnetic field is perpendicular to the direction of wave 
propagation, in this case the cavity axis (4). 
Figure 5.5 shows the field distributions in cavity resonator B. 
 
Figure 5.5: Diagram showing E (electric) and H (magnetic) 
field distributions within the cavity resonator.  Colour is 
representative of field strength, with red being the strongest, 
yellow medium strength and blue being where the field is 
weakest within the cavity. Images produced with COMSOL ® 
simulation software by J Cuenca and used with permission.  
Figure 5.5 shows the electric field is strongest in the centre of the cavity 
and the magnetic field conversely is strongest around the perimeter. 
Samples could therefore be placed in the cavity resonator where the 
electric field was strongest and accurate heating could be achieved. How 
the cavity could accommodate different samples is shown in figure 5.6.  
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Figure 5.6: Schematic representation of a microwave cavity 
resonator used in this study, able to accommodate a sample 
as shown. Diagram courtesy of  Dr.  J.  Cuena, Cardiff School of 
Engineering.  
This arrangement demonstrated in figure 5.6 allowed the investigation of 
sample interaction with microwaves. Exploring these interactions 
underpinned experimental work in this chapter. 
5.1.5 Microwave/material interactions: general principles 
5.1.5.1 Permittivity 
When exposed to microwaves, the degree of heating achieved within an 
exposed material will be ultimately dictated by the inherent properties of 
said material (1). Therefore, understanding how a reactant will behave 
when exposed to microwaves helps to guide experiments and allows 
selection of reactants according to their inherent dielectric properties. A 
key material property to consider is permittivity. 
Permittivity, rather than describing the energy permitted through a 
material, relates to the material’s opposition to an external electric field. 
Permittivity is denoted ε and is a fundamental property used to compare 
dielectric materials. For example, the permittivity constant for a vacuum is 
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1.0 and that of water (at room temperature) is 80.1 and for Teflon is 2.1 
(1). 
Once irradiation with electromagnetic fields occurs, an interaction on a 
molecular level takes place within the exposed material and there are 
several properties dictating this response. At microwave frequencies the 
most important mechanism of energy transfer within a material is dipole 
polarisation (21). An oscillating electric field causes agitation of molecules 
(figure 5.5); however, this induced rotation of polar molecules is not always 
as fast as the oscillation of the electric field at a given frequency (electric 
field oscillates between its maximum and zero values 1010 times per second 
at 2.45 GHz (9)); this disconnect is the phenomenon that underpins 
dielectric loss, a dimensionless parameter that describes the dissipation of 
energy (in the form of heat) by a dielectric when subjected to 
electromagnetic radiation. 
 
Figure 5.7: Schematic of a container fil led with water 
exposed to microwaves.  The oscil lating electric (E) f ield 
causes orientation changes in the water molecule due to its  
polarity. The molecules align themselves back and forth with 
the E field.  
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Furthermore, microwaves also heat via ionic conduction. This describes the 
influence of microwaves on charged particles in solution and explains the 
interaction of ions and microwaves. Ions will oscillate when exposed to a 
microwave E-field causing collisions with neighbouring molecules and this 
kinetic energy is released as heat. Ionic conduction heating explains why 
microwave heating of de-ionised water occurs at a slower rate than the 
same volume of ordinary tap water (22,23). 
5.1.5.2 Complex permittivity 
Permittivity (ε) comprises two distinct contributory parameters denoted ε’ 
and ε’’, their relationship is expressed by the formula for complex 
permittivity and is shown by equation 5.2: 
                                                                                                            (5.2) 
Where ε is the complex dielectric permittivity of a vacuum, ε’ is the real 
part of the complex dielectric permittivity, ε’’ is the imaginary part of the 
complex dielectric permittivity and   is an imaginary constant. ε’’ can also 
be described as the dielectric loss, and ε’ as the amount of energy that can 
be stored within the heated material (21). Another way of looking at these 
two dimensionless parameters is the real part of the complex permittivity 
(ε’) represents the storage of energy within the dielectric and the 
imaginary part (ε’’) is proportional to the ability of the dielectric material to 
dissipate microwave energy (1,21). 
5.1.5.3 Central Perturbation theory 
Perturbation theory describes measurable phenomena that occur when an 
object is placed inside a cavity resonator and subsequently perturbs the 
resonant frequency and Q (i.e. bandwidth) of the cavity (24,25).  
In the 1960s Waldron described the derivation of equations to explain the 
central perturbation theory of a resonant cavity (26), giving a formula for 
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the frequency shift seen when a sample is introduced to a resonant cavity; 
this theory can be simplified to equations 5.3 and 5.4. 
      
  
  
  
  
                                                                                                        (5.3) 
     
   
  
  
  
                                                                                                                 (5.4) 
In these equations, ε’ is the energy stored by the material (real part of 
permittivity); ε’’ is the energy losses (imaginary part of permittivity); ∆f is 
the change in frequency on inserting the sample; Vs is the sample volume; 
Ve is the effective volume of the resonant cavity (i.e. its physical volume 
multiplied by a scaling factor, which is 0.269 for the resonant mode used 
here); ∆BW is the change in bandwidth on inserting the sample and f0 is the 
starting (i.e. unperturbed) resonant frequency.  
The cavity resonator used in this study was designed such that a sample 
could be placed in the cavity and changes in resonant frequency of the 
cavity could be measured. The cavity resonator will have a natural 
frequency (a frequency of oscillation that is freely adopted when supplied 
with energy). Therefore, the system resonates when subjected to an 
oscillating field with a frequency close to its own natural frequency. This 
resonance can be damped if energy is lost from the system (when a sample 
is introduced to the cavity for example, as shown in the figure 5.6) and this 
can be measured. Moreover, the degree to which the resonant frequency 
of the cavity was damped was dependent on dielectric properties of the 
material inserted into the cavity (24,26).  
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Figure 5.8 shows a microwave cavity and a network analyser experimental 
set-up to measure central perturbation.  
 
Figure 5.8: Experiment set-up to measure the changes in 
resonance of a microwave cavity (B) secondary to the 
introduction of a sample (C) by a network an alyser (A).  
An exemplar output perturbation measurement by a network analyser is 
shown in figure 5.9, in which the cavity’s transmitted power (in dBm) is 
plotted against frequency (GHz).  
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Figure 5.9: Schematic of sample characterisation data that is 
produced by microwave sensing applications.   
Using this sensing capability, studies have used microwave perturbation 
measurements to characterise a diverse range of materials, including those 
biological in origin. For example, Blakey et al. characterised cells according 
to lipid content using microwave sensing (27). Furthermore, the dielectric 
characterisation of pathology samples, including malignant cells, has been 
demonstrated (28,29). Dielectric characterisation of non-biological material 
(a strategy used in this work) has previously been investigated including 
polymers (30–32) and organic solvents (33,34). 
5.1.6 Microwave/material interactions: practical applications 
5.1.6.1 Microwave-initiated polymerisation 
Polymer chemistry has embraced modern microwave delivery methods, 
using microwave technology to enhance polymer synthesis. Since first 
appearing in the literature in 1979 (35), microwave assisted polymerisation 
has been the subject of over 2000 publications with a gradual increase over 
the last 20 years (figure 5.10). 
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Figure 5.10: Results from a search of ‘microwave assisted 
polymerisation’ on Web of Science ™  Core Collection.  This is 
also shown graphically by Schubert et al.  in their 2004 review 
(3) and updated in their 2007 review (36).  
Polymer synthesis reactions not possible with conventional heating have 
been reported using microwaves. For example, Singh et al. reported the 
synthesis of polyacrylamide using a reduced initiator concentration 
(potassium persulfate) under atmospheric conditions in a domestic 
microwave. Repeating the reaction conditions using conventional heating 
did not produce a polymer (37). Some authors have also reported 
microwave synthesised polymers with specific properties not 
demonstrated in polymers produced using conventional heating. In 2008 
Zhao et al. produced a poly (N-isopropyl acrylamide) hydrogel under 
microwave conditions that demonstrated increased swelling ability 
secondary to a higher degree of porosity when compared to the same 
hydrogel produced with conventional heating (38). Other examples of 
enhanced polymer synthesis using microwaves include: increased 
monomer conversion rates (39); increased curing rates for epoxy resins (9); 
the manufacture of polymers with increased molecular weights (40,41); 
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improved control of resultant polymer molecular weight (42,43); and 
improved polydispersity indexes of polymer beads (42,44,45). 
5.1.6.2 Molecular imprinting and microwaves 
The field of molecular imprinting has also used microwaves to facilitate 
imprinting for a variety of templates. Using microwave-initiated 
polymerisation, a significant increase in reaction rates (up 70-fold) 
compared with conventional heating techniques has been demonstrated 
by imprinters (46–48). Furthermore, differences in MIP performance 
dependent on microwave heating have been previously highlighted. For 
example, using a classical imprinting model of caffeine and theophylline, 
Turner et al. demonstrated reduced MIP binding capacity by microwave 
heated polymers (using a research scale bench-top microwave reactor) 
compared to conventionally synthesised polymers (oven heated) (46). This, 
the authors concluded, was a result of reduced surface area for binding 
sites found in the microwave MIP. 
Schwarz et al. also found differences in binding performance between MIPs 
synthesised with microwaves compared to conventional heating. However, 
unlike Turner el al., the overall binding capacities were similar, the 
difference was more subtle. Their template was resveratrol, a polyphenol 
compound, and analysis to determine the distribution of high and low 
affinity sites in the synthesised MIPs revealed different organisation of 
these binding sites on MIPs manufactured using microwave assisted 
polymerisation compared to those manufactured with conventional 
heating. This resulted in a more selective microwave MIP compared to its 
thermal counterpart when binding to resveratrol analogues compared to 
resveratrol was investigated (47).  
The microwave application device used in the vast majority of 
microwave/molecular imprinting studies is primarily used as a heating tool 
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and the sensing application of microwaves is seldom explored. The 
opportunity to track the formation of a MIP using resonance data obtained 
from a sophisticated cavity resonator system (as in this study) is potentially 
a powerful tool in the investigation of polymer formation. 
5.1.6.3 Microfluidics and microwaves 
Custom-made microfluidic mini-reactors have been used in combination 
with microwave heat to facilitate a wide range of organic synthesis 
reactions (49–51). Effective combination of microfluidic and microwave 
systems ranging from relatively simple straight microfluidic capillaries 
travelling through microwave reactors (52,53), to more complex 
microfluidic systems micromilled onto PTFE chips (54,55) have been shown. 
Furthermore, the sensing capability of microwaves in an integrated MF 
system has also been utilised with permittivity measurements being used 
to characterise non biological (organic solvents (33), polymer composites 
(56)) and biological materials (bacterial pathogens (57), cancer cells (58), 
and yeast (59)). 
The ability to effectively target microwaves at droplets in microfluidic 
systems has also been previously explored (60,61). For example, in their 
2013 paper, Boybay et al. demonstrated a microwave device with sensing 
and heating capabilities that were dependent on the composition of a 
particular droplet passing through the device (60). The system could also 
detect changes in droplet size by measuring resonant frequency shifts 
initiated by a passing droplet.  
The combination of microwave resonators, microfluidics and molecular 
imprinting using both sensing and heating application was explored in this 
study and described in this chapter.   
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5.2 Chapter aim and objectives 
The aim of this chapter was to develop a method for preparing molecularly 
imprinted polymer beads using microwave radiation to initiate 
polymerisation. The approach was to deliver microwaves as part of an 
integrated microfluidic /microwave system, in which slugs of aqueous 
monomer solution were exposed to microwaves as they travelled in an 
organic continuous phase. 
Key objectives of this chapter were as follows: 
1. The optimisation of the hybrid microfluidic/microwave system 
including formation of a reliable protocol for microwave-initiated 
polymerisation. 
2. The use of a microwave cavity resonator as a sensing instrument to 
track polymerisation. 
3. To demonstrate the ability to carry out molecular imprinting at a 
liquid/liquid interface and produce molecularly imprinted beads 
capable of surfactant (LPS surrogate) detection. 
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5.3 Materials and methods 
5.3.1 Materials 
All organic solvents were of HPLC grade and were obtained from Fisher 
Scientific, (Loughborough, UK). All PTFE and PET tubing was from Fisher 
Scientific. The t-junction fitting (PTFE), zero volume connectors (PTFE) and 
standard connector fittings and ferrules were from Upchurch Scientific, UK.  
5.3.2 Analysis 
5.3.2.1 Microwave sensing data 
Microwave sensing data was collected on Fieldfox N9912A Vector Network 
Analyser (Agilent Technologies, USA) and exported to LabVEIW (National 
Instruments, TX, USA). 
5.3.2.2 Fluorescence  
Fluorescence analysis was undertaken using a FLUOstar OPTIMA 
platereader (BMG Labtech GmbH, Ortenburg, Germany). Analysis of 
binding performance data obtained from fluorescence analysis was carried 
out with GraphPad Prism® V8 software (Bmax and Kd values from single-site 
specific binding curve fitting algorithm). 
5.3.3 Material characterisation using microwaves 
5.3.3.1 Dielectric characterisation 
Using a microwave resonant cavity (described in section 5.1.2.3), dielectric 
properties of the following were measured: DI water, chloroform, hexane, 
toluene, acrylamide (AAm) (0.15 g ml-1 solution), N,N’- methylene-bis-
acrylamide (MBAam) (0.03 g ml-1 solution); monomer solution A (AAm 0.15 
gml-1, MBAam 0.02 g ml-1); monomer solution B (AAm 0.15 g ml-1, MBAam 
0.03 g ml-1); monomer solution C (AAm 0.15 g ml-1, MBAam 0.04 g ml-1); 
and polyacrylamide (PAAm) gel. All samples were placed in a specialised 
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PTFE vial (designed to sit in the cavity resonator) and were the same 
volume (200 µl). The following parameters were measured: sample 
volume; volume of resonant cavity; change in bandwidth and the start 
frequency. 
5.3.3.2 Cavity resonance perturbation 
The power transmission between low power ports of the cavity resonator 
as a function of frequency was measured on placement of the reactants 
listed in section 5.3.3.1 into the cavity. These resonant frequency 
measurements allowed investigation of cavity resonance perturbation by 
each sample.  
5.3.4 Method development: system components 
5.3.4.1 Microwave delivery 
The microfluidic system described in chapter four was further modified to 
allow microwave-initiated polymerisation capability. Initially, this 
modification was a domestic microwave. However, the fully optimised MF 
system utilised a cavity resonator. 
5.3.4.2 Tubing 
The MF tubing system was modified to accommodate the cavity resonator 
and several iterations of in-cavity tubing configurations were developed 
and tested. Tubing was initially taped to the inside of the cavity resonator; 
thereafter the feasibility of concentrically coiling PTFE tubing onto 
cardboard inserts was investigated.  
5.3.4.3 Temperature detection 
Temperature measurements were taken by an infrared camera. The 
camera was positioned to measure temperature as the tubing emerged 
from the cavity resonator (figure 5.11). 
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Figure 5.11: Photograph of IR camera placement as part of 
integrated MF/microwave experimental set -up.  
5.3.5 Microwave-initiated polymerisation 
5.3.5.1 Polymerisation protocol development 
An optimal polymerisation strategy for the preparation for polyacrylamide 
beads was established through systematic variation of: energy supplied 
(dBM off maximum); total period of protocol (ms); duty cycle (ratio of the 
duration of the energy delivered to the total period of a signal); and the 
addition of a resonance sweep. Serial observational studies using gradual 
changes in all variables until polymer beads emerged from the system was 
undertaken. At key junctures manufactured beads were photographed and 
filmed peri-production.  
5.3.6 Dynamic polymerisation sensing 
5.3.6.1 Overview 
The polymerisation process was tracked using serial central perturbation 
measurements during the polymerisation of a nominated monomer 
solution. This dynamic polymerisation sensing was carried out in two ways. 
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Firstly, polymerisation took place outside the resonator and then polymer 
samples were transferred to the resonator for sensing measurements (ex-
resonator polymerisation sensing) and secondly, both polymerisation and 
sensing took place in the resonator (in-resonator polymerisation sensing). 
To regulate the temperature of in-resonator sensing, the resonator itself 
was placed in a bench-top oven. 
5.3.6.2 Ex-resonator polymerisation sensing  
Resonance peak measurements were taken for the empty cavity and for an 
empty glass vial. Thereafter, the following solutions were sealed in 
polymerisation glass vials and degassed for 15 minutes: DI water only (5 
ml); polymer 1 (AAm 0.75 g (10.5 mmol) no crosslinker, 5 ml DI water, 1.5 
ml MeOH); polymer 2 (AAm 0.75 g (10.5 mmol), MBAam 0.2 g ( 1.3 mmol), 
AAPH 6 mg (0.02 mmol), 5 ml DI water, 1.5 ml MeOH); polymer 3 (AAm 
0.75 g (10.5 mmol), MBAam 0.3 g (2 mmol), AAPH 6 mg (0.02 mmol), 5ml 
DI water, 1.5 ml MeOH); polymer 4 (AAm 0.75 g (10.5 mmol), MBAam 0.4 g 
(2.6 mmol), AAPH 6 mg (0.02 mmol), 5 ml DI water, 1.5 ml MeOH). 
Following de-gassing, 200 µl of each sample were placed into small, bottom 
tapered glass vials with care taken to minimise transfer time. If any residual 
solution was accidentally deposited on the rim or walls of the small glass 
vials the sample was discarded.  
Polymer four was then taken forward for a time-tracked sensing 
experiment. Following de-gassing, 200 µl of polymer 4 solution was 
transferred into a small, tapered end glass vial. Polymer four as tested (200 
µl) therefore constituted the following: AAm 0.024 g (0.34 mmol); MBAam 
0.0124 g (0.08 mmol); AAPH 0.18 mg (0.68 µmol). This vial was placed in a 
heat sink at 60  C and at the following time points perturbation 
measurements were taken: 0; 5; 10; 15; 20; 25; 30; 35; 40; 45; 50 and 55 
minutes. Transport from heat sink to cavity resonator for measurement 
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was two seconds. The measurements taken were: temperature, 
bandwidth, resonance peak centre, Q factor and dielectric loss. 
5.3.6.3 In-resonator polymerisation sensing experiment in oven 
The following solution (referred to as polymer 4) was sealed in 
polymerisation glass vials and degassed for 15 minutes: AAm 0.75 g (10.5 
mmol), MBAam 0.4 g (2.6 mmol) 5 ml DI water, 1.5 ml MeOH. Following 
de-gassing 200 µl of the solution was placed into a small, bottom tapered 
glass vial with care taken to minimise transfer time. Polymer 4 as tested 
(200 µl) therefore constituted the following: AAm 0.024 g (0.34 mmol); 
MBAam 0.0124 g (0.08 mmol); AAPH 0.18 mg (0.68 µmol). This vial was 
placed into the cavity resonator that in-turn was place in an oven to heat. 
The following measurements were taken: temperature (fiberoptic 
temperature monitoring), bandwidth, resonance peak centre, Q factor and 
dielectric loss. 
5.3.7 Molecular imprinting experiments  
5.3.7.1 Benzethonium chloride analysis (LPS surrogate template) 
Benzethonium chloride (BC) was analysed by fluorescence (λex 280 nm/ λem 
330 nm) over concentration range of 4.5 µM to 2.2 mM. Fluorescence was 
recorded using 200 µl of each concentration in a 96 well plate (three 
repeats of each). 
5.3.7.2 Benzethonium polymer bead production 
Molecularly imprinted and non-imprinted beads were produced using the 
microfluidic/microwave system. The following experimental conditions 
were used: 
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 Aqueous phase: AAm 0.75 g (10.5 mmol); MBAam 0.3 g (2 mmol), 
DI water 5 ml; 1.5 ml MeOH; AAPH 6 mg (0.02 mmol) 
 Organic Phase: toluene 
 Aqueous phase flow speed: 1.5 ml hr-1 
 Organic phase flow sped: 3 ml hr-1 
Two distinct sets of beads were produced: NIP (plain polyacrylamide beads 
with no BC added) and MIP (polyacrylamide beads produced with BC added 
to the organic phase (13 µM BC; 100 µl per run)). Post production all beads 
were immersed in DI water for 24 hours with regular changing of water 
(every 8 hours) and filtering via Whatman 1 paper.  
5.3.7.3 Benzethonium detection in washings 
To eliminate detection of free BC (BC not removed during template 
removal stage) during binding studies, serial washings were analysed by 
fluoroscopy during a time frame reflective of the post-production handling 
of the manufactured beads (beads were washed over 24 hours).  
5.3.7.4 Benzethonium bead binding studies 
Binding studies were carried out using the beads produced in section 
5.3.7.2. Standard solid phase extraction (SPE) cartridges with a filter placed 
at the distal end were also was cap sealed, 300 mg (wet weight) beads 
were then packed into SPE cartridges and incubated for 12 hours with 
incremental concentrations of BC solution. Filtrates were then analysed 
with fluorescence spectroscopy (λex 280 nm/ λem 310 nm). Three repeats of 
each NIP and MIP cartridges were prepared. This experimental process is 
shown in figure 5.12. 
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Figure 5.12: Schematic of BC binding experiment.  1.)  Polymer 
beads (NIP: plain PAAm beads; MIP: beads produced in the 
presence of BC in organic phase) were packed into SPE 
cartridge; 2.)  Known concentrations of BC solutio n were 
introduced to cartridges; 3.)  Following incubation overnight 
the filtrate was obtained by applying pressure to the top of  
the cartridge 
The following concentrations of BC solution were used in the binding 
experiment (three repeats of each): blank (DI water only); 1 µ ml-1; 2 µ ml-1; 
4 µ ml-1; 8 µ ml-1 and 10 µ ml-1. 
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5.4 Results and discussion 
5.4.1 Material characterisation using microwaves 
5.4.1.1 Dielectric characterisation 
Results of relative dielectric loss measurements are shown in figure 5.13. 
Dielectric loss (’’) was calculated using the equation 5.5 which describes 
the relationship between the following parameters: Vs: sample volume; Ve: 
Volume of resonant cavity x scaling factor (0.269); ∆BW: change in 
bandwidth and f: start frequency.   
     
   
 
  
   
                                                                                                       (5.5) 
 
Figure 5.13: Dielectric loss measurements.  AAm: 2 M solution 
AAm; MBAam:  2 M solution MBAam; monomer solution A : 
AAm 0.15 g ml
- 1
,  MBAam 0.02 g ml
- 1
; monomer solution B :  
AAm 0.15 g ml
- 1
,  MBAam 0.03 g ml
- 1
;  monomer solution C :  
AAm 0.15 g ml
- 1
,  MBAam 0.04 g ml
- 1
; PAAm : polyacrylamide 
gel formed from monomer solution B.  
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Table 5.2 shows the relative dielectric loss measurement (dimensionless 
parameter) for tested solvents.  
Table 5.2: Relative dielectric loss measurements for four test  
solvents, shown as mean value, N=3.  
 
Solvent 
 
Relative dielectric loss  (SD) 
 
Water 
 
0.7467 (0.0035) 
Chloroform 0.1167 (0.0007) 
Toluene 0.0056 (6.05x10
-5
) 
Hexane 0.0013 (0.0006) 
The results from figure 5.13 and table 5.2 show relative dielectric loss 
measurements for a range of aqueous solutions and organic solvents. A 
significant result shown in figure 5.13 is the drop in relative dielectric loss 
seen between a non-polymerised monomer solution and the PAAm gel. As 
the solution polymerised, the inherent ability to absorb electromagnetic 
radiation decreased and the material became less efficient at converting 
microwave energy into heat. This was predicted considering the interaction 
of materials and microwaves on a molecular level. The heat generated as 
dielectric heating takes places is reliant on a molecule being able to 
orientate itself in parallel with an electric field. Once locked within a solid 
matrix, this ability decreases.  
Tested solvents also demonstrated different relative dielectric loss 
measurements. Furthermore, the results were aligned with the polarity, 
and therefore electronegativity, of each solvent. Efficient volumetric 
heating of any given sample by microwaves is dependent on dielectric 
properties. Such properties will not only dictate the samples ability to be 
polarised (permittivity, ’) but how efficiently this absorbed 
electromagnetic radiation is converted to heat (loss factor, ’’) (1,62). 
Electronegativity is an important consideration when predicting the 
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behaviour of a dielectric. The Hildebrand Solubility Factor, the 
Rohrschneider Polarity Scale and calculations of dipole moments can all 
provide an overview from which prediction of behaviour when exposed to 
microwaves can be made. Table 5.3 shows electronegativity parameters for 
the organic solvents used in this study. 
Table 5.3: Electronegativity parameters of the solvents used 
in section.
 a
 taken from (63,64)  
b
 taken from (64,65) ;
c
 taken 
from (66) ; 
d
 calculated from (66)  as one Debye unit  = 
3.34x10
- 30
 Coulomb-metres.  
Solvent 
 
Hildebrand 
solubility 
a 
Rohrschneider 
polarity scale 
b 
Dipole moment 
(µ.10
-30
/cm) 
c 
 
Dipole moment 
(debye units, 
D) 
d 
 
Water 
 
9.0 
 
23.4 
 
6.2 
 
1.85 
Chloroform 4.4 9.3 3.8 1.04 
Toluene 2.3 8.9 1.0 0.36 
Hexane 0.1  8.0 0.0 0.0 
 
Therefore, predictably from its high electronegativity, water demonstrated 
the highest dielectric loss when exposed to microwaves in comparison to 
other solvents in this study. Thereafter, chloroform, toluene and hexane 
demonstrated dielectric behaviour aligned with their polarity. 
5.4.1.2 Cavity resonance perturbation 
a. Organic phase studies 
Shown in figure 5.14 are the resonance peaks for several organic solvents, 
showing changes in measured response of the cavity resonator at low 
power transmissions dependent on the solvent sample within the cavity.  
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Figure 5.14: Central perturbation resonance peaks for a 
series of organic solvents prior to choosing the continuous 
(organic) phase of MF experiments.  The dashed l ine 
represents the control which was an  empty vial sat within the 
cavity resonator. The peak for water is also shown.  
When the cavity was perturbed with solvents, change in resonant 
frequency was observed to be a function of increasing solvent polarity. This 
was demonstrated by a change in the measured response of the cavity 
resonator (at low power transmissions). Similar results have been 
demonstrated previously by studies using central perturbation capabilities 
to demonstrate differences in solvents (33,34,54). A rightward shift of the 
resonance curve (reduction in the peak curve amplitude) and a decrease in 
peak width can be observed when a series of organic solvents are 
compared to water.  
Prior to experiments using a cavity resonator, on-bench studies integrating 
MF with a modified domestic microwave formed the bulk of initial studies. 
During these experiments chloroform was used as the organic phase. 
However, experiments with a microwave cavity resonator used toluene as 
the organic phase. Figure 5.15 shows comparison of resonance peaks for 
chloroform and toluene. 
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Figure 5.15: Comparison of resonance peaks from central 
perturbation measurements of an empty vial  within the 
cavity (control)  and chloroform (top ) and toluene (bottom).  
The shift seen between each organic solvent and water is of similar 
magnitude, therefore toluene was a suitable substitute for chloroform as a 
continuous phase in the MF/microwave experiments. Furthermore, 
problems were encountered during chloroform experiments with loss of 
segmented flow as chloroform approached its boiling point (61.2   C). 
Therefore, a change to toluene was made considering its boiling point of 
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110.6   C and relative dielectric loss (’’) of 0.0056 compared to 0.117 for 
chloroform.  
Interestingly, a recognised advantage of using microwave for organic 
synthesis is the ability to superheat solvents to temperatures beyond their 
boiling point, effectively negating the concern with solvent boiling points. 
However, this can only only take place in a sealed vessel (67,68). In 2001 
Chemat and Esveld studied this superheating of solvents in detail and 
highlighted the ability to accelerate reactions due to this solvent 
superheating alone (69). However, in the system developed for this study, 
the polymerisation reaction cannot take place in a sealed system as the 
continuous flow and eventual emergence from the tubing of a polymer 
bead is the key to bead production. Therefore, boiling points of reactants 
were an important consideration. 
The results shown in figures 5.14 and 5.15 allowed the rational choice of 
organic phase solvent for ongoing experiments. Overall, the aim was for 
microwave energy to be delivered with maximal efficiency to the 
segmented portion of fluid flow within the MF tubing (aqueous 
component). Therefore, choosing a solvent that had a dielectric loss (’’) 
measurement far lower than that of water (is inefficient at converting 
microwave energy to heat) indicated energy would not be ‘taken up’ by the 
solvent and would be available to heat the aqueous phase, initiating 
polymerisation.  
b. Aqueous phase studies 
Shown in figure 5.16 are dielectric characterisation results from the 
aqueous reactants of subsequent MF/microwave polymerisation 
experiments. The effect on output transmission at low power inputs from 
the cavity resonator was tested depending on the presence of certain 
aqueous solutions.  
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Figure 5.16 : A.)  resonance graphs for aqueous monomer 
solutions used in ongoing experiments; B.)  resonance peaks 
for three mixed monomer solutions. Monomer solution A: 
AAm 0.15 gml
- 1
,  MBAam 0.02 gml
- 1
; monomer solution B: 
AAm 0.15 gml
- 1
,  MBAam 0.03 gml
- 1
; and monomer solution C:  
AAm 0.15 gml
- 1
,  MBAam 0.04 gml
- 1
.  
 
The presence of both AAm and MBAam in solution caused greater 
perturbation of resonant frequency than that of water alone; the presence 
of monomers therefore affects the transmission output from the 
microwave cavity at a given power input.  
As with interpretation of the perturbation results for organic solvents, the 
electronegativity of aqueous solutions was considered. The dipole moment 
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is an indicator of bond polarisation and therefore reflects the variation in 
electronegativity of constituent atoms. Overall molecule conformation and 
these electronegativity gradients are the key determents of the dipole 
moment which is measured in Debye units (1 Debye ≡ 3.34 x 10-30 
coulomb-meters), for example water dipole moment is 1.84 Debye units. In 
comparison, Marstokk et al. measured the dipole moment of acrylamide 
(70), giving the overall measurement as 3.44 Debye units (planar geometry; 
carbonyl and vinyl groups in syn-conformation). It was expected, therefore, 
that the addition of a species with a high dipole moment (in comparison to 
water) would lead to an increased loss factor being observed and the 
output resonance of the cavity would demonstrate a decreased peak 
resonant frequency. This is indeed shown in the resonance peaks shown in 
figure 5.16. 
5.4.2 Method development: system components 
5.4.2.1 General overview 
Chapter four described the manufacture of a microfluidic system capable 
of generating segmented flow. The dispersed phase (aqueous) travelled in 
the continuous phase (organic) following flow manipulation at a t-junction. 
For ongoing experiments, the system developed in chapter four required 
the integration of a ‘polymerisation point’ at which aqueous beads could 
be polymerised. Shown in figure 5.17 is the final iteration schematic of the 
integrated system. 
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Figure 5.17: Schematic of the integrated MF/microwave 
system. As packets of aqueous monomer solution travel 
through the cavity  they were subjected to microwaves and 
polymerisation is initiated.  Transit through system is 
indicated by the dashed line. (PTFE: polytetrafluroethelene; 
PAAm: polyacrylamide).  
5.4.2.2 Microwave delivery 
The delivery of microwaves in experiments was with a cavity resonator 
described in section 5.1.4.4. 
5.4.2.3 Tubing 
The two key considerations for the tubing in relation to the microwave 
resonator were the proximity to the energy source and the microwave 
exposure time. Figure 5.18 shows an initial step in the configuration of 
tubing within the resonator, followed by the successful tubing arrangement 
shown in figure 5.19. 
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Figure 5.18: Example of initial experiment set -up where MF 
tubing is taped in concentric circle around the edge of the 
microwave cavity resonator.  
As the microwave-initiated polymerisation protocol and microfluidic flow 
rates were optimised, the tubing arrangement shown in figure 5.18 was 
deemed unnecessary. These optimisation steps allowed the reduction of 
tubing length needed within the cavity to facilitate effective polymerisation 
of aqueous beads. Traversing of tubing through the 40 mm length of cavity 
via a central cavity port sufficed for this purpose. This arrangement is 
shown in figure 5.19. 
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Figure 5.19: Optimised tubing configuration.  The 
polymerisation protocol was optimised with the tubing 
simply traversing directly through the cavity (40 mm in 
cavity).  
5.4.2.4 Temperature detection 
An infrared camera was used to detect temperature of tubing prior to 
entry into the cavity resonator and for 12 cm following emergence. The 
temperature profile obtained from the camera is shown in figure 5.20. 
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Figure 5.20: Temperature profile of MF PTFE tubing.  At t ime 
zero the temperature indicated represents the temperature 
of the tubing just prior to entering the cavit y resonator.  
The sharp rise in temperature along the 40 mm length from entering the 
cavity to emerging is shown; the temperature of the tubing rises from   
26.4  C to 59.1  C over this distance. Temperature then drops at a rate of 
approximately 0.28  C per mm along the tubing as readings are taken more 
distal to the microwave cavity. 
However, the use of IR temperature detection in this study should be 
treated with caution. Previous work by chemist Oliver Kappe highlighted 
the unreliable nature of IR temperature detection in microwave assisted 
organic synthesis reactions (11,71,72). Essentially, Kappe firmly dissuaded 
the use of IR sensing in favour of fibreoptic temperature sensing.  
Undoubtedly IR has limitations; however, in this study we are not 
comparing per se the polymerisation of acrylamide with conventional and 
microwave heating. The temperature comparison is an added 
measurement but not the overarching aim of this experimental section. 
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Therefore, the use of an IR camera as an available and accessible tool in 
this instance is justified. Furthermore, the creation of a temperature profile 
is an interesting finding rather than just actual figures obtained, allowing 
visualisation of the rapid heating and then cooling of the MF tubing as it 
traverses the microwave cavity.  
The temperature generated by the cavity resonator was of paramount 
importance when choosing the solvent for the continuous MF phase (in 
terms of the proximity to solvent boiling point). Furthermore, the 
temperature was an important consideration regarding the choice of 
initiator species. The initiator used in these experiments was 2’2’ azo (2-
methyl-propionamide) dihydrochloride (AAPH), a free-radical initiator that 
decomposes on exposure to UV and heat. AAPH can spontaneously 
decompose at 37-40 °C to give free radical species (73,74), a reaction that 
is also pH dependent (73). However, polymerisation reactions at 
temperatures above the decomposition temperature of AAPH have been 
reported (75–77). Furthermore, an important consideration concerning 
choice of initiator is t1/2 value (time required to reduce the initial initiator 
content of a solution by 50%, at a given temperature) and AAPH has a 10 
hour t1/2 temperature of 56 °C in water. 
5.4.2.5 Miscellaneous components 
The bead generating system is dependent on optimisation of all 
components, including syringe drivers and choice of syringe. Syringe drivers 
are an integral part of the MF system and must have quick response time 
when settings are changed and also have a smooth, ‘ratchet’ free motion 
when in action. Segmented flow generation can be markedly disrupted if 
the driver fails to deliver a smooth forward motion.  
In their 2014 paper, Li et al. quantified the fluctuations seen in MF flow 
secondary to the pump motor by looking at ripples at the interface of two 
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co-flowing liquid streams (78). The liquid/liquid interface in this Li et al. 
experiment was designed to have low interfacial tension therefore this 
interface was easily disturbed by flow fluctuations (group use polyethylene 
glycol 17% and tripotassium phosphate with an estimated IF tension of 
0.03 mN m-1 (79)). Li et al. correlated the amplitude of ripples generated to 
syringe pump motor function, concluding these ripples would be masked in 
systems with liquid/liquid interfaces of higher IF tension. The IF tension 
between water and toluene (the liquids used in the experiments described 
in this chapter) is estimated at 37.3 mN m-1 (at 20   C, averaged over pH 4-9 
(80)). Therefore, considering this higher IF tension value, it is plausible that 
small disturbances in flow due to pump motor function may be 
undetectable to the naked eye.  
The material of syringe for both the aqueous and organic phases was glass, 
offering smoother flow than polymer syringes. Friction between the 
plunger and inside walls of glass syringes is lower than that for plastic 
syringes. For routine use this is inconsequential, but when used to drive 
small volumes of fluid through microfluidic channels, the smoother flow 
seen with glass syringes is beneficial.  
5.4.3 Microwave-initiated polymerisation 
5.4.3.1 Polymerisation protocol development 
Whilst directly observing for the emergence of white polymer beads from 
the cavity resonator within the MF tubing, the following microwave 
delivery parameters were investigated: duration (ms); power (dBm); pulse 
period (ms) and high time (ms). Duration refers to the total cycle time, 
power refers to the applied microwave power measured in dBm (decibel-
milliwatts), pulse period refers to the duration in milliseconds of each sub-
cycle during overall duration and the high time refers to the amount of 
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time during this that the power is applied (forming the duty cycle, figure 
5.21).  
 
Figure 5.21: Representation of a duty cycle.  In the finalised 
microwave-initiated polymerisation protocol a 10% duty cycle 
was used (in a 100 ms cycle, power is delivered for 10 ms ).  
These parameters were systematically tested in various combinations with 
observation of the corresponding segmented flow appearance within the 
MF tubing. During initial microwave protocol experiments, runs produced 
liquid output (no polymerisation) or weak ‘beads’ that disintegrated within 
minutes of being expelled from the MF tubing (inadequate polymerisation). 
Also observed was the production of seemingly intact polymer beads that 
would amalgamate post production and therefore had a short shelf life, 
not allowing post production use for binding studies. However, eventually 
the production of robust polymer beads was observed under the 
conditions of microwave delivery shown in table 5.4. 
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Table 5.4: The finalised microwave-initiated polymerisation 
protocol.  
Phase 
Duration 
(ms) 
Back off power 
(dBm) 
Pulse period 
(ms) 
 
High Time 
(ms) 
 
Resonance sweep 
 
100 
 
0 
 
0 
 
0 
Modulation 5000 6 100 10 
Resonance sweep 100 0 0 0 
Modulation 5000 6 100 10 
Resonance sweep 100 0 0 0 
Modulation 5000 6 100 10 
 
This finalised protocol was the result of successive systematic experiments 
to find the optimal settings of the following parameters: energy supplied 
(dBm off maximum); total period of protocol (ms); duty cycle (ratio of the 
duration of the energy delivered to the total period of a signal); addition of 
resonance sweep. Through the course of these experiments it became 
evident the most influential factor in achieving effective polymerisation 
was the control of heating by varying the duty cycle of the microwave 
radiation.  
5.4.3.2 Manufactured polymer beads 
Once the protocol shown in table 5.4 was found to reliably result in the 
emergence of polymer beads from the microwave cavity the manufacture 
of PAM beads could take place. The change in colour from clear to white 
polymer was obvious to the naked eye and indicated successful 
polymerisation (figure 5.22). 
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Figure 5.22: Photograph documentation of the microwave 
polymerisation protocol at work.  1.)  Segmented flow can be 
seen in the MF tubing as it emerges from a microwave cavity 
resonator. 2.)  Following commencement of polymerisation 
protocol these clear ‘beads’ travelling in the tubing can be 
observed transforming from clear to white.  
As an example of early polymer production, figure 5.23 shows the 
appearance of successfully polymerised aqueous ‘slugs’ in the 
experimental stages during which the MF flow dynamics and microwave-
initiated polymerisation protocol were still being optimised.  
 
Figure 5.23: Photographs of early ‘slugs’ produced with the 
integrated MF/microwave system and using the microwave 
protocol in early stages of development.  
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Figure 5.24 shows beads representative of those produced in later 
experimental stages. 
 
Figure 5.24: Photographs of polymer beads produced in later 
experimental stages and representative  of polymer beads 
produced in benzethonium chloride experiments.  
Comparison of the polymer beads in figures 5.23 and 5.24 demonstrates 
the progression from polymer slugs to the production of spherical polymer 
beads as the system was optimised. 
5.4.4 Dynamic polymerisation sensing 
Previous experimental sections have looked at individual reactants and 
how their dielectric properties dictate interaction with microwaves. Taking 
this sensing capability in a different direction, it was hypothesised the 
formation of the polymer could be monitored using the changing dielectric 
properties of the material as polymerisation progressed. Furthermore, it 
was thought it may have been possible to distinguish between levels of 
crosslinking dependent on the material’s dielectric properties. 
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Shown in figure 5.25 is the comparison of cavity perturbation 
measurements of polymers with differing degrees of crosslinking (shown 
by a change in the measured response of the cavity resonator at low power 
transmissions). These resonance peaks are compared to those of water, an 
empty glass vial and PTFE tubing.  
 
Figure 5.25: Resonance peaks for dynamic polymerisation 
sensing experiments.  Polymer 1:  0.75 g AAm, no crosslinker); 
polymer 2:  0.75 g AAm, 0.2 g MBAam; polymer 3:  0.75 g 
AAm, 0.3 g MBAam; polymer 4 : 0.75 g AAm, 0.4 g MBAam 
Figure 5.25 demonstrates a shift downwards in resonance frequency for all 
polymers in comparison to water, reflecting a reduction in peak curve 
amplitude. Furthermore, resonance peak widths for all polymers are 
increased in comparison to water. It is interesting to compare these 
findings with the resonance peaks shown in figure 5.16; in solution 
monomers demonstrated a decrease in peak curve amplitude compared to 
water, however, when these monomers polymerise the curve amplitude 
increases reflecting a reduced ability to damp the resonance of the system. 
This is explained by polymer matrix formation and increased crosslinking 
reducing the ability of polar molecules to agitate when exposed to an 
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oscillating E-field. Permittivity therefore decreases as less energy can be 
stored in the material and energy is dissipated. 
Monomer solutions with differing concentrations of crosslinker (MBAam) 
were purposefully used in these experiments. However, unfortunately this 
method of dynamic polymer sensing using low power microwave 
transmissions was not sensitive enough to detect any changes in 
perturbation secondary to degree of polymer crosslinking. However, the 
possibility of being able to track the formation of a polymer using changing 
dielectric properties was still of interest.  
From the tested polymers shown in figure 5.25, polymer four was used for 
a polymerisation tracking experiment. Polymer 4 as tested (200 µl) 
constituted the following: AAm 0.024 g (0.34 mmol); MBAam 0.0124 g 
(0.08 mmol); and AAPH 0.18 mg (0.68 µmol). Shown in figure 5.26 are the 
resonance peaks measured from the microwave cavity every five minutes 
for one hour as the solution polymerised. There are clear differences in 
peak amplitudes between the polymer when at an early aqueous/gel stage 
(up to 10 minutes) and when a white solid polymer has formed. 
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Figure 5.26: Resonance peaks from central perturbation measurements for polymer four (0.75 g AAm, 0.4 g MBAam, 5ml DI 
water and 1.5 ml MeOH, 200µl).  As the polymer cured in a heat sink at 60   C the vial was swiftly transferred to the resonant 
cavity and a resonance peak was measur ed at the indicated time intervals. A clear distinction between the gel/clear stages 
and the opaque stages is seen.
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Figure 5.27 shows how the Q factor of the sample changed from 366 to 940 
(mean, n=3) as the polymerisation time increased. This is reflected in the 
peak morphology shown in preceding figure 5.26 (as Q factor increased, 
the resonance peaks became sharper). 
 
Figure 5.27: Change in Q  factor of resonant cavity  as polymer 
forms (conventional heating,  60
  
 C heat sink)  
As polymerisation proceeded there was a step-wise change in the dielectric 
properties of the material, evidenced by a change in resonance of the 
system.  
The temperature dependence of the central perturbation measurement is 
an important consideration. Cavity resonators are carefully designed 
considering the dependence of the cavity resonant frequency on cavity 
dimensions (14,18,81). Therefore, dimension change caused by thermal 
expansion of a metal cavity may contribute to shifts in resonant frequency 
observed when a sample is introduced; the reason for change is then a 
temperature affect only, not a change in the dielectric properties of the 
sample (81). The relationships between temperature of the cavity and 
changes in the cavity radius (a) are shown in equation 5.6a and 5.6b (81). 
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These equations demonstrate the linear nature of thermal expansion due 
to temperature increase 
                                                                                                         (5.6a) 
                                                                                                          (5.6b) 
where    and    represent the change in cavity radius and resonant 
frequency, respectively; a(T) represents the cavity radius at any given 
temperature;      is the cavity frequency at any given temperature; and 
the initial cavity dimensions and frequency are represented by a0 and   . 
However, the change in resonant frequency of the cavity due to any 
thermal expansion dimension changes is a negative relationship; cavity 
resonant frequency decreases with thermal expansion. This is 
demonstrated in equation 5.7 (82):   
  
  
  
  
  
                                                                                                           (5.7) 
where f is measured resonant frequency;  f0 is the initial resonant 
frequency; a0 is the initial cavity radius; and the cavity radius at any given 
temperature is a. Therefore, any increase in cavity dimensions due to 
thermal expansion causes a decrease in cavity resonant frequency (f).  
The logistics of this experiment involved the transit of the vial containing 
developing polymer from a heat sink to the resonator with a transit time of 
approximately two seconds. This may have introduced sample temperature 
fluctuations as the vial cooled on emergence from the 60 degree heat sink. 
Despite fluctuations in temperature on exposure to room temperature, 
cumulatively the temperature of the vial is increasing over the time of the 
experiment. However, once the vial was placed in the cavity following 
transit from the heat sink, cavity resonance data acquisition time was 
minimal (of the order of seconds); therefore, the likelihood of a significant 
thermal expansion (enough to cause dimension changes in the cavity and 
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affect the resonant frequency) in this time is low. The increase in resonant 
frequency shown in figure 5.26 is therefore caused by changes in dielectric 
properties of the sample. 
Furthermore, resonant frequency is also dependent on the size of the 
sample. However, this can be ignored when considering that the size of the 
cavity is far greater than that of the sample and its relative affect is 
minimal (82). The temperature generated by polymerisation within the 
sample vial is also a consideration. The mainstay of dielectric 
characterisation by central perturbation measurement research is focused 
on the characterisation of materials having completed any formation 
reactions, rather than the reaction itself. However, temperature correction 
with consideration of the enthalpy change of an ensuing reaction within 
the cavity has previously been employed by researchers (83). The 
polymerisation of AAm crosslinked with MBAam is an exothermic reaction 
with an enthalpy of polymerisation of AAm of 17-20 kcal mol-1 (84,85). 
However, considering the reaction ongoing in the glass vial placed in the 
cavity resonator contained 0.34 mmol of AAm, even at 20 kcal mol-1 the 
enthalpy of polymerisation would have been 6.8 cal (equivalent to 28.5 
joules). Much like the contribution of the sample size, this parameter 
would have negligible effect on any thermal expansion of the microwave 
cavity resonator and therefore on any observed change in resonant 
frequency. 
In order to reduce any temperature fluctuations caused during sample 
transit, polymerisation sensing was then carried out with the cavity 
resonator kept in a temperature-controlled environment (i.e. a finely 
controlled scientific oven). 
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5.4.5 Polymerisation sensing experiment in oven 
The resonator was placed in a bench top oven allowing accurate 
temperature sensing and measurement of permittivity (’) and loss factor 
(’’). This experiment used the same monomer solution used to generated 
results in section 5.4.4 (0.75 g AAm, 0.4 g MBAam, 5 ml DI water and 1.5 ml 
MeOH (200 µl)) and polymerisation took place in the resonator. 
Measurements were taken over 18 minutes (time point chosen as white 
polymer had formed by this time point and the early stages of polymer 
formation were studied). 
A fibreoptic pyrometer recorded temperature of the resonator inside the 
oven, providing the temperature profile shown in figure 5.28.  
 
Figure 5.28: Temperature profile from the cavity resonator 
that was in a bench-top oven.  
Fluctuations in the temperature correspond to the oven door opening 
(sample placed in resonator; temperature briefly falls) and then shut again 
(temperature rises). Temperature sensing in this experiment followed 
recommendations from several reviews about the accurate recording of 
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temperature in microwave-initiated organic reactions (11,67,71,72); the 
thermometer was fibreoptic, rather than infrared. 
Shown in figure 5.29 are the ’ and ’’ values obtained from the sensing of 
polymerisation within the glass vial in the resonator (that was in-turn in an 
oven). These dielectric properties were recorded over 1068 seconds.  
 
Figure 5.29: Graph showing  ’  (real part permittivity) and 
calculation of  ’ ’  (imaginary part permittivity - dimensionless 
parameters) of polymer sampl e as it forms within the cavity 
resonator.  
From 0 to 200 seconds the sample begins to heat and polymerisation 
begins. Interestingly, a definite step change can then be seen at 200 
seconds which could represent a phase change. The rates of change for 
both parameters dramatically decrease following the step change, ’ 
continues to fall do a greater degree than the small drop seen in dielectric 
loss (’’). Initially as water in the sample is heated, absorption of 
microwave energy is high due to low opposition to electromagnetic energy 
(permittivity reflects a material’s opposition to electric field). However, as 
polymerisation takes place and a phase change is potentially seen, the 
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material begins to establish opposition to electric field which is reflected by 
a slowing of the drop in permittivity seen in figure 5.27. 
The ability to detect small changes in flux generation at early 
polymerisation is a highly interesting prospect. Brown et al. demonstrated 
a difference between polar and non-polar monomers and their behaviour 
under microwave irradiation. By comparing polar (methyl acrylate and 
methyl methacrylate) and non polar (styrene) monomers polymerised by 
microwaves and conventional heating they observed an increase in 
polymerisation rate for the polar monomers under microwave irradiation 
but not for the non-polar monomers (86). 
The data shown in figure 5.29 supported the hypothesis that observed 
shifts in resonant frequency perturbation by the sample were resultant of 
changes in sample dielectric properties and not simply a reflection of 
temperature change. This can be further explained by figure 5.30 showing 
temperature at permittivity plots. 
 
Figure 5.30: Graph showing  ’  (real part permittivity) of 
sample as it  polymerises within the cavity resonator (which 
in-turn is placed in an oven) compared to the temperature 
fluctuation within the oven  
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Figure 5.30 shows the change in sample ’ when placed into the cavity 
resonator from room temperature. Room temperature in this environment 
was 19 to 21°C. The sample then increased in temperature reaching 
approximately 62 °C as it sat within the cavity. Therefore, at the lower 
room temperature estimate of 19 °C, a temperature increase of 43 °C 
corresponded to a change in ’ from 1.0237 to 1.0232 at 200 seconds, 
giving a rate of ’ change of approximately 0.0000116 per degree rise in 
temperature. At 1000 seconds ’ is 1.0217 (-0.002 from time zero) this 
change in ’ would therefore have corresponded to a temperature of 
approximately 172 °C; well above the boiling point of any water still 
remaining in the sample. Considering there was no boiling or destruction of 
the sample, the measured decrease in ’ as temperature rises is due to 
changes in dielectric properties of the sample and not merely a reflection 
of increased temperature. 
A vast amount of literature concerning microwave-initiated polymerisation 
makes no reference to the sensing capability of microwaves; they are used 
as a heating tool only. However, microwave dielectric loss spectroscopy is a 
tool employed by several groups to characterise a variety of materials 
including natural rubber/carbon composites (87), titanium dioxide disks 
(88), magnesium titanate powder (89), and even fruit, meat and grain (for 
quality control purposes) (90–92). Dielectric sensing using broadband 
dielectric spectrometers is also used to provide dielectric characterisation, 
and this method has been used for polymers. However, this method has 
been employed only once the polymer composite has been formed, rather 
than during the polymerisation process itself (93–95). Therefore, this work 
offers an interesting application of microwave sensing to track polymer 
formation. 
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5.4.6 Molecular imprinting experiments  
5.4.6.1 Benzethonium chloride analysis (LPS surrogate template) 
The chemical structure of LPS consists of a hydrophilic polysaccharide and a 
hydrophobic lipid portion (lipid A); therefore, LPS is amphipathic in nature. 
This structural arrangement determines conformation and activity of LPS 
and is a key consideration for the investigation of LPS interaction with 
antibiotics and host immune cells. Benzethonium chloride (BC), a 
quaternary ammonium salt, has an amphipathic structure and was used a 
as a surrogate for LPS as a template in the molecular imprinting process. 
The structure of BC is shown in figure 5.31. 
 
Figure 5.31: Structure of Benzethonium Chloride.  
(benzyldimethyl [2-[2(p-1,3,3,3-tetramethybutylphenoxy) 
ethoxy] ethyl]-ammonium chloride).  
To ensure accurate detection of BC in the filtrate of binding experiment 
samples, the limitation of fluorescence detection of BC using available 
analysis equipment was established. Previous studies concerned with the 
detection of BC have established a fluorescence profile. For example, 
Karumbamkandathil et al. investigated the shape transformations of BC 
micelles, using BC purchased from the same supplier (96). Using an 
excitation wavelength of 270 nm, an emission maxima of 307+/- 1 nm was 
observed for all BC samples analysed in this study over the concentration 
range of 0.035 mM to 4.13 mM (96). Therefore, BC was analysed by 
fluorescence (λex  280 nm/ λem 330 nm) over concentration range of 4.5 µM 
to 2.2 mM. Figure 5.32 shows a series of calibration curves obtained from 
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the fluorescence analysis of various concentrations of BC solution, from µM 
to mM concentrations. All calibration data were fitted with linear 
regression and coefficient of determination (R2) values determined. 
 
Figure 5.32: Calibration curves of fluorescence intensity 
(arbitrary units) as a function of BC concentration.  
Al l  samples were analysed at λex 280 nm/ λem 330 nm. 
Equation of the lines and R2 values were as follows A)  y= 
107651х + 158.4; R2: 0.999; B)  y= 1556.7х + 1336.2; R2: 
0.990; and C)  y= 5127.4х + 567.7; R2: 0.977.
A
. 
C
.
. 
B
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Shown in figure 5.32, the coefficient of determination (R2) values for 
calibration graphs demonstrated data fitted well within the graph equation 
and therefore ongoing accurate determination of values obtained from 
binding studies was possible. 
5.4.6.2 Benzethonium chloride imprinted polymer bead production 
The aim of this experimental section was the successful production of 
molecularly imprinted polymer beads that could subsequently bind to BC. 
Shown in figure 5.33 is a highly simplified schema of the theoretical 
interaction of BC at the aqueous/organic interface.  
 
Figure 5.33: Schematic representing method of polymer bead 
production capable of subsequent BC detection.  Microfluidic 
and microwave integrated system was utilised for this 
specialised bead production. Highly simplified and theoretical 
surface interaction shown, representing the self assembly (at 
a liquid-liquid interface) step of  an imprinting process. The 
amphipathic nature of BC lends itself to the arrangement 
shown at the interface between the aqueous bead and the 
organic carrier phase.  
The interaction of surfactants and polymers has been extensively reported 
and several comprehensive reviews on the subject published (97–99), 
however, studies are typically concerned with surfactant interaction with a 
formed polymer; not with interactions as the polymer is forming (as in this 
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study). When discussing polymer/surfactant interaction the critical 
aggregation concentration (CAC) is an important factor. The CAC is the 
surfactant concentration at which the polymer becomes saturated with 
surfactant (100,101). It is widely accepted that CAC is lower than CMC and 
it is not until this CAC is reached that the optimal polymer/surfactant 
interaction take place (101). CMCs of cationic surfactants (such as BC) are 
higher than that of zwitterionic surfactants (102,103), therefore, perhaps 
promotion of surfactant/ polymer interaction is easier with cationic 
surfactants considering their relatively higher CMCs. 
5.4.6.3 Benzethonium detection in washings 
It was important to show in binding studies that any BC detected in the 
filtrate of study samples was not merely BC leaching from a BC MIP. Shown 
in figure 5.34 are the absorbance profiles (at λ280 nm) of serial samples 
analysed during the washing stages post MIP and NIP bead production.  
 
Figure 5.34: Absorbance (arbitrary units) of washing samples 
at 280 nm (reflecting the presence/or not of BC).  Multiple 
serial samples were taken to track the effectiveness of the 
template removal washing stage.  
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Marked variation is seen in sample absorbance at 280 nm for both MIP and 
NIP in the first 60 minutes. Results in the first 15 minutes are interesting as 
seemingly washings from NIP polymer beads (beads prepared with no BC 
present) also showed absorbance levels in keeping with BC detection. This 
is most likely due to the presence of un-reacted monomers or small 
particles of polymer that also demonstrated absorption at 280 nm. Results 
then deviate between 30 and 60 minutes and, as expected, washings from 
the MIP polymer show increased absorbance at 280 nm compared to those 
from the NIP washings. Absorbance then decreases to baseline when 
washings from an extended time period are analysed. Analysis in this way 
is not quantitative, but shows BC removal using washing protocol used in 
binding experiments.  
5.4.6.4 Benzethonium chloride imprinted bead binding studies 
A binding study was carried out to investigate the ability of MIP beads to 
detect BC using NIP beads as control. Packed into SPE cartridges, both sets 
of beads were exposed to various concentrations of BC solution and 
binding capability analysed by fluorescence. Figure 5.35 shows the results 
of this binding experiment with binding isotherms for both MIP and NIP. 
 
Chapter Five: Microwave-initiated polymerisation 
 
264 
 
 
Figure 5.35: Binding isotherms for BC MIP and NIP showing 
the amount of BC bound to polymer (nmol per mg of 
polymer) at µM free concentrations of BC.  
The two binding isotherms shown in figure 5.35 demonstrated markedly 
different morphology. The curved isotherm for MIP binding is compared to 
a straight-line for NIP binding. The derived binding performance data for 
MIP binding were as follows: Bmax: 0.014 nmol/mg polymer and Kd:     1.217 
µM (analysis of binding performance data was carried out with GraphPad 
Prism® V8 software from single-site specific binding curve fitting 
algorithm). The binding results for NIP showed a linear isotherm from 
which binding performance parameters could not be derived; results for 
NIP were therefore suggestive of non-specific binding (unsaturatable 
system) and the result of low affinity binding sites in abundance. This is in 
comparison to the curved isotherm seen for MIP/BC interaction, which 
suggests the presence of binding sites within the MIP bead.  
However, interpretation of these results are somewhat guarded for two 
main reasons. Firstly, wide error bars are apparent (for NIP more than MIP) 
and secondly, investigating results at lower concentrations would be 
desirable. Nevertheless, results shown in figure 5.35 are encouraging; they 
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indicate a difference in the binding capability of the two differently 
manufactured polymers and indicate the ability of a MIP produced in a 
novel MF/microwave system to bind its original target molecule. 
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5.5 Chapter conclusions 
Presented here are several approaches to circumvent problems 
encountered in the molecular imprinting of a complex molecule. The 
molecular imprinting process had moved towards self assembly of 
template and functional monomers at a liquid/liquid interface, therefore a 
microfluidic system was developed (chapter four) to promote this process. 
The main problem to overcome was initiating polymerisation within 
microfluidic tubing and the development of an integrated MF/microwave 
cavity resonator system for the manufacture of polymer beads is described 
in this chapter. Furthermore, the ability to measure dielectric properties 
whist polymerising samples allowed dynamic dielectric characterisation of 
the polymerisation process. 
This chapter demonstrates the versatility of microwave-initiated 
polymerisation with the combination of microwave heating and 
polymerisation with microfluidics, building on previous work of our partner 
engineering department showing efficient heating of MF systems by 
microwaves (54). In this work Morgan et al. demonstrated efficient heating 
of microfluidic systems with using a high Q cavity resonator, they also 
utilised the sensing capability of the system obtaining permittivity data on 
a range of organic solvents. 
The use of microwave irradiation to assist polymer synthesis is not new; it 
is undertaken on a large scale by groups dedicated to this field of organic 
synthesis chemistry (11,16,104). However, the use of microwave sensing 
applications is relatively underrepresented in the literature considering the 
scale of microwave assisted polymerisation. This chapter documents 
utilisation of microwave resonant cavities to measure polymerisation 
process dynamics on a small scale, alluding to interesting further scope of 
microwave sensing.  
  
Chapter Five: Microwave-initiated polymerisation 
 
267 
 
5.6 References 
1.  Stuerga D. Microwave–Materials Interactions and Dielectric 
Properties: From Molecules and Macromolecules to Solids and 
Colloidal Suspensions. In: Microwaves in Organic Synthesis. Wiley-VCH 
Verlag GmbH & Co. KGaA; 2012. p. 1–56.  
2.  Gawande MB, Shelke SN, Zboril R, Varma RS. Microwave-Assisted 
Chemistry: Synthetic Applications for Rapid Assembly of 
Nanomaterials and Organics. Acc Chem Res. 2014 Apr 15;47(4):1338–
48.  
3.  Wiesbrock F, Hoogenboom R, Schubert US. Microwave-Assisted 
Polymer Synthesis: State-of-the-Art and Future Perspectives. 
Macromol Rapid Commun. 2004;25(20):1739–1764.  
4.  Thostenson ET, Chou T-W. Microwave processing: fundamentals and 
applications. Compos Part Appl Sci Manuf. 1999 Sep;30(9):1055–71.  
5.  Hoz A de la, Díaz-Ortiz Á, Moreno A. Microwaves in organic synthesis. 
Thermal and non-thermal microwave effects. Chem Soc Rev. 2005 Jan 
25;34(2):164–78.  
6.  Lew A, Krutzik PO, Hart ME, Chamberlin AR. Increasing Rates of 
Reaction:  Microwave-Assisted Organic Synthesis for Combinatorial 
Chemistry. J Comb Chem. 2002 Mar 1;4(2):95–105.  
7.  Tierney J, Lidström P. Microwave Assisted Organic Synthesis. John 
Wiley & Sons; 2009. 293 p.  
8.  Razzaq T, Kappe CO. On the energy efficiency of microwave-assisted 
organic reactions. ChemSusChem. 2008;1(1–2):123–32.  
9.  Johnston K, Pavuluri SK, Leonard MT, Desmulliez MPY, Arrighi V. 
Microwave and thermal curing of an epoxy resin for microelectronic 
applications. Thermochim Acta. 2015 Sep 20;616:100–9.  
10.  Koopmans C, Iannelli M, Kerep P, Klink M, Schmitz S, Sinnwell S, et al. 
Microwave-assisted polymer chemistry: Heck-reaction, 
transesterification, Baeyer–Villiger oxidation, oxazoline 
polymerization, acrylamides, and porous materials. Tetrahedron. 2006 
May 8;62(19):4709–14.  
11.  Kappe CO. Controlled microwave heating in modern organic synthesis. 
Angew Chem Int Ed Engl. 2004 Nov 26;43(46):6250–84.  
Chapter Five: Microwave-initiated polymerisation 
 
268 
 
12.  Sosnik A, Gotelli G, Abraham GA. Microwave-assisted polymer 
synthesis (MAPS) as a tool in biomaterials science: How new and how 
powerful. Prog Polym Sci. 2011 Aug;36(8):1050–78.  
13.  Villemin D, Thibault-Starzyk F. Domestic microwave ovens in the 
laboratory. J Chem Educ. 1991 Apr 1;68(4):346.  
14.  Kappe CO, Stadler A. Equipment Review. In: Microwaves in Organic 
and Medicinal Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA; 2005. 
p. 29–55.  
15.  Lidström P, Tierney J, Wathey B, Westman J. Microwave assisted 
organic synthesis—a review. Tetrahedron. 2001 Nov 5;57(45):9225–
83.  
16.  Raner KD, Strauss CR, Trainor RW, Thorn JS. A New Microwave 
Reactor for Batchwise Organic Synthesis. J Org Chem. 1995 Apr 
1;60(8):2456–60.  
17.  Kappe CO, Stadler A. Introduction: Microwave Synthesis in 
Perspective. In: Microwaves in Organic and Medicinal Chemistry. 
Wiley-VCH Verlag GmbH & Co. KGaA; 2005. p. 1–7.  
18.  Ondruschka B, Bonrath W, Stuerga D. Devlopment and design of 
reactors on microwave-assited chemistry. In: Microwaves in Organic 
Synthesis. Wiley-VCH Verlag GmbH & Co. KGaA; 2012. p. 57–126.  
19.  Kappe CO, Stadler A. Microwave Theory. In: Microwaves in Organic 
and Medicinal Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA; 2005. 
p. 9–28.  
20.  Subramanian V, Sobhanadri J. New approach of measuring the Q 
factor of a microwave cavity using the cavity perturbation technique. 
Rev Sci Instrum. 1994 Feb 1;65(2):453–5.  
21.  Mishra RR, Sharma AK. Microwave–material interaction phenomena: 
Heating mechanisms, challenges and opportunities in material 
processing. Compos Part Appl Sci Manuf. 2016 Feb;81:78–97.  
22.  Kappe CO, Stadler A. Microwave Theory. In: Microwaves in Organic 
and Medicinal Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA; 2005. 
p. 9–28.  
23.  Gabriel C, Gabriel S, Grant EH, Grant EH, Halstead BSJ, Mingos DMP. 
Dielectric parameters relevant to microwave dielectric heating. Chem 
Soc Rev. 1998 Jan 1;27(3):213–24.  
Chapter Five: Microwave-initiated polymerisation 
 
269 
 
24.  Carter RG. Accuracy of microwave cavity perturbation measurements. 
IEEE Trans Microw Theory Tech. 2001;49(5):918–23.  
25.  Kraszewski AW, Nelson SO. Observations on resonant cavity 
perturbation by dielectric objects. IEEE Trans Microw Theory Tech. 
1992 Jan;40(1):151–5.  
26.  Waldron RA. Perturbation theory of resonant cavities. Proc IEE Part C 
Monogr. 1960;107(12):272.  
27.  Blakey RT, Mason A, Al-Shamma’a A. Dielectric Characterisation of 
Lipid Droplet Suspensions Using the Small Perturbation Technique. In: 
Advancement in Sensing Technology. Springer Berlin Heidelberg; 
2013. p. 81–91.  
28.  Huo Y, Bansal R, Zhu Q. Modeling of noninvasive microwave 
characterization of breast tumors. IEEE Trans Biomed Eng. 2004 
Jul;51(7):1089–94.  
29.  Lazebnik M, Popovic D, McCartney L, Watkins CB, Lindstrom MJ, 
Josephine Harter, et al. A large-scale study of the ultrawideband 
microwave dielectric properties of normal, benign and malignant 
breast tissues obtained from cancer surgeries. Phys Med Biol. 
2007;52(20):6093.  
30.  Castles F, Isakov D, Lui A, Lei Q, Dancer CEJ, Wang Y, et al. Microwave 
dielectric characterisation of 3D-printed BaTiO3/ABS polymer 
composites. Sci Rep. 2016 Mar 4;6:srep22714.  
31.  Massoni E, Silvestri L, Bozzi M, Perregrini L, Alaimo G, Marconi S, et al. 
Characterization of 3D-printed dielectric substrates with different infill 
for microwave applications. In: 2016 IEEE MTT-S International 
Microwave Workshop Series on Advanced Materials and Processes for 
RF and THz Applications (IMWS-AMP). 2016. p. 1–4.  
32.  Brosseau C, Quéffélec P, Talbot P. Microwave characterization of filled 
polymers. J Appl Phys. 2001 Mar 30;89(8):4532–40.  
33.  Rowe DJ, Porch A, Barrow DA, Allender CJ. Microfluidic device for 
compositional analysis of solvent systems at microwave frequencies. 
Sens Actuators B Chem. 2012 Jul 5;169:213–21.  
34.  Rowe DJ, Porch A, Barrow DA, Allender CJ. Microfluidic Microwave 
Sensor for Simultaneous Dielectric and Magnetic Characterization. 
IEEE Trans Microw Theory Tech. 2013 Jan;61(1):234–43.  
Chapter Five: Microwave-initiated polymerisation 
 
270 
 
35.  Hoogenboom R, Schubert US. Microwave-Assisted Polymer Synthesis: 
Recent Developments in a Rapidly Expanding Field of Research. 
Macromol Rapid Commun. 2007 Feb 19;28(4):368–86.  
36.  Hoogenboom R, Schubert US. Microwave-Assisted Polymer Synthesis: 
Recent Developments in a Rapidly Expanding Field of Research. 
Macromol Rapid Commun. 2007 Feb 19;28(4):368–86.  
37.  Singh V, Tiwari A, Kumari P, Sharma AK. Microwave accelerated 
synthesis and characterization of poly(acrylamide). J Appl Polym Sci. 
2007 Jun 15;104(6):3702–7.  
38.  Zhao Z, Li Z, Xia Q, Xi H, Lin Y. Fast synthesis of temperature-sensitive 
PNIPAAm hydrogels by microwave irradiation. Eur Polym J. 2008 
Apr;44(4):1217–24.  
39.  Stange H, Ishaque M, Niessner N, Pepers M, Greiner A. Microwave-
Assisted Free Radical Polymerizations and Copolymerizations of 
Styrene and Methyl Methacrylate. Macromol Rapid Commun. 2006 
Jan 23;27(2):156–61.  
40.  Holtze C, Antonietti M, Tauer K. Ultrafast Conversion and Molecular 
Weight Control through Temperature Programming in Microwave-
Induced Miniemulsion Polymerization. Macromolecules. 2006 Aug 
1;39(17):5720–8.  
41.  Zhu X, Chen J, Zhou N, Cheng Z, Lu J. Emulsion polymerization of 
methyl methacrylate under pulsed microwave irradiation. Eur Polym J. 
2003 Jun;39(6):1187–93.  
42.  Gao J, Wu C. Modified Structural Model for Predicting Particle Size in 
the Microemulsion and Emulsion Polymerization of Styrene under 
Microwave Irradiation. Langmuir. 2005 Jan 1;21(2):782–5.  
43.  Sierra J, Palacios J, Vivaldo‐Lima E. Effect of Microwave Activation on 
Polymerization Rate and Molecular Weight Development in Emulsion 
Polymerization of Methyl Methacrylate. J Macromol Sci Part A. 2006 
Mar 1;43(3):589–600.  
44.  Wu H, Li F, Lin Y, Yang M, Chen W, Cai R. Synthesis of telechelic C60 
end-capped polymers under microwave irradiation. J Appl Polym Sci. 
2006 Feb 5;99(3):828–34.  
45.  Assem Y, Greiner A, Agarwal S. Microwave-Assisted Controlled Ring-
Closing Cyclopolymerization of Diallyldimethylammonium Chloride Via 
the RAFT Process. Macromol Rapid Commun. 2007 Sep 18;28(18–
19):1923–8.  
Chapter Five: Microwave-initiated polymerisation 
 
271 
 
46.  Turner NW, Holdsworth CI, Donne SW, McCluskey A, Bowyer MC. 
Microwave induced MIP synthesis: comparative analysis of thermal 
and microwave induced polymerisation of caffeine imprinted 
polymers. New J Chem. 2010 Apr 1;34(4):686–92.  
47.  Schwarz LJ, Potdar MK, Danylec B, Boysen RI, Hearn MTW. 
Microwave-assisted synthesis of resveratrol imprinted polymers with 
enhanced selectivity. Anal Methods. 2014 Dec 12;7(1):150–4.  
48.  Hou J, Li H, Wang L, Zhang P, Zhou T, Ding H, et al. Rapid microwave-
assisted synthesis of molecularly imprinted polymers on carbon 
quantum dots for fluorescent sensing of tetracycline in milk. Talanta. 
2016 Jan 1;146:34–40.  
49.  He P, Haswell SJ, Fletcher PDI, Kelly SM, Mansfield A. Scaling up of 
continuous-flow, microwave-assisted, organic reactions by varying the 
size of Pd-functionalized catalytic monoliths. Beilstein J Org Chem. 
2011 Aug 23;7:1150–7.  
50.  Jachuck RJJ, Selvaraj DK, Varma RS. Process intensification: oxidation 
of benzyl alcohol using a continuous isothermal reactor under 
microwave irradiation. Green Chem. 2006 Dec 23;8(1):29–33.  
51.  Kunz U, Kirschning A, Wen H-L, Solodenko W, Cecilia R, Kappe CO, et 
al. Monolithic polymer/carrier materials: Versatile composites for fine 
chemical synthesis. Catal Today. 2005 Aug 15;105(3–4):318–24.  
52.  Comer E, Organ MG. A Microcapillary System for Simultaneous, 
Parallel Microwave-Assisted Synthesis. Chem – Eur J. 2005 Dec 
9;11(24):7223–7.  
53.  Comer E, Organ MG. A Microreactor for Microwave-Assisted Capillary 
(Continuous Flow) Organic Synthesis. J Am Chem Soc. 2005 Jun 
1;127(22):8160–7.  
54.  Morgan AJL, Naylon J, Gooding S, John C, Squires O, Lees J, et al. 
Efficient microwave heating of microfluidic systems. Sens Actuators B 
Chem. 2013 May;181:904–9.  
55.  Chretiennot T, Dubuc D, Grenier K. A Microwave and Microfluidic 
Planar Resonator for Efficient and Accurate Complex Permittivity 
Characterization of Aqueous Solutions. IEEE Trans Microw Theory 
Tech. 2013 Feb;61(2):972–8.  
56.  Mani KB, Hossan MR, Dutta P. Thermal analysis of microwave assisted 
bonding of poly(methyl methacrylate) substrates in microfluidic 
devices. Int J Heat Mass Transf. 2013 Mar 1;58(1):229–39.  
Chapter Five: Microwave-initiated polymerisation 
 
272 
 
57.  Li H, Multari C, Palego C, Ma X, Du X, Ning Y, et al. Differentiation of 
live and heat-killed E. coli by microwave impedance spectroscopy. 
Sens Actuators B Chem. 2018 Feb 1;255(Part 2):1614–22.  
58.  Nerguizian V, Alazzam A, Stiharu I, Burnier M. Characterization of 
several cancer cell lines at microwave frequencies. Measurement. 
2017 Oct 1;109:354–8.  
59.  Nikolic-Jaric M, Romanuik SF, Ferrier GA, Bridges GE, Butler M, Sunley 
K, et al. Microwave frequency sensor for detection of biological cells 
in microfluidic channels. Biomicrofluidics. 2009 Sep 1;3(3):034103.  
60.  Boybay MS, Jiao A, Glawdel T, Ren CL. Microwave sensing and heating 
of individual droplets in microfluidic devices. Lab Chip. 2013 Oct 
7;13(19):3840–6.  
61.  Koziej D, Floryan C, Sperling RA, Ehrlicher AJ, Issadore D, Westervelt R, 
et al. Microwave dielectric heating of non-aqueous droplets in a 
microfluidic device for nanoparticle synthesis. Nanoscale. 2013 Jun 
21;5(12):5468–75.  
62.  Stuerga D, Pribetich P. Key Ingredients for Mastery of Chemical 
Microwave Processes. In: Microwaves in Organic Synthesis. Wiley-VCH 
Verlag GmbH & Co. KGaA; 2012. p. 105–26.  
63.  Hansen CM. The Universality of the Solubility Parameter. Prod RD. 
1969 Mar 1;8(1):2–11.  
64.  Barwick VJ. Strategies for solvent selection — a literature review. TrAC 
Trends Anal Chem. 1997 Jun;16(6):293–309.  
65.  Snyder LR. Classification of the solvent properties of common liquids. 
J Chromatogr A. 1974 May 22;92(2):223–30.  
66.  Reichardt C, Welton T. Solvents and Solvent Effects in Organic 
Chemistry. John Wiley & Sons; 2011. 425 p.  
67.  Kappe CO. Microwave dielectric heating in synthetic organic 
chemistry. Chem Soc Rev. 2008 May 22;37(6):1127–39.  
68.  Van der Eycken E, Appukkuttan P, De Borggraeve W, Dehaen W, 
Dallinger D, Kappe CO. High-Speed Microwave-Promoted Hetero-
Diels−Alder Reactions of 2(1H)-Pyrazinones in Ionic Liquid Doped 
Solvents. J Org Chem. 2002 Nov 1;67(22):7904–7.  
69.  Chemat F, Esveld E. Microwave Super-Heated Boiling of Organic 
Liquids: Origin, Effect and Application. Chem Eng Technol. 2001 Jul 
1;24(7):735–44.  
Chapter Five: Microwave-initiated polymerisation 
 
273 
 
70.  Marstokk K-M, Møllendal H, Samdal S. Microwave spectrum, 
conformational equilibrium, 14N quadrupole coupling constants, 
dipole moment, vibrational frequencies and quantum chemical 
calculations for acrylamide. J Mol Struct. 2000 Jun 13;524(1–3):69–85.  
71.  Kappe CO, Pieber B, Dallinger D. Microwave Effects in Organic 
Synthesis: Myth or Reality? Angew Chem Int Ed. 2013 Jan 
21;52(4):1088–94.  
72.  Herrero MA, Kremsner JM, Kappe CO. Nonthermal Microwave Effects 
Revisited:  On the Importance of Internal Temperature Monitoring 
and Agitation in Microwave Chemistry. J Org Chem. 2008 Jan 
1;73(1):36–47.  
73.  Werber J, Wang YJ, Milligan M, Li X, Ji JA. Analysis of 2,2’-Azobis (2-
Amidinopropane) Dihydrochloride Degradation and Hydrolysis in 
Aqueous Solutions. J Pharm Sci. 2011 Aug 1;100(8):3307–15.  
74.  Peyrat-Maillard MN, Cuvelier ME, Berset C. Antioxidant activity of 
phenolic compounds in 2,2′-azobis (2-amidinopropane) 
dihydrochloride (AAPH)-induced oxidation: Synergistic and 
antagonistic effects. J Am Oil Chem Soc. 2003 Oct 1;80(10):1007.  
75.  Lyoo Won Seok, Kwak Jin Woo, Choi Kyu Ha, Noh Seok Kyun. 
Preparation of high molecular weight poly(vinyl alcohol) with high 
yield by emulsion polymerization of vinyl acetate using 
2,2′‐azobis(2‐amidinopropane) dihydrochloride. J Appl Polym Sci. 
2004 Oct 22;94(6):2356–62.  
76.  Dey RE, Zhong X, Youle PJ, Wang QG, Wimpenny I, Downes S, et al. 
Synthesis and Characterization of Poly(vinylphosphonic acid-co-acrylic 
acid) Copolymers for Application in Bone Tissue Scaffolds. 
Macromolecules. 2016 Apr 12;49(7):2656–62.  
77.  Camli ST, Buyukserin F, Yavuz MS, Budak GG. Fine-tuning of functional 
poly(methylmethacrylate) nanoparticle size at the sub-100nm scale 
using surfactant-free emulsion polymerization. Colloids Surf 
Physicochem Eng Asp. 2010 Aug 20;366(1):141–6.  
78.  Li Z, Mak SY, Sauret A, Shum HC. Syringe-pump-induced fluctuation in 
all-aqueous microfluidic system implications for flow rate accuracy. 
Lab Chip. 2014 Jan 21;14(4):744–9.  
79.  Shum HC, Sauret A, Fernandez-Nieves A, Stone HA, Weitz DA. 
Corrugated interfaces in multiphase core-annular flow. Phys Fluids 
1994-Present. 2010 Aug 1;22(8):082002.  
Chapter Five: Microwave-initiated polymerisation 
 
274 
 
80.  Saien J, Akbari S. Interfacial Tension of Toluene + Water + Sodium 
Dodecyl Sulfate from (20 to 50) °C and pH between 4 and 9. J Chem 
Eng Data. 2006 Sep 1;51(5):1832–5.  
81.  Cuenca JA, Slocombe DR, Porch A. Temperature Correction for 
Cylindrical Cavity Perturbation Measurements. IEEE Trans Microw 
Theory Tech. 2017 Jun;65(6):2153–61.  
82.  Molla J, Ibarra A, Margineda J, Zamarro JM, Hernandez A. Dielectric 
property measurement system at cryogenic temperature and 
microwave frequencies. IEEE Trans Instrum Meas. 1993 
Aug;42(4):817–21.  
83.  Eichelbaum M, Stößer R, Karpov A, Dobner C-K, Rosowski F, Trunschke 
A, et al. The microwave cavity perturbation technique for contact-free 
and in situ electrical conductivity measurements in catalysis and 
materials science. Phys Chem Chem Phys. 2011 Dec 14;14(3):1302–12.  
84.  Abu-Thabit NY. Thermochemistry of Acrylamide Polymerization: An 
Illustration of Auto-acceleration and Gel Effect. World J Chem Educ 
World J Chem Educ. 2017 Apr 21;5(3):94–101.  
85.  Kishore K, Santhanalakshmi KN. Thermal polymerization of acrylamide 
by differential scanning calorimetry. J Polym Sci Polym Chem Ed. 1981 
Oct;19(10):2367–75.  
86.  Brown SL, Rayner CM, Perrier S. Microwave-Accelerated RAFT 
Polymerization of Polar Monomers. Macromol Rapid Commun. 2007 
Feb 19;28(4):478–83.  
87.  Lucchese L, Liauw CM, Allen NS, Edge M, Thompson F, Whitehouse RS. 
Use of microwave dielectric loss for characterisation of natural 
rubber/carbon black composites. Polym Bull. 2000 Mar 1;44(2):187–
94.  
88.  Templeton A, Wang X, Penn SJ, Webb SJ, Cohen LF, Alford NM. 
Microwave Dielectric Loss of Titanium Oxide. J Am Ceram Soc. 2000 
Jan 1;83(1):95–100.  
89.  Ferreira VM, Baptista JL, Kamba S, Petzelt J. Dielectric spectroscopy of 
MgTiO3-based ceramics in the 109–1014Hz region. J Mater Sci. 1993 
Jan;28(21):5894–900.  
90.  Nelson SO, Guo W, Trabelsi S, Kays SJ. Dielectric spectroscopy of 
watermelons for quality sensing. Meas Sci Technol. 2007;18(7):1887.  
Chapter Five: Microwave-initiated polymerisation 
 
275 
 
91.  Castro-Giráldez M, Aristoy M-C, Toldrá F, Fito P. Microwave dielectric 
spectroscopy for the determination of pork meat quality. Food Res 
Int. 2010 Dec;43(10):2369–77.  
92.  Jha SN, Narsaiah K, Basediya AL, Sharma R, Jaiswal P, Kumar R, et al. 
Measurement techniques and application of electrical properties for 
nondestructive quality evaluation of foods—a review. J Food Sci 
Technol. 2011 Feb 18;48(4):387–411.  
93.  Li H, Liu G, Liu B, Chen W, Chen S. Dielectric properties of 
polyimide/Al2O3 hybrids synthesized by in-situ polymerization. Mater 
Lett. 2007 Mar;61(7):1507–11.  
94.  Xie L, Huang X, Wu C, Jiang P. Core-shell structured poly(methyl 
methacrylate)/BaTiO3 nanocomposites prepared by in situ atom 
transfer radical polymerization: a route to high dielectric constant 
materials with the inherent low loss of the base polymer. J Mater 
Chem. 2011 Apr 5;21(16):5897–906.  
95.  Lu J, Moon K-S, Kim B-K, Wong CP. High dielectric constant 
polyaniline/epoxy composites via in situ polymerization for embedded 
capacitor applications. Polymer. 2007 Mar 8;48(6):1510–6.  
96.  Karumbamkandathil A, Ghosh S, Anand U, Saha P, Mukherjee M, 
Mukherjee S. Micelles of Benzethonium Chloride undergoes spherical 
to cylindrical shape transformation: An intrinsic fluorescence and 
calorimetric approach. Chem Phys Lett. 2014 Feb 11;593:115–21.  
97.  Nedjhioui M, Moulai-Mostefa N, Morsli A, Bensmaili A. Combined 
effects of polymer/surfactant/oil/alkali on physical chemical 
properties. Desalination. 2005 Nov;185(1–3):543–50.  
98.  Dong Y, Sundberg DC. Estimation of polymer/water interfacial 
tensions: hydrophobic homopolymer/water interfaces. J Colloid 
Interface Sci. 2003 Feb 1;258(1):97–101.  
99.  La Mesa C. Polymer–surfactant and protein–surfactant interactions. J 
Colloid Interface Sci. 2005 Jun;286(1):148–57.  
100.  Tugay AV, Zakordonskiy VP. Regularities in the association of 
polymethacrylic acid with benzethonium chloride in aqueous 
solutions. Russ J Phys Chem. 2006 Jun;80(6):909–14.  
101.  Khan MY, Samanta A, Ojha K, Mandal A. Interaction between aqueous 
solutions of polymer and surfactant and its effect on physicochemical 
properties. Asia-Pac J Chem Eng. 2008 Sep 1;3(5):579–85.  
Chapter Five: Microwave-initiated polymerisation 
 
276 
 
102.  Rosen MJ, Kunjappu JT. Surfactants and Interfacial Phenomena. John 
Wiley & Sons; 2012. 618 p.  
103.  Lukáč M, Pisárčik M, Lacko I, Devínsky F. Surface-active properties of 
nitrogen heterocyclic and dialkylamino derivates of 
hexadecylphosphocholine and cetyltrimethylammonium bromide. J 
Colloid Interface Sci. 2010 Jul 15;347(2):233–40.  
104.  Kappe CO, Dallinger D, Murphree SS. Practical Microwave Synthesis 
for Organic Chemists: Strategies, Instruments, and Protocols. John 
Wiley & Sons; 2008. 312 p.  
 
Chapter Six: General Discussion and Conclusions 
277 
 
Chapter 6. General Discussion and 
Conclusions 
 
 
  
Chapter Six: General Discussion and Conclusions 
278 
 
6.1 Background 
Mankind has been trying to outsmart microscopic pathogens for millennia. 
Even prior to any notion of bacteria and viruses, medicine and science has 
been familiar with the signs and symptoms of severe infection. However, 
despite the scientific advancements since our ancestors, people still die 
due to infectious causes. Sepsis, the deregulated host response to infection 
(1), affects over 30 million people globally per year (2) and poses a 
significant economic burden for healthcare systems worldwide. Clinicians 
have biomarkers to help diagnose and monitor therapy for a range of 
maladies, troponin and Brain Natriuretic Peptide (BNP) in heart disease or 
Prostate Specific Antigen (PSA) in prostate cancer, for example. However, 
no such impactful biomarker is available for the diagnosis of sepsis. 
Therefore, there is an unmet clinical need that warrants investigation of 
sepsis syndrome biomarkers.  
The focus of this work was lipopolysaccharide and its potential as a 
biomarker for sepsis. Novel ways of facilitating the molecular imprinting of 
LPS were investigated and lead to extensive work with microwave-initiated 
polymerisation strategies. However, significant hurdles were met along the 
way and these are further explored in section 6.3. 
Polymyxin is a versatile peptide antibiotic and it features heavily in this 
work. It is an antibiotic of interest to a few key research groups who have 
produced vast bodies of work looking at the molecular basis of polymyxin 
resistance (3), the structural manipulation of PMB to give PMB 
nonapeptide (4,5) and the investigation of current clinical PMB use (6). 
Furthermore, the extracorporeal removal of endotoxin in sepsis is an 
ongoing area of investigation. However, clinical trials of extracorporeal 
PMB cartridges have not provided a robust case for the widespread use of 
this therapy in sepsis (7–10). This highlights an ongoing problem with large, 
multi centred, randomised control trials in sepsis; casting the net too wide 
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over a whole spectrum of patients with sepsis could be the downfall of 
effective interventions that would benefit a small subsection of these 
patients. Endotoxin removal strategies may only be of benefit in the sickest 
of patients with sepsis and therefore be reserved for this cohort.  
Despite the high morbidity and mortality rates caused by Gram positive 
infection (11), there has been a recent surge in multi drug resistant strains 
of Gram negative organisms (11). For example, the number of Carbapenem 
resistant enterobacteriaceae (CRE) infections is rising globally (12,13). In 
2002 there were 3 recorded cases of CRE in the UK compared to over 2000 
cases in 2015 (14). Incidentally, polymyxin B is considered to be one of the 
most effective treatments for CRE (15). Furthermore, antimicrobial 
resistance is a major global concern (16) and it is conceivable we will have 
no effective antimicrobials in the future with which to fight pathogens. 
Therefore, maybe a paradigm shift away from antibiotics to alternative 
approaches such as extracorporeal sequestration of pathogens should be 
considered for the treatment of sepsis. 
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6.2 Thesis synopsis 
Described herein was the step-wise approach to the molecular imprinting 
of a complex biomacromolecule via adaptation of conventional imprinting 
techniques. Experimental chapters described the advance from imprinting 
on a solid Merrifield resin support, to imprinting at a liquid/liquid interface. 
This process involved the integration of microfluidic and microwave 
technologies and the modification of polymyxin B. Referring back to the 
summary diagram shown in chapter one, Figure 6.1 explains the thesis path 
from chapter two to chapter five. Novel elements of this work are 
indicated. Limitations of the work are expanded on in section 6.3. 
 
Figure 6.1: Simplified pathway diagram for experimental work  
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Chapter two described initial molecular imprinting experiments. Using a 
solid resin support, the immobilisation of polymyxin was a vital stage in this 
work and the high affinity of polymyxin B for LPS was utilised. Results from 
this chapter were mixed and overall the successful synthesis of an efficient 
detection system for LPS using surface imprinting on Merrifield resin was 
not demonstrated. Part of the problem was using a solid support and 
therefore the remainder of experimental work moved away from using 
surface imprinting at a solid/liquid interface. 
Without the resin as a backbone, it was desirable that PMB integrated into 
a polymer therefore producing a standalone molecularly imprinted 
polymer bead. This process was outlined in chapter three and two main 
routes for the synthesis of a polymerisable PMB were described. The 
interaction of PMB and LPS relies on a delicate balance of charges to 
promote electrostatic interaction of PMB and the lipid A portion of LPS 
(17,18). Attaching methacrylate moieties to PMB involved the same free 
amine groups that impart an overall positive charge, therefore some of 
these free amine groups had to be preserved and one route was more 
efficient than the other at achieving this. Reasonable binding data were 
demonstrated using a p-PMB polymer from the glycidyl methacrylate 
experimental arm.  
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Table 6.1 compares the main synthesised products from chapters two and 
three and their respective LPS binding capability. 
Table 6.1: Table comparing the major products from chapters 
two and three and their respective binding abil ity to LPS.   
* azide molar equivalence to chloride (2 mmol/g resin)  
** monomer composition: p -PMBG MA  0.74 mmol, acrylamide  
3 mmol, N’N - methylenebisacrylamide 0.3 mmol;  
***monomer composition: p -PMBG MA  0.74 mmol, acrylamide  
2 mmol, N’N - methylenebisacrylamide 0.5 mmol.  
Chapter Product 
 
Bmax nmol/mg 
product 
 
Kd µM 
Chapter 2: 
azidomethyl resin plus 
PMB 
 
0.5 molar 
equivalent 
azidomethyl 
resin* 
0.103 0.328 
 
1 molar 
equivalent 
azidomethyl 
resin* 
0.216 0.950 
Chapter 3: p-PMBGMA 
polymer (glycidyl 
methacrylate route) 
 
p-PMB polymer 
composition A** 
0.069 0.327 
 
p-PMB polymer 
composition B*** 
0.133 0.074 
 
Chapter four described the manufacture of a microfluidic system designed 
to generate segmented flow of two immiscible fluids at a t-junction. 
Thereafter, chapter five described microwave-initiated polymerisation via 
the institution of a microwave delivery protocol. Furthermore, the use of a 
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microwave resonator cavity allowed the rational choice of organic phase 
solvent (comparing chloroform and toluene) and also the tracking of 
polymerisation using microwave sensing.  
Chapter five ended with benzethonium chloride experiments. Acting as a 
LPS surrogate, benzethonium chloride was used as a template in a 
molecular imprinting process within the integrated microfluidic and 
microwave system. Subsequent binding experiments demonstrate ability of 
the produced benzethonium chloride imprinted bead to bind to the original 
template with a Bmax of 0.014 nmol per mg product and a Kd of 0.536 µM. 
Since completion of experimental work for this thesis, microwave-initiated 
polymerisation in the process of MIT continues to be exploited by 
researchers to manufacture MIPs (19,20). Furthermore, in a time when the 
environmental impact of much human activity is under scrutiny, the use of 
microwave-assisted organic synthesis offers a more efficient (and therefore 
energy saving) way of synthesising polymers. This notion of microwave-
assisted polymerisation as part of a ‘green chemistry’ strategy has recently 
been reviewed (21). This environmental consideration supplements other 
advantages of using microwave-assisted organic synthesis, strengthening 
its appeal for use to manufacture MIPS.  
Advances in sepsis research continually add potential biomarker candidates 
to the diverse set already under investigation. For example, in early 2019, 
Yamamoto et al. published work on Presepsin, a biomarker that has 
previously been the subject of both meta-analysis and laboratory-based 
work (22,23). Presepsin is the N-terminal fragment of the soluble CD14 
glycoprotein that is expressed by certain immune cells and has a central 
role in LPS recognition. Yamamoto et al. showed a potential value of 
presepsin in the diagnosis of sepsis, demonstrating better diagnostic value 
than other studies looking at procalcitonin have demonstrated (22). Also in 
early 2019, Castello et al. Published investigative work on the extracellular 
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matrix protein osteopontin. This reasonably sized (102 patients) single 
centre study, demonstrated a further complexity of biomarker research. 
They showed that osteopontin had reasonable diagnostic value for patients 
with sepsis in an emergency medicine setting; however, it had poor 
prognostic value (24).  
Sepsis biomarker research therefore continues to re-iterate how 
increasingly unlikely it is we will discover just one key biomarker to 
facilitate the early detection of sepsis, and potentially a completely new set 
of biomarkers will be required to prognosticate. 
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6.3 Limitations and development 
Results from chapter two highlighted issues with Merrifield resin 
experiments that required aqueous conditions. Despite the addition of a 
hydrophilic iniferter, the behaviour of Merrifield resin in water was 
undesirable and, for example, the chapter demonstrated poor iniferter 
loading onto modified Merrifield resin in aqueous conditions. Experimental 
findings such as this were the main push towards an alternative approach 
to imprinting that negated the use of a solid support. 
Purchased FITC labelled LPS was used in this work in several binding 
studies. However, FITC labelled LPS (Sigma Aldrich) has limitations owing to 
the FTIC labelling efficiency. If the molecular weight of LPS is assumed to be 
10,000 g mol-1 approximately one in ten LPS molecules are labelled. 
Alternative labelling techniques have been described including a method 
for labelling with quantum dots (25) and also labelling with Alexa 488 
hydrazide;  a described method of which was capable of generating highly 
fluorescent LPS conjugates (26). Increased detection ability may have been 
possible by using alterative LPS probes to demonstrate binding with both 
Merrifield resin composites in chapter two and p-PMB polymers in chapter 
three. 
In chapter three, Merrifield resin experiments had been abandoned and 
polymyxin was the focus. However, this work was on a small scale. In 
general, yields of p-PMB product were poor and the purification processes 
relatively inefficient. Furthermore, detailed characterisation of synthesised 
polymers was lacking. Possible further desirable steps include FTIR analysis 
of p-PMB polymers and matched (plain) polymers plus characterisation and 
analysis of any residual monomers from p-PMB synthesisis reactions. 
However, this chapter highlighted a potential method for the synthesis of 
methacrylate polymyxin, it would be interesting to carry out this synthesis 
on a larger scale and investigate the potential for manufacturing a 
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polymerisable polymyxin film coating. This would provide an interesting 
insight into this alternative method of coating extracorporeal circuits for 
the removal of endotoxin. 
Chapters four and five can be thought of as one body of work, with chapter 
four introducing the system development explored further in chapter five. 
Both chapters explored the potential for microfluidic/microwave 
integration in the manufacture of polymer beads and the potential for 
liquid/liquid interface surface imprinting. However, the suitability of 
benzethonium chloride use could be seen as an experimental limitation. 
There are obvious differences in the structure of lipopolysaccharide and 
benzethonium chloride; however the amphipathic nature of the two 
molecules is an important similarity. Furthermore, the availability and 
economic considerations of using a surrogate molecule for fluorescently 
labelled LPS were important. Considering this background, the proof-of-
concept benzethonium chloride studies described in Chapter five have 
merit in the testing of a novel hybrid microfluidic/ microwave system. 
Moreover, a significant limitation of this work is the lack of p-PMB polymer 
utilisation in microfluidic/microwave experiments. The explanation hinges 
on poor yield and therefore availability of p-PMB polymer in significant 
quantity for ongoing work. Certainly, if improvements were made to the 
synthesis process for p-PMB, it would be interesting to see how it behaved 
in the MF system. 
Furthermore, the use of alternative UV transparent material could have 
been explored. In section the experiment to initiate polymerisation with 
UV prior to exploring microwave initiated polymerisation is introduced. 
This method was not successful; however, alternative microfluidic tubing 
materials could have been used. For example, glass and quartz tubing are 
UV transparent; however, several attempts were made to use glass tubing 
(not documented in experimental sections) and difficultly was encountered 
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in the suitability of connecting components of the fluidic system. COC 
(cyclic olefin copolymer) tubing is another alternative and has superior 
optical properties (27). Synthesized from the polymerisation of cyclic olefin 
monomers and ethene, successful combinational approaches of COC 
tubing and UV initiated polymerisation have been reported (28). An 
interesting outcome from working with polymerisation and microwaves 
was the exploitation of the sensing capability of microwaves to document 
the polymerisation process. There is potential to explore this further and 
on a larger scale with the tracking of polymerisation of a more diverse 
range of polymers and under a variety of conditions. Microwave sensing is 
an established tool in many engineering and material science disciplines 
and emerging work is also harnessing the detection abilities of microwaves 
combined with molecularly imprinted polymers (27). It would be 
interesting to explore further the benefits of radiofrequency technology in 
the field of molecular imprinting. 
Highlighted in chapter five, section 5.4.4, are the considerations 
surrounding temperature effects on microwave initiated organic synthesis 
reactions. Delineation of observed reaction steps between those caused by 
the electromagnetic radiation and those caused merely by a change in 
temperature is vitally important. Temperature control is therefore a 
fundamental consideration in the design of cavity resonators. Materials 
with high thermal stability can be used and their Coefficient of (linear) 
Thermal Expansion (CTE) taken into consideration (the degree to which a 
material expands on heating) and is measured in ppm/◦C. Aluminium, for 
example, has a CTE of 23 ppm/◦C (30), which is relatively high (titanium 8.5 
ppm/◦C; copper 16.8 ppm/◦C (30)). However, aluminium has other derisible 
characteristics for microwave cavity resonators and therefore 
compensating for any observed cavity dimension effects at any given 
temperature due to its known CTE value can be taken into consideration. 
Furthermore, groups employ methods of microwave irradiation combined 
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with simultaneous cooling, with specifically designed microwave delivery 
devices. Such devices (the CEM-Discover-CoolMate® for example) cool the 
reaction vessel whist the microwave irradiation is applied using 
compressed air or cooling fluid (31). Reactions can then be observed with 
temperatures well below those expected during a microwave initiated 
organic synthesis reaction. Using such devices could be a consideration for 
future work; moreover, optimisation of temperature measurement (using 
exclusively fibreoptic and not infrared devices) is also an important 
consideration. 
Moreover, sensitivity analysis and design of experiements (DOE) is an 
important consideration for chapter five. Detailed in section 5.3.5.1 are the 
set of experiments that were used to establish a protocol for the successful 
polymerisation of beads within a microfluidic system via microwave-
initiated polymerisation. The general conduct of this experiment could 
have been improved with consideration of the fundamental experimental 
design, highlighting a limitation in this chapter. Sensitivity analysis by DOE 
could have been employed considering the number of parameters under 
manipulation; this would have provided a framework to establish the 
parameter with greatest impact on experiment outcomes. Using a 
sensitivity analysis by DOE model, variables that have little impact on 
results could have been dropped from ongoing iterations of the 
microwave-initiated polymerisation protocol (32). Therefore, for any future 
work looking at the polymerisation of beads within my hybrid 
microfluidic/microwave system (using different monomers for example), a 
framework provided by a DOE sensitivity analysis could be employed to 
improve the robustness of experiments.  
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